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ABSTRACT 
 
To better understand how the stem cells respond to environmental 
factors such as diet and carcinogen, we investigated the chemo-protective 
effects of dietary agents (n-3 PUFA and curcumin) on DNA damage response 
in colonic stem cells isolated from Lgr5-EGFP-IRES-CreERT2 knock in mice 
injected with AOM.  We demonstrated that n-3 PUFA and curcumin synergize 
to promote targeted apoptosis of damaged Lgr5+ stem cells in part by 
enhancing p53 signaling in Lgr5+ stem cells at the tumor initiation stage. In 
addition, at the pre-tumor stage of tumorigenesis in colon cancer, we 
demonstrated n-3 PUFA and curcumin combination synergistically reduces 
nuclear -catenin levels in aberrant crypt foci, a surrogate marker of colon 
cancer.  In order to assess the dose-dependency of n-3 PUFA and curcumin 
action, we also calculated the median effective concentration and the Human 
equivalent dose of n-3 PUFA + curcumin required to remove DNA damaged 
Lgr5+ stem cells by targeted apoptosis. 
In order to further elucidate the effects of oncogenesis on the biophysical 
properties of the colonocyte plasma membrane at the pre tumor stage, we 
generated CDX2P-CreERT2-Apc580S/+; KrasLSL-G12D/+ (ACK) transgenic mice. 
Our findings demonstrate for the first time that oncogenic Apc and Kras 
increase plasma membrane order by perturbing cholesterol homeostasis and 
promoting cell proliferation. Genes associated with cholesterol uptake and de 
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novo synthesis of cholesterol are enhanced in ACK mice. This process is 
associated with the upregulation of Myc signaling, a well-known upstream 
mediator of cholesterol homeostasis. Our preliminary findings also indicate that 
the addition of exogenous cholesterol can dose-dependently promote cell 
proliferation in colonic cell lines and mouse colonic organoids. In 
complementary experiments, we also investigated the chemo-protective effects 
of dietary agents on cholesterol homeostasis and plasma membrane order in 
ACK mice. Our findings indicate that perturbed plasma membrane order and 
cholesterol homeostasis is ameliorated by n-3 PUFA + curcumin feeding. 
In summary, our results indicate for the first time that fish oil plus 
curcumin synergistically reduce colon cancer risk in part by modulating (i) p53 
signaling in Lgr5+ stem cells, and (ii) plasma membrane properties implicated 
in the regulation of the colon cancer cells and tumor development. 
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1. INTRODUCTION 
 
1.1 Colon cancer 
 
Colorectal cancer (CRC) is the second leading cause of cancer-related 
death in developed countries, and almost half of the population will develop at 
least one benign intestinal tumor during their lifetime (Jemal et al., 2011). There 
has been a steady decline in the incidence of CRC in patients age 50 years or 
older, but the opposite trend has been observed for young adults. For patients 
20 to 34 years, the incidence rates of localized, regional, and distant colon and 
rectal cancers have increased. An increasing incidence rate was also observed 
for patients with rectal cancer aged 35 to 49 years. Based on current trends, in 
2030, the incidence rates for colon and rectal cancers will increase by 90.0% 
and 124.2%, respectively, in patients 20 to 34 years and by 27.7% and 46.0%, 
respectively, in patients 35 to 49 years (Bailey et al., 2015). Despite recent 
advances in early detection and therapeutic intervention, CRC remains one of 
the most deadly cancers in the United States (Jemal et al., 2011). While surgical 
removal leads to high cure rates of localized disease, metastatic CRCs are 
typically associated with a poor prognosis with the majority of patients dying 
within two years upon diagnosis, resulting in a five-year survival rate of just 10% 
(Markowitz et al., 2002). Therefore, developing strategies for prevention and 
treatment of this pernicious disease is of the utmost importance. Both genetic 
and environmental factors modulate colon cancer risk (Kim et al., 2016a; 
Tomasetti and Vogelstein, 2015; Wu et al., 2016). Additionally, many modifiable 
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factors, including diet, exercise, and smoking play a role in more than 50% of 
colon cancer cases (Beyaz et al., 2016; Kim et al., 2016b).  
 
1.1.1 Histological progression of colon cancer 
Formation of colon cancer is a multi-step process that results from a 
systematic accumulation of both genetic and epigenetic perturbations that 
cause normal colonic epithelial cells to transform and progress into cancer (Di 
Gregorio et al., 1997). Colonic transformation progressing through multiple 
distinct histologically abnormal stages. 
Aberrant crypts foci:  Aberrant crypts foci (ACF) are putative early stage 
biomarkers of colonic carcinogenesis, and consist of hyperplastic epithelium 
(Takayama et al., 1998). ACF are defined as crypts with dysplastic 
microadenomas, with enlarged, elongated, intermittent stratified nuclei with 
loss of polarity, mucin depletion and dysplasia) as defined by (Di Gregorio et 
al., 1997). It currently remains unclear whether ACF serve as precursors for 
human colon cancer, although many studies have shown that ACF incidence 
increases with increased risk factors for colon cancer (Hata et al., 2004; 
Iwamoto et al., 2000; Rudolph et al., 2005). 
Polyps:  Polyps are macroscopic growths of hyperplastic or dysplastic 
cells that can be observed in the colon. Polyps contain a short stalk with a 
raised, nodular foci of hyperplastic epithelium (Di Gregorio et al., 1997). They 
share many of the cellular features of dysplasia but are more nodular and 
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elevated above the surrounding epithelium. Some polyps are innocuous, 
whereas others can develop into cancer. Polyps are classified as either 
hyperplastic, adenomatous, or serrated (Noffsinger, 2009). Hyperplastic polyps 
are traditionally classified as benign lesions.  However, it has been clearly 
demonstrated that adenomatous polyps and adenomas can develop into 
carcinomas subsequent to a well-established accumulation of molecular 
alterations (Vogelstein et al., 1988; Vogelstein et al., 1989).  Recently, it has 
been shown that serrated polyps can also serve as precursors to colon cancer. 
The molecular alterations that contribute to this pathway of tumorigenesis, 
termed the serrated neoplasia pathway, are distinct from those affiliated with 
the adenoma-to-carcinoma conversion (Noffsinger, 2009). Although some 
polyps serve as precursors for cancer, polyps are considered benign growths 
because they have not yet broken through the basement membrane. 
Adenomas: Adenomas are nodular, raised, circumscribed foci of 
neoplastic epithelial cells arising from the mucosa (Di Gregorio et al., 1997). In 
this case, epithelial cells form irregularly branching tortuous glands that do not 
extend beyond the muscularis mucosa. Typically, the stroma contain small 
numbers of neutrophils and lymphocytes (Di Gregorio et al., 1997; Naini and 
Odze, 2013; Suzui et al., 2013). The transformation from adenoma to 
carcinoma takes an average of eight to twelve years, but most adenomas are 
thought to never develop into cancer (Saif and Chu, 2010). 
Carcinoma:  Once one of these abnormal growths breaches the 
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basement membrane and begins infiltrating into the surrounding tissue, it is 
classified as a carcinoma and is considered malignant (Di Gregorio et al., 
1997). Colon carcinomas can penetrate into underlying stromal layers and 
smooth muscle and eventually metastasize to distal locales.  The major site of 
colon cancer metastasis is the liver (Chambers et al., 2002). 
 
1.1.2 Molecular progression of cancer by intrinsic and extrinsic factors 
Early insights into the central role of the genome in cancer development 
emerged in the late nineteenth and early twentieth centuries from studies by 
David von Hansemann and Theodor Boveri (Stratton et al., 2009). Examination 
of dividing cancer cells under the microscope, these pioneers documented the 
presence of bizarre chromosomal aberrations. This led to the proposal that 
cancers are abnormal clones of cells characterized by and caused by 
abnormalities of hereditary material. Following the discovery of DNA as the 
molecular substrate of inheritance (Avery et al., 2000) and determination of its 
structure (Watson and Crick, 1953), this speculation was supported by the 
demonstration that agents that damage DNA and generate mutations can also 
cause cancer (Loeb and Harris, 2008).  
 
1.1.3 Molecular progression of colon cancer by intrinsic factors 
Colorectal tumorigenesis often begins with precursor lesions in the 
colonic epithelium, and is driven by a series of genetic and epigenetic 
alterations (Fearon and Vogelstein, 1990; Vogelstein and Kinzler, 2004). One 
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of the earliest genetic changes is the loss of the Apc tumor suppressor gene, 
which antagonizes β-catenin signaling and is mutated in the majority of CRCs 
(Moran et al., 2010). Another key early event is the activation of the oncogenic 
Kras, which is mutated in over one-third of CRCs (Jancik et al., 2010; 
Vogelstein and Kinzler, 2004). Genetic instability has also been implicated to 
contribute to colorectal tumorigenesis (Grady and Carethers, 2008; Lengauer 
et al., 1997).  
 
1.1.4 Molecular progression of colon cancer by extrinsic factors (alkylating 
agents) 
Alkylating agents are a ubiquitous family of reactive chemicals that 
transfer alkyl carbon groups onto a broad range of biological molecules, 
thereby altering their structure and potentially disrupting their function. 
Alkylating agents are practically unavoidable due to their abundance in the 
environment and within living cells. Major sources of external alkylating agents 
include constituents of air, water and food such as biological byproducts (e.g., 
abiotic plant material) and pollutants (e.g. tobacco smoke and fuel combustion 
products) (Ballschmiter, 2003; Hamilton et al., 2003; Hecht, 1999). Internally, 
alkylating agents can arise as byproducts of oxidative damage or from cellular 
methyl donors such as S-adenosylmethionine, a common cofactor in 
biochemical reactions (Rydberg and Lindahl, 1982; Taverna and Sedgwick, 
1996). Due to the cytotoxic, teratogenic and carcinogenic effects caused by 
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alkylation damage, alkylating agents pose significant threats to human health. 
Azoxymethane (AOM), an alkylating agent, and its metabolic precursor, 
1, 2-dimethylhydrazine (DMH), are commonly used carcinogens to study the 
molecular mechanisms of colon carcinogenesis in rodents (Femia and Caderni, 
2008; Magnuson et al., 2000; Rosenberg et al., 2009). These preferred model 
carcinogens induce colonic tumors that exhibit pathological features known to 
be associated with human sporadic colorectal cancer (Corpet and Pierre, 
2005). DMH and AOM are pro-carcinogens, which require metabolic activation 
by cytochrome P450 (P450) enzymes, primarily CYP2E1 (Sohn et al., 2001). 
DMH undergoes N-oxidation to form AOM, which, upon hydroxylation, yields 
methylazoxymethanol (MAM). MAM is unstable, with a half-life of ∼12 hr. It 
subsequently decomposes to yield formaldehyde and a highly reactive 
methyldiazonium ion, which alkylates the DNA bases, resulting in the formation 
of DNA adducts, including O6-methylguanine (O6-mG) and N7-methylguanine 
(N7-mG) (Rosenberg et al., 2009). Persistence of O6-mG can lead to mutations 
in oncogenes and the initiation of tumorigenesis (Takahashi and Wakabayashi, 
2004).  
The prevailing hypothesis is that the liver plays a critical role in 
DMH/AOM bioactivation in vivo and that the reactive intermediates produced 
by the liver are transported to the colon via the blood or bile to induce 
carcinogenicity (Fiala, 1977; Pozharisski et al., 1975; Zedeck et al., 1977). This 
is a plausible hypothesis, given that the colon generally possesses much lower 
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levels of P450 enzymes, relative to the liver.  
Due to their chemical reactivity as a methylating agent, AOM produce 
significant levels of 7meG, 3meA and O6meG lesions as the primary alkylated 
DNA adducts. Alkylation of oxygen atoms within DNA bases generates the 
important premutagenic lesion O6-methylguanine (O6meG) (6~8%) and, to 
lower extent, O4-methylthymine (0.3%) (Beranek, 1990). Among the oxygen 
atoms of DNA, the O6-position of guanine represents a major site of 
methylation by SN1-type alkylating agents to generate O6meG. Even though 
alkyl lesions are generated to a much lesser extent than N-alkyl adducts, the 
induction of O6meG lesions by alkylating agents is of great biological relevance 
because O6meG can readily mispair with thymine during DNA replication to 
cause many of the mutagenic and cytotoxic biological effects of alkylating 
agents. Alkylating agents can also modify other nitrogen and oxygen atoms in 
DNA besides the aforementioned sites to generate additional toxic and 
mutagenic lesions.  
The major repair mechanisms for alkylation damage include direct DNA 
repair by the AlkB dioxygenase enzyme and the O6-methylguanine-DNA 
methyltransferase (MGMT) repair protein; and by the multistep pathways of 
base excision repair (BER) and nucleotide excision repair (NER). Among these 
repairing mechanisms, MGMT directly repairs O6meG and O6Cl-ethylG lesions 
via transfer of the alkyl group to its active site cysteine residue (Sedgwick et 
al., 2007). If DNA damage is not repaired by MGMT, O6MeG adducts have 
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dramatic biological consequences that include cytotoxicity, mutagenicity, 
clastogenicity and carcinogenicity (Becker et al., 1996; Kaina et al., 1991). 
Owing to their mispairing properties, persistent O6MeG lesions favor the 
incorporation of thymine instead of cytosine, which results in G:C to A:T 
transition mutations (Swann, 1990).  
The formed O6MeG:T mispair is also recognized by the mismatch 
excision repair (MMR) system (Duckett et al., 1996), leading to a variety of 
downstream effects. Upon activation, the MMR system initiates a futile repair 
process that finally results in the generation of DNA single-strand breaks with 
subsequent collapse of the replication fork, giving rise to DNA double-strand 
breaks (DSBs) (Mojas et al., 2007; Ochs and Kaina, 2000). O6MeG-triggered 
DSBs are repaired via homologous recombination, which was shown to 
enhance cell survival at the expense of increased rates of sister chromatid 
exchanges (Roos et al., 2009). Non-repaired DSBs trigger cell death and the 
formation of chromosomal aberrations (Roos et al., 2009). The O6-MeG:T 
mispair leads to apoptotic cell death via DSB formation in the second 
replication cycle following damage induction (Quiros et al., 2010). G:C to A:T 
transition mutations induced by AOM is clinically relevant because AOM hyper-
activates -catenin and Kras signaling, which are dysregulated in sporadic 
colorectal cancer in humans (Hata et al., 2004; Takahashi and Wakabayashi, 
2004).   
Both the homologous recombination (HR) and non-homologous end 
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joining (NHEJ) pathways repair DSBs; HR uses homologous DNA (sister 
chromatids) as a template to resynthesize DNA across the break, which results 
in sister chromatid exchanges (SCEs); whereas, NHEJ joins the DNA ends with 
little or no homology. The translesion DNA synthesis (TLS) pathway uses low-
fidelity DNA polymerases to bypass lesions that stall high-fidelity replicative 
polymerases, thereby alleviating any blocks during DNA replication. 
Importantly, HR generally results in error-free repair, whereas NHEJ and TLS 
are usually error-prone repair mechanisms that can give rise to mutations 
(Deans and West, 2011; Kee and D'Andrea, 2010; Lange et al., 2011).  
Finally, DNA adducts introduced by alkylating agents can compromise 
genome integrity by inducing mutagenesis (promoting cancer induction) and/or 
blocking essential biological processes such as DNA replication and 
transcription (leading to cell death). Moreover, certain lesions can also be 
processed into cytotoxic products that can engage other DNA repair pathways 
or induce programmed cell death. Thus, alkylating agents are able to modify a 
variety of biological molecules to generate a spectrum of lesions that can elicit 
a number of biological effects. 
 
 
1.1.5 Location of colon cancer 
 
Colon cancer can arise in either the right side (proximal) or left side 
(distal) of the colon.  Interestingly, research findings have implicated differing 
genetic alterations as the cause of colonic transformation in left-sided 
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compared to right-sided colorectal cancers (Iacopetta, 2002; Meza et al., 2010; 
Sugai et al., 2006). Microsatellite instability has been shown to be primarily 
located in right-sided cancers, whereas chromosomal instability is more 
common in left-sided colon cancer (Lindblom, 2001). CpG island methylator 
phenotype (CIMP) incidence most often occurs in right-sided colon cancers 
(Hawkins et al., 2002). Furthermore, mutations in Tp53 and Kras genes occur 
predominantly in left-sided carcinomas (Bleeker et al., 2000; Sugai et al., 2006). 
The differences between left- and right-sided colon cancers provide evidence 
for different mechanisms contributing to colonic transformation. 
 
1.1.6 Apc-Kras Molecular progression of colon cancer by intrinsic factors  
 
CRC develops through a series of well-characterized histopathological 
changes resulting from specific mutations in selected oncogenes and tumor 
suppressor genes. At least four sequential genetic changes need to occur to 
ensure CRC evolution (Fearon and Vogelstein, 1990). One oncogene, Kras, as 
well as the tumor suppressor genes adenomatous polyposis coli (Apc), Smad4 
and Tp53, are the main targets of these genetic changes. Of note, mutations in 
the Apc gene are responsible for familial adenomatous polyposis and also have 
a rate-limiting role in the initiation of the majority of sporadic CRCs. The major 
tumor suppressor function of the Apc protein is a negative regulator of Wnt 
signaling, where it forms part of the β-catenin destruction complex, comprising 
Axin, Glycogen synthase kinase-3 beta (Gsk3β) and Casein Kinase 1 (Ck1). 
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Mutations in Apc lead to β-catenin stabilization and, consequently, to the 
deregulation of the Wnt pathway through the activation of T-cell factor (Tcf)/ 
lymphocyte enhancer binding factor (Lef) target genes such as Myc (Gregorieff 
and Clevers, 2005). Approximately, 80% of colon cancers have biallelic Apc 
mutations (Kinzler and Vogelstein, 1996; Sparks et al., 1998), often with 
complete lack of expression from one allele and expression of a truncated form 
from the other. Most of genetically modified mice carrying different mutations 
in the Apc gene (Taketo, 2006) show an intestinal tumor predisposition 
phenotype and develop few to many adenomas. Remarkably, Myc deletion 
suppresses all the phenotypes of the Apc tumor suppressor loss and halts 
intestinal regeneration (Ashton et al., 2010; Sansom et al., 2007). 
Kras is another important and frequently mutated gene during colorectal 
carcinogenesis. Kras mutations are found in 35–42% of CRCs and advanced 
adenomas (Pretlow and Pretlow, 2005; Worthley and Leggett, 2010). Genetic 
and biochemical studies have firmly established the central role of Kras-
dependent signaling in regulating colorectal tumor cell proliferation, growth, 
survival, invasion and metastasis formation (Pretlow and Pretlow, 2005; 
Smakman et al., 2005). The most studied Kras effector pathways are the Raf-
Mek-Erk mitogen-activated protein kinase (MAPK) and the phosphatidylinositol 
3-kinase (PI3K)-AKT effector pathways (Worthley and Leggett, 2010) with 
inhibitors of components of both pathways currently under clinical evaluation 
(Dasari and Messersmith, 2010; Deng et al., 2004; Dienstmann and Tabernero, 
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2011; Ikenoue et al., 2005; Li et al., 2006a). As Kras and Braf mutations are 
mutually exclusive in colorectal tumors (Rajagopalan et al., 2002; Yuen et al., 
2002), aberrant activation of Braf signaling is considered critical for Kras-
mediated colorectal oncogenesis (Yuen et al., 2002). 
 
1.1.7 Myc - oncogene metabolic disease 
 
Multiple studies have used a candidate gene approach to address the 
nature of the Wnt/Tcf4 target gene program in CRC. Among these, Myc (He et 
al., 1998) is an essential component of this program in transformed intestinal 
epithelial cells. The Myc proto-oncogene is aberrantly overexpressed in over 
half of human cancers (Dang, 2012). For example, proto-oncogene Myc is 
overexpressed in approximately 70% of colorectal tumors (Erisman et al., 
1985). It is one of the most frequently amplified oncogenes in human cancers 
and a member of the larger Myc family (Brodeur et al., 1984; Nau et al., 1985). 
Dysregulation of Myc, such as amplification, chromosome translocation or loss 
of upstream repressors, have been detected in many human cancers 
(Beroukhim et al., 2010; He et al., 1998).  
Compelling evidence has underscored the multifaceted role of Myc in 
controlling cancer metabolism. Myc persistently emerges as a global growth 
regulator that drives glucose metabolism, glutamine metabolism, fatty acid 
synthesis, oxidative phosphorylation, nucleotide synthesis and ribosomal 
biogenesis (Hsieh et al., 2015). 
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1.2 Lgr5+ stem cells  
 
1.2.1 Wnt signals drive self-renewal of the healthy intestinal epithelium 
The first genetic mouse experiment linking Wnt signaling with adult stem 
cell biology involved the deletion of the Tcf4/Tcf7l2 gene (Korinek et al., 1998). 
Tcf4 constitutes the nuclear effector of Wnt signaling that, when bound by the key 
regulated protein -catenin, will activate Wnt target gene expression. Absence of 
this transcription factor completely blocks development of the intestinal crypts. The 
same phenotype was reported for transgenic mice in which Wnt signaling was 
inhibited using Dickkopf-1 (Dkk1) (Kuhnert et al., 2004; Pinto et al., 2003), Dkk1 
being a secreted Wnt antagonist (Glinka et al., 1998). Along these lines, the 
induced deletion in adult mice of the -catenin gene (Fevr et al., 2007; Ireland et 
al., 2004) or Tcf4 (van Es et al., 2012) blocks all crypt stem cell activity.  
As the mirror image of this phenomenon, it was found that the colon cancer 
tumor suppressor Apc serves as a negative regulator of -catenin stability. Levels 
of free cytoplasmic -catenin are normally exceedingly low but rapidly increase 
upon Wnt signaling, after which -catenin can engage and activate Tcf4. Apc was 
observed to bind -catenin (Rubinfeld et al., 1993; Su et al., 1993). In Apc mutant 
colon cancer cells, -catenin levels are aberrantly increased (Munemitsu et al., 
1995), leading to the inappropriate activation of Tcf4 target genes (Korinek et al., 
1997). The same effect occurs when the -catenin gene sustains activating point 
mutations (Morin et al., 1997; Rubinfeld et al., 1997). The Wnt/Tcf4-driven genetic 
program in colon cancer was first determined by microarray in 2002 (van de 
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Wetering et al., 2002).  
 
1.2.2 Intestinal crypt homeostasis and structure 
The epithelium of the intestine forms a single-cell-layer barrier between 
the hazardous chemical and biological contents of the gut lumen and the host. 
Likely because of this, the intestinal epithelium undergoes intense self-renewal. 
With a renewal cycle of 4–5 days, it is the fastest proliferating tissue in adult 
animals (Clevers, 2013; de Lau et al., 2014). The epithelium of the small 
intestine is organized into repetitive units, consisting of villi that protrude into 
the lumen and are surrounded at their base by the crypts of Lieberku¨hn, 
invaginations into the underlying connective tissue. Villi serve to maximize the 
surface epithelium for the uptake of nutrients. New epithelial cells are 
constantly birthed in the crypts. While having an overall similar setup, the colon 
differs from the small intestine by the absence of villi, creating a flat surface 
epithelium. While typical Paneth cells are missing in the colon, deep-crypt-
secretory cells have been proposed to represent their colonic counterpart 
(Altmann, 1983). Indeed, it has recently been shown that a c-Kit positive 
population of goblet cells resides directly adjacent to Lgr5+ stem cells at the 
colonic crypt bottom. This cell type produces Notch ligands and EGF similar to 
Paneth cells, and that it can functionally support Lgr5+ stem cells in organoid 
cultures (Rothenberg et al., 2012). Colonic transit amplifying (TA) cells 
differentiate toward the goblet and absorptive cell lineages. 
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1.2.3 Leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5) stem 
cells  
Two types of representative stem cells are currently defined in intestinal 
crypts: cycling crypt base columnar (CBC) cells (Barker et al., 2007) and 
quiescent “+4” cells (Potten et al., 1997). Lgr5 is a Wnt target gene that marks 
proliferative stem cells in several Wnt-dependent stem cell compartments, that 
is, the small intestine and colon (Barker et al., 2007), the stomach (Barker et 
al., 2010) and the hair follicle (Jaks et al., 2008). Rapidly cycling Lgr5+ stem 
cells fuel the rapid turnover of the adult intestinal epithelium (Sato et al., 2009; 
Schepers et al., 2011), and its properties are not shared by other crypt cells 
(Barker and Clevers, 2010; Li and Clevers, 2010). 
Lgr4 and Lgr6 are Lgr5 homologs, encode orphan 7-transmembrane 
receptors that are close relatives of the receptors for follicle stimulating 
hormone (FSH), luteinizing hormone (LH) and thyroid- stimulating hormone 
(TSH) (Barker and Clevers, 2010). Lgr6, marks multipotent stem cells in the 
epidermis (Snippert et al., 2010), whereas the expression of Lgr4 marks a much 
broader expressing crypt cell type, including Lgr5+ stem cells (Van Schoore et 
al., 2005).  
Homozygous disruption of Lgr5 results in neonatal lethality due to 
ankyloglossia, a fusion of the tongue to the floor of the oral cavity (Morita et al. 
2004). The origin of this abnormality corresponds with the expression of Lgr5 in 
the epithelium of the tongue and in the mandible of developing embryos. 
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Conditional deletion of Lgr5 in the intestines of adult mice revealed no overt 
phenotype, while deletion of Lgr4 reduced the proliferation of CBC cells in 
intestinal crypts (de Lau et al. 2011). The combined removal of Lgr4 and Lgr5 
aggravated this phenotype, abolishing the crypt stem cell compartment. Gene 
expression profiling indicated that removal of Lgr4 and Lgr5 specifically affected 
expression of the Wnt-driven crypt program, implying a functional connection 
between the two Lgrs and the Wnt pathway. Finally, homozygous mutant Lgr6 
mice displayed no apparent phenotype (Snippert et al. 2010). 
 
1.2.4 Lgr5 ligands 
It has been demonstrated that Lgr4 and Lgr5 function as receptors of the 
R-spondin family of stem cell factors to potentiate Wnt/-catenin signaling 
(Carmon et al., 2011; de Lau et al., 2011; Glinka et al., 2011). R-spondins 
(RSPOs) are a group of four secreted proteins (RSPO1–4) that share an overall 
identity of 40–60% at the amino acid sequence level and are comprised of 
similar domains (Kim et al., 2006). They were originally identified as Wnt 
agonists based on their robust, positive effect on Wnt/-catenin signaling 
(Kazanskaya et al., 2004; Nam et al., 2006). Stimulation of Lgr4 or Lgr5 with 
any of the four RSPOs greatly potentiates -catenin dependent transcription 
induced by Wnt3a, with RSPO2 and RSPO3 showing the highest potency and 
affinity (Carmon et al., 2011).  
Upon binding of Wnt to the Frizzled/Low-density lipoprotein receptor-
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related protein receptor complex (Fz/LRP), Wnt target genes are activated, 
including Lgr5. Two other Wnt target genes, Rnf43 and Znrf3, encode 
transmembrane E3 ligases containing a cytoplasmic RING domain (Koo et al., 
2012) and serve as components of a negative feedback loop. Enzymatic 
interaction of the Rnf43/Znrf3-associated RING domain with the Fz/LRP 
complex leads to polyubiquitination of the intracellular loops of the 7TM domain 
of Fz. The resulting endocytosis of Fz/Lrp abrogates Wnt signaling (Glinka et 
al., 2011). However, when R-spondin is present, it is recruited to Lgr5 or its 
homolog, Lgr4, which enables R-spondin to interact with Rnf43/Znrf3. As a 
consequence, Wnt/Fz/Lrp receptor complexes persist on the plasma 
membrane, enhancing Wnt signal strength and duration (animation at 
http://www.nymus3d.nl/video/rspondin) (de Lau et al., 2014). 
Taken together, Lgr5 and Lgr4 receptors serve to efficiently recruit R-
spondin ligands and bring these into position for interaction with Rnf43/Znrf3. 
This interaction leads to membrane clearance of the Ring finger proteins, the 
consequent persistence of surface Frizzled receptors, and the boosting of Wnt 
signal strength (de Lau et al., 2014). 
 
1.2.5 Lgr5 in cancer 
The expression of Lgr5 occurs in stem cells at sites of active proliferation 
and is the direct consequence of active Wnt signaling. The transformation of 
Lgr5+ stem cells drives intestinal neoplasia in the Apcflox/flox mouse model, 
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indicating that Lgr5+ crypt stem cells are the cell-of-origin of cancer (Barker et 
al., 2009). Not unexpectedly, Lgr5 expression occurs also in human colon cancer 
(van de Wetering et al. 2002; McClanahan et al. 2006). Likely as a result of Wnt 
pathway mutations, Lgr5 is also strongly expressed in cancers of the ovary, liver, 
and lung (Yamamoto et al. 2003; McClanahan et al. 2006; Zucman-Rossi et al. 
2007; Tanese et al. 2008).  
 
1.3 Lipids and cellular membrane biology 
1.3.1 Cellular lipid classes 
 
Lipid metabolism involves a very large number of metabolic reactions 
spanning different compartments in eukaryotic cells, resulting in the 
formation of a diverse group of chemical compounds (Nielsen, 2009).  Lipids 
can be divided into the following classes: (1) fatty acids (FAs) that mainly 
serve as intermediates in lipid biosynthesis; (2) free sterols, e.g., 
cholesterol, that serve as structural components in membranes; (3) sterol 
esters that are formed from FAs and sterols and serve as lipid storage 
compounds, mainly as lipid bodies; (4) triacylglycerols (TAG) that are 
formed from glycerol and FAs that serve as lipid storage, mainly in lipid 
bodies; (5) phospholipids/phosphoglycerides (PLs) that are formed from 
FAs, glycerol and an alcohol moiety, e.g., inositol, choline or ethanolamine, 
that serve as structural components of membranes; and (6) sphingolipids 
that contain a sphingosine backbone and a very long chain FA. These 
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phospholipids serve as structural components at the cell surface as well as 
key signaling roles, e.g., regulation of endocytosis, ubiquitin dependent 
proteolysis and cell cycle control (Nielsen, 2009; Rohrig and Schulze, 
2016).  Despite the large chemical variety of lipids, they all have the same 
key carbon precursor, namely acetyl-CoA, and all initial steps of 
lipid/cholesterol biosynthesis occur in the cytosol (Rohrig and Schulze, 
2016).  Lipid biosynthesis involves two branches from acetyl-CoA, one 
leading to sterols and the other leading to FAs that serve as building blocks 
for biosynthesis of TAG, phospholipids, sterol esters and sphingolipids.   
 
1.3.2 Composition of cellular membranes 
Eukaryotic cells contain different types of membranes, including the 
plasma, endosomal, nuclear and mitochondrial membranes.  The specific 
lipid composition of these membranes influences function, and since these 
membranes carry out vastly different functions, inherently their composition 
is extremely diverse (van Meer et al., 2008). Their heterogeneous 
composition is the result of de novo lipid synthesis (Kennedy pathway) and 
exogenous substrate availability (Lands’ cycle). Unlike proteins that are 
directly encoded in the genome, lipid composition is the result of an indirect 
influence of biosynthetic enzymes and exogenous substrate availability.   
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1.3.3 Plasma membrane and signal transduction 
 
The plasma membrane is composed of a heterogeneous mixture of 
lipids/cholesterol and proteins whose distinct organization maintains 
efficient signal transduction. Lipid rafts, enriched in sphingolipids, 
cholesterol and associated proteins, are special plasma membrane 
microdomains with an increased structural order, which are designated 
liquid ordered domains in plasma membranes (Sezgin et al., 2017). These 
lipid rafts are believed to be dynamic and small (5–200 nm) membrane 
microdomains, which play a critical role as sorting platforms for many 
membrane-associated proteins (Frisz et al., 2013; Hancock, 2006; Kraft, 
2013; Levental and Veatch, 2016; Lingwood and Simons, 2010). 
Importantly, these domains are generally below the resolution of light 
microscopy (~200 nm).  However, using specialized forms of microscopy 
that rely on non-radiative transfer of energy or single molecule localization, 
it is now possible to directly observe nanoscale dynamics of membrane 
lipids in living cells (Eggeling et al., 2009; Sahl et al., 2014).  For example, 
the increased accessibility of super-resolution microscopy techniques has 
shed new light on the nanoscale organization of membrane proteins 
(Sezgin, 2017; Wang et al., 2014).  
According to the emerging membrane biology picture, protein and 
lipid nanoclusters can be organized to form domains that are capable of 
facilitating signaling events (Ariotti et al., 2014; Garcia-Parajo et al., 2014; 
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Zhou and Hancock, 2015).  The formation of these nanoclusters is believed 
to be driven by cortical actin and/or proximal transmembrane proteins 
(Garcia-Parajo et al., 2014). Currently, protein-protein, lipid-lipid and 
protein-lipid nanoclusters are considered a predominant feature of the 
plasma membrane and appear to mediate critical signaling processes 
(Ariotti et al., 2014), including signal integration and cross talk of the 
transduction of oncogenic Ras and the epidermal growth factor receptor 
(EGFR) (Ariotti et al., 2014; Janosi et al., 2012; Zhou et al., 2012) regulated 
pathways. This is noteworthy, because there is emerging evidence that 
drugs and select membrane active dietary components, which we term 
membrane targeted dietary bioactives (MTDBs), e.g., n-3 PUFA and 
curcumin, can attenuate Ras and EGFR (Ariotti et al., 2014; Nussinov et al., 
2015) activity by modulating nanocluster organization. It also has been 
suggested that disrupting clustering/dimerization of membrane associated 
proteins can lead to attenuation of downstream oncogenic signaling and the 
suppression of tumor growth (Fuentes et al., 2017).  
 
1.3.4 The role of cholesterol in plasma membrane physiology 
Approximately 90% of cellular cholesterol resides in the plasma 
membrane (Kim et al., 1991; Lange et al., 1989; Ueland et al., 1986), and 
increases in cholesterol promote plasma membrane order (Montero et al., 
2008).  This is significant, because highly ordered/rigid lipid rafts are 
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increased in many types of cancer (Li et al., 2006; Patra, 2008) and some 
multidrug-resistant cancers (Yang et al., 2009; Yi et al., 2013).  The term 
‘rigidity’ refers to the packing of the lipids in the membrane, and cholesterol 
favors the production of more tightly pack “rigid” domains. This increased 
rigidity associated with increased lipid rafts typically facilitates efficient 
cellular signaling.  Interestingly, multidrug-resistant cells have remodeled 
their membrane to be in a state that is more rigid and thus receptive to 
activation (Li et al., 2015; Raghavan et al., 2015).   
 
1.3.5 Cellular function of membrane cholesterol 
Cholesterol is an essential component of higher eukaryotic 
membranes and plays an important role in cell membrane organization, 
dynamics and function (Bloch, 1983). It is the end product of a sterol 
biosynthetic pathway involving more than 20 enzymes (Singh et al., 2013).  
According to the ‘Bloch hypothesis’, the sterol biosynthetic pathway 
parallels sterol evolution. In other words, the cholesterol biosynthetic 
pathway has evolved to optimize properties of eukaryotic cell membranes 
for specific biological functions (Hedlund et al., 2011). As an important 
membrane component, cholesterol helps to generate a semi-permeable 
barrier between cellular compartments and to regulate membrane fluidity. 
Cholesterol favors the formation of highly packed and ordered, rigid 
domains.  A common term used for the ordered domains is “lipid-rafts” 
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(Levental and Veatch, 2016; Sezgin et al., 2017).  From a functional 
perspective, the cholesterol / phospholipid composition of cellular 
membranes is known to influence lipid raft formation and the ability of 
plasma membrane receptors / signaling proteins to function properly (Griffié 
et al., 2015; Hou et al., 2016; Phillips et al., 2009). 
 
1.3.6 Membrane cholesterol in stem cells 
In preclinical studies, diet-induced obesity (DIO) augments self-
renewal of intestinal Lgr5+ stem cells, the cells-of-origin of intestinal cancer 
(Barker et al., 2007, 2009), and bestows a stemness related phenotype, 
e.g., organoid-initiating capacity in non-stem cell progenitors (Beyaz et al., 
2016).  This is consistent with recent work from our lab indicating that DIO 
promotes colonic Lgr5+ stem cell expansion during cancer initiation 
(DeClercq et al., 2015).  In comparison, in preclinical models of 
atherosclerosis, inactivation of cholesterol efflux transporters (ABCA1 and 
ABCG1) increases the number of circulating hematopoietic stem cells 
(HSPCs) (Feng et al., 2012; Gomes et al., 2010; Yvan-Charvet et al., 2007) 
and activate inflammatory cells (Lang and Cimato, 2014).  From a 
mechanistic perspective, the Wnt/-catenin pathway maintains a stem 
cell/progenitor phenotype in many cell types (Pinto and Clevers, 2005).  
Interestingly, recent evidence indicates that cholesterol selectively 
activates canonical Wnt signaling (Sheng et al., 2014).  This is noteworthy, 
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because Wnt positively regulates cholesterol uptake for growth of cancer 
cells (Scott et al., 2015). Collectively, these findings suggest that lipid 
metabolism may play a critical role in stem cell signaling, thereby 
modulating cancer risk. 
 
1.3.7 Plasma membrane/ cholesterol in cancer and anti-cancer therapy 
There is evidence suggesting that disruption of lipid rafts in cancer 
can lead to increased responsiveness to anti-cancer therapies (Fedida-
Metula et al., 2012; Irwin et al., 2011). Additionally, some anti-cancer drugs 
have beneficial effects through alteration of the protein content of lipid rafts 
(George and Wu, 2012; Hryniewicz-Jankowska et al., 2014).  In colon 
cancer, lipid rafts have been shown to function in cell death (apoptosis)-
mediated signaling (Lacour et al., 2004; Rebillard et al., 2007), cell 
entry/bioavailability of bioactive compounds (Adachi et al., 2007) and 
localization of key proteins involved in immune response (Bene et al., 
2004).  These findings indicate that lipids can no longer be ignored in the 
structures of membrane complexes, due to their ability to fine-tune and 
stabilize different signaling interfaces (Barrera et al., 2013; Levental et al., 
2016; Lin et al., 2016). For several viruses, a dependence on cholesterol 
for virus entry and/or morphogenesis has been shown. Cholesterol 
depletion of virus-infected cells affects integrity of the virus envelope, 
causes disruption of the viral envelope, and adversely affects virus 
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infectivity (Barman and Nayak, 2007; Imhoff et al., 2007).  For this reason, 
there is considerable interest in identifying alternative strategies for 
lowering cholesterol, micronutrient supplementation and pharmaceutical 
development.  
 
1.3.8 Role of mitochondrial membrane/ cholesterol in cancer and anti-cancer 
therapy 
Mitochondria are cholesterol-poor organelles which contain 0.5 to 3% 
of the cholesterol content found in plasma membranes (Maxfield and Tabas, 
2005; Soccio and Breslow, 2004).  Interestingly, expression of oncogenic 
Ras results in the down regulation of the cholesterol transporter ATP-
binding cassette transporter A1/cholesterol exporter (ABCA1) (Smith and 
Land, 2012), a key player in cholesterol metabolism. As a result, cholesterol 
accumulates in the mitochondria, which inhibits the release of death 
promoting molecules (Smith and Land, 2012). Similarly, mitochondria from 
rat or human hepatocellular carcinoma (HC) cells (HCC) or primary tumors 
from patients with HC exhibit increased mitochondrial cholesterol levels 
(Montero et al., 2008). Elevated cholesterol in mitochondria membranes 
may decrease membrane fluidity. This in turn, may inhibit mitochondrial 
permeability transition (MPT), decreasing the capacity of the pro-cell 
death/apoptotic Bax protein to oligomerize and penetrate into the 
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mitochondrial outer membrane, which will ultimately promote cancer cell 
survival (Colell et al., 2003; Montero et al., 2008).   
 
1.4 n-3 PUFA and curcumin 
1.4.1 Effect of n-3 PUFA and curcumin on colon cancer 
 
It is clear that select extrinsic bioactives, e.g., n-3 polyunsaturated fatty 
acids (n-3 PUFA) and curcumin, independently reduce aberrant crypt foci 
(ACF) and polyp formation in humans (Carroll et al., 2011; West et al., 2010) 
and combinations of the two have been reported to exert synergistic effects 
related to the suppression of chronic inflammation and cell proliferation and the 
promotion of apoptosis in breast and pancreatic cancers (Altenburg et al., 2011; 
Jia et al., 2011; Saw et al., 2010; Siddiqui et al., 2013; Swamy et al., 2008). 
From a mechanistic perspective, the combination of n-3 PUFA and curcumin 
has been shown to suppress NFB activation in mouse colonic mucosa (Jia et 
al., 2011) in part by altering plasma membrane composition (Kim et al., 2009), 
which is required for activation of the apoptotic pathways (Beneteau et al., 
2008; Gajate and Mollinedo, 2011). The suppression of inflammatory mediators 
such as COX-2, inducible nitric oxide synthase (iNOS), prostaglandin E2 
(PGE2), 5-lipoxygenase (5-LOX) and cytosolic phospholipase A2 (cPLA2) has 
also been linked to the synergistic action of curcumin and n-3 PUFA, e.g., 
docosahexaenoic acid (DHA) (Saw et al., 2010; Swamy et al., 2008).  
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DHA and curcumin synergistically induce p53 activation (Altenburg et 
al., 2011; Siddiqui et al., 2013), a well-known tumor suppressor (Stracquadanio 
et al., 2016; Vogelstein et al., 2000).  This is noteworthy, because p53 functions 
in part to inhibit NFB activity, thereby inducing apoptosis in human colon 
cancer cells (Shao et al., 2000) (Puszynski et al., 2009). In contrast, the loss of 
p53 during tumor progression promotes an NFB dependent inflammatory 
microenvironment (Schwitalla et al., 2013b), which is a critical event in the 
commitment of stem cells to apoptosis following DNA damage (Davidson et al., 
2015; Dumitru et al., 2012).  
 
1.4.2 n-3 PUFA and curcumin disrupt plasma membrane order 
 
The two lipid bilayers of the plasma membrane each have unique 
interactions. The cytofacial (inner) leaflet interacts directly with the actin 
cytoskeleton. The exofacial (outer) leaflet is the site for ligand-receptor 
interactions, as well as glycosylated protein interactions. Several classes of 
MTDBs, because of size, hydrophobic/hydrophilic interactions, or steric 
hindrances, do not readily intercalate or incorporate into the phospholipid 
membrane.  
Both DHA and curcumin are capable of modulating plasma membrane 
structure and EGFR function (Soung and Chung, 2011; Turk et al., 2012), 
which regulates colon cancer stem cell proliferation (Feng et al., 2012). In 
addition, there is emerging evidence that n-3 PUFA, can attenuate Ras and 
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EGFR (Ariotti et al., 2014; Nussinov et al., 2015) activity by modulating 
nanocluster organization. With respect to its membrane targeting properties, 
curcumin associates with the head group region of the phospholipid bilayer 
(Barry et al., 2009; Hung et al., 2008), whereas n-3 PUFA interact with the tail 
group region within rafts (Shaikh et al., 2004; Shaikh et al., 2015; Shaikh et al., 
2009a).  It also has been suggested that disrupting clustering/dimerization 
of membrane associated proteins can lead to attenuation of downstream 
oncogenic signaling and the suppression of tumor growth (Fuentes et al., 
2017).  
 
1.4.3 Clinical impact of lipids and cholesterol in cancer 
 
According to emerging findings, lipids and membrane biology in part 
underlie the impact of diet on cancer prevention (Fuentes et al., 2017; Hou 
et al., 2016).  With regard to human health, high cholesterol intake is known 
to increase colorectal cancer risk (Järvinen et al., 2001). Increased free 
cholesterol (1.5-fold) and esterified cholesterol (2-fold) in tumor tissue as 
compared to normal tissue has been reported in human colon cancer 
patients (Dessì et al., 1994).  Interestingly, an inverse relationship between 
serum cholesterol levels and the risk for colon cancer has been reported 
(Broitman et al.; Forones et al.). In terms of colon cancer patients, liver 
metastases are significantly associated with elevated low-density 
lipoprotein (LDL) cholesterol levels and LDL receptor (LDLR) expression 
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levels are upregulated and associated with progression of colorectal cancer 
(Wang et al., 2017a). Epidemiologic studies suggest that statins, a 
cholesterol synthesis inhibitor, prevent certain malignancies (Hindler et al., 
2006), including melanoma (Downs et al., 1998), breast (Boudreau et al., 
2004; Cauley et al., 2003), colon (Cardwell et al., 2014; Lakha et al., 2012; 
Poynter et al., 2005), and prostate cancer (Shannon et al., 2005).  
Interestingly, elevated mitochondrial cholesterol in cancer cells (Montero et 
al., 2008) is associated with the suppression of programmed cell death 
(apoptosis) and the promotion of malignant cell transformation (Smith and 
Land, 2012) and chemotherapy resistance (Montero et al., 2008). In 
addition, apoptosis resistance was restored by cholesterol synthesis 
inhibitors and cholesterol depletion agents establishing a cause-and-effect 
relationship between mitochondrial membrane cholesterol (membrane 
order) and  membrane-mediated apoptotic signal (Montero et al., 2008).  
 
1.5 Current study 
 
The major objective of this research is to determine the response of 
Lgr5+ stem cells to extrinsic (carcinogen and diet compounds) and intrinsic 
factors (oncogenic Apc and Kras), mediators of CRC. The evidence discussed 
herein strongly suggests that n-3 PUFA and curcumin have broad-acting 
effects on mammalian physiology and fast cycling Lgr5+ stem cells. Our data 
specifically address the effects of n- 3 PUFA and curcumin on the response of 
 30 
 
Lgr5+ stem cells to alkylation-induced DNA damage. In addition, we have 
assessed the effects of the oncogenes and MTDBs on plasma membrane 
physiology. This study also elucidated the mechanism by which DHA and 
curcumin functions in chemoprevention.  
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2. HOMEOSTATIC RESPONSES OF COLONIC LGR5+ STEM CELLS TO 
CARCINOGEN* 
 
2.1 Introduction 
The transformation of Lgr5+ stem cells drives intestinal neoplasia in the 
Apcflox/flox mouse model, indicating that Lgr5+ crypt stem cells are the cell-of-
origin of cancer (Barker et al., 2009). Colon cancer has been suggested to 
follow a cancer stem cell (CSC) hierarchical model (Asfaha et al., 2015; Li et 
al., 2011). Although cycling Lgr5+ stem cells fuel the rapid turnover of the adult 
intestinal epithelium (Sato et al., 2009; Schepers et al., 2011), and its properties 
are not shared by other crypt cells (Barker and Clevers, 2010; Li and Clevers, 
2010), the role of Lgr5+ cells in colorectal cancer (CRC) pathogenesis has not 
been well investigated. Therefore, it is important to identify the properties of 
Lgr5+ cells at the initiation stage of colon tumorigenesis because transformation 
of Lgr5+ stem cells is an extremely efficient route towards initiating intestinal 
cancer (Barker et al., 2009). Recently, DNA damage responses in Lgr5+ cells 
have been reported (Hua et al., 2012; Li et al., 2011; Metcalfe et al., 2014), 
however to date, colonic Lgr5+ cytokinetics have not been examined in the  
*This chapter is reprinted with permission from “Homeostatic responses of colonic LGR5 + stem cells 
following acute in vivo exposure to a genotoxic carcinogen” by Eunjoo Kim; Laurie A Davidson; Roger S 
Zoh; Martha E Hensel; Bhimanagouda S Patil; Guddadarangavvanahally K Jayaprakasha; Evelyn S 
Callaway; Clinton D Allred; Nancy D Turner; Brad R Weeks & Robert S Chapkin. Carcinogenesis 2016, 
37(2):206-214. doi: https://doi.org/10.1093/carcin/bgv250. Copyright (2016) by Oxford Journals. 
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context of an alkylating agent induced DNA damage model of CRC.  Critical to 
the prevention of colon cancer is the removal of O6-methylguanine (O6meG) 
DNA adducts, either through repair, for example, via O6-methylguanine-DNA 
methyltransferase (MGMT) or targeted apoptosis (Meikrantz et al., 1998). 
MGMT is an inducible repair enzyme (Boldogh et al., 1998) that acts by 
transferring the methyl group from guanine in DNA to a cysteine residue on the 
repair protein (Montesano et al., 1990), resulting in rapid removal of 
promutagenic O6-meG DNA adducts and the irreversible inactivation of the 
repair enzyme (Boldogh et al., 1998). 
Cells with unrepaired DNA adducts may be eliminated through the 
activation of the apoptotic cascade, resulting in their selective removal 
(Thompson, 1995). In general, during the initiation of tumorigenesis following 
carcinogen exposure, there is an immediate apoptotic response to DNA 
damage in the colonic epithelium (Hirose et al., 1996). This is consistent with 
the fact that O6-meG DNA lesions trigger apoptosis (Meikrantz et al., 1998).                                                                                                                                             
The life-time risk of cancer is strongly correlated with the total number of 
stem cell divisions (Tomasetti and Vogelstein, 2015). Although the effect of 
DNA alkylating agent administration on O6-meG DNA adduct repair, apoptosis 
and proliferation in colonic crypts has been reported in preclinical models (Hong 
et al., 1999; Hong et al., 2000; Hua et al., 2012; Metcalfe et al., 2014), there is 
no information on the interrelationship among these phenotypes in DNA 
damaged adult colonic Lgr5+ stem cells. We therefore determined how colonic 
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Lgr5+ stem cells respond to the administration of azoxymethane (AOM), a well-
characterized experimental colon carcinogen and DNA alkylating agent (Hawks 
and Magee, 1974), in terms of O6-meG DNA adduct removal by MGMT, 
apoptosis, and cell cycle arrest. In this study, we provide evidence that Lgr5+ 
stem cells exhibit elevated AOM induced-DNA damage compared to 
differentiated cells. We also show that Lgr5+ stem cells profoundly induce 
MGMT to delete O6meG and promote untargeted apoptosis upon AOM 
exposure. These data document for the first time how the rapidly cycling Lgr5+ 
stem cell population responds to environmental factors at the initiation stage of 
colon tumorigenesis. 
 
2.2 Material and methods 
2.2.1 Animals, diet, and study design 
The animal use protocol was approved by the University Animal Care 
Committee of Texas A&M University and conformed to NIH guidelines. Lgr5-
EGFP-IRES-CreERT2 (Barker et al., 2009) knock-in mice 6-7 wk old were 
acclimated for 1 wk and then provided with a semi-purified diet (Table 1) for 3 
wk prior to injection with AOM (Sigma Chemical (St. Louis, MO); 10 mg/kg body 
weight). Mice were injected with EdU (Life Technologies) 2 h prior to sacrifice. 
Twelve (n=8) and 24 hr (n=8) following a single intraperitoneal injection of AOM, 
animals were euthanized by CO2 asphyxiation. Control mice (n=3) received a 
single saline injection. Immediately after termination, the colon was rapidly 
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removed, flushed with ice-cold saline and immediately fixed in 4% 
paraformaldehyde for immunofluorescence (IF) analyses. Figure 1 shows the 
timeline of the treatments and the experimental design. 
 
 
 
 
Table 1. Experimental diets. 
 
 
 
 
 
 
 
Figure 1. Timeline of treatments and the experimental design. Lgr5-EGFP-IRES-CreERT2 
mice were provided with corn oil diet for 3 weeks prior to carcinogen injection. Mice were 
subsequently injected one time with AOM or saline at 10 mg/kg body weight. 12 or 24 hr 
following injection, mice were terminated and the colon was extracted for stem cell isolation.  
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2.2.2 In vivo DNA damage and repair measurement 
Formalin-fixed paraffin-embedded 4 m colon sections were deparaffinized, 
rehydrated through graded ethanol and stained with antibodies using standard 
procedures. DNA double strand breaks (DSBs) were measured by IF using a 
rabbit monoclonal phospho-gamma H2AX (H2AX) Ser139 antibody (9718, Cell 
Signaling; dilution 1:200), Lgr5+ stem cells were labeled using goat polyclonal 
GFP antibody (ab6673, Abcam; dilution 1:400) and O6meG DNA adduct removal 
was estimated by the induction of MGMT expression using a mouse monoclonal 
MGMT antibody (ab54306, Abcam; prediluted). Secondary antibodies were anti-
rabbit Alexa 647 (711-605-152, Jackson ImmunoResearch: dilution 1:400) for 
H2AX, anti-goat 488 (705-545-147, Jackson ImmunoResearch) for GFP and 
anti-mouse Alexa 546 (A10036, Life Technologies) for MGMT.  The DNA damage 
(or repair) index was determined by dividing the number of H2AX (or MGMT) 
positive cells by the total number of cells in each crypt column and multiplying by 
100.  
 
2.2.3 In vitro apoptosis measurement 
To investigate whether alkylating agent-induced DNA damage triggered 
apoptotic cell death in colonic Lgr5+ stem cells, apoptotic bodies were 
visualized using the TACS 2 TdT-Fluor in situ apoptosis detection kit (Trevigen) 
as per the manufacturer’s instructions. Negative control slides were incubated 
without TdT enzyme. The apoptotic index was determined by dividing the 
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number of apoptotic cells by the total number of cells in the crypt column and 
multiplying by 100. 
 
2.2.4 In vivo measurement of cell proliferation 
To investigate the effects of alkylating agent-induced DNA damage on cell 
cycle in colonic epithelial cells, proliferative activity was measured using the 
Click-iT EdU Alexa Fluor 555 Imaging kit (Life Technologies) as per the 
manufacturer’s instructions.  Negative control slides were incubated without 
Alexa Fluor. 
 
2.2.5 Slide scoring 
Images of colonic crypts were captured on an inverted TE 300 Nikon 
Eclipse fluorescence microscope equipped with 40x/1.30 Nikon Plan Fluor oil 
immersion objective and a Photometrics Cool snap EZ digital CCD camera. 
The external light source was powered by a mercury lamp. Images were 
processed using NIS Image software, version 3.2 (Nikon).  A total of 426 
GFPhigh crypts from 8 mice were counted at 12 and 24 hr post AOM exposure 
and 150 GFPhigh crypts from 3 saline injected mice (control) were examined.   
 
2.2.6 Statistics 
GraphPad Prism6 was used to analyze DNA adduct removal, apoptosis 
and proliferation and to produce graphs. Two-way analysis of variance 
 37 
 
(ANOVA) was used to determine the effect of carcinogen in Lgr5+ stem cells 
compared to differentiated cells over time. Comparisons between different time 
points were analyzed using one-way ANOVA.  
 
2.3 Results 
2.3.1 Lgr5+ stem cells are preferentially damaged by carcinogen 
To elucidate the unique properties of colonic Lgr5+ stem cells in terms of 
their response to DNA damage, we assessed Lgr5+ stem cell homeostasis in 
the context of AOM-induced tumorigenesis. Lgr5+ stem cells and differentiated 
cells were tracked using the Lgr5-EGFP-IRES- CreERT2 knock-in mouse. In 
this model, GFP expression is driven by the Lgr5 locus, leading to high GFP 
expression in Lgr5+ stem cells (GFPhigh), which is distinguishable from Lgr5- 
cells (GFPneg) within crypts (Barker et al., 2007). Fluorescence microscopy was 
used to visualize GFPhigh (Lgr5+) cells by fluorescence within the context of the 
colonic crypt. In addition, sequencing results confirmed that GFPhigh cells highly 
expressed Lgr5 and other stem cell markers, whereas GFPneg cells expressed 
differentiated cell markers, e.g., Atoh1 (Table 2). 
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Table 2. Representative differentially expressed genes in GFPhigh versus GFPneg cells.  
Cells were sorted by GFP intensity and subsequently sequenced. 
 
 
O6-meG is the dominant mutagenic adduct introduced by AOM (Kondo 
et al., 2010). O6-meG:T mispairs can stall DNA replication when not repaired 
before replication, resulting in double strand breaks (DSBs) (Karran and 
Bignami, 1992). DSBs are always followed by phosphorylation of H2AX (Kuo 
and Yang, 2008). Hence, H2AX foci in the nucleus are a useful marker of the 
DSBs induced by S-phase dependent genotoxins during replication (Kuo and 
Yang, 2008; Staszewski et al., 2008). We hypothesized that AOM would induce 
more DSBs in GFPhigh cells compared to GFPneg, due to the fact that Lgr5+ cells 
are actively proliferating and AOM induced-DSBs are formed during replication 
(Staszewski et al., 2008).  We therefore assessed the cytotoxic effects of AOM 
by quantifying H2AX (phospho S139) labeling.  As shown in Figure 2A, H2AX 
levels in the proximal colon were barely detectable similar to saline control 
indicating that the distal colon is the primary target of AOM.  Following AOM 
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exposure, colonic cells in the distal colon were intensely stained for H2AX at 
12 h, which persisted through the 24 hr time point.  DNA damage levels were 
5.7-fold higher (P<0.01) in GFPhigh stem cells as compared to GFPneg cells 
(Figure 2B).  
 
 
 
Figure 2. Carcinogen (AOM)-induced DNA DSBs in mouse colonic crypts at 12 and 24 hr 
post-AOM injection. (A) Quantitative comparison of the number of H2AX + (DNA damaged) cells 
per crypt in the distal and proximal colon in saline versus AOM injected mice. (B) Quantitative 
comparison of the % of H2AX + stem cells (GFP high) and differentiated cells (GFP neg) per crypt. 
A total of 426 Lgr5 GFP +crypts from eight mice were counted at 12 hr, 150 Lgr5 GFP + crypts from 
three mice were counted at 24 hr and 150 crypts from three saline control mice were examined. 
DAPI stained nuclei along the mouse colonic crypt were counted and stem cells were determined 
by counting cells double stained for GFP and DAPI within Lgr5 GFP + crypts. Statistically 
significant differences between time points were determined using two-way ANOVA followed by 
Fisher’s LSD multiple comparison testing. Different letters or * indicate significant differences 
between treatment groups (p < 0.05). 
 
 
 
A B 
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2.3.2 Lgr5+ stem cells preferentially promote damage-induced apoptosis in 
response to carcinogen 
It has been reported that O6-meG can generate stalled replication and 
DSBs, resulting in the induction of apoptosis (Karran and Bignami, 1992).  In 
addition, stem cells exhibit a lower apoptotic threshold due to mitochondrial 
priming (Dumitru et al., 2012; Liu et al., 2013).  This is noteworthy, because an 
excess number of stem cells can cause cancer (Verzi and Shivdasani, 2010) 
and “apoptosis resistance” has been reported in normal and cancer stem cells 
(Kruyt and Schuringa, 2010). Therefore, we quantified the levels of AOM-
induced apoptotic GFPhigh and GFPneg cells per crypt in the distal colon. For this 
purpose, we used the TUNEL assay to colocalize apoptosis with H2AX and 
GFP (Lgr5+ cells). To corroborate the frequency of epithelial cells undergoing 
apoptosis, paraffin-embedded sections were also assessed by H&E staining 
(Figures 3A&C).  
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Figure 3. Quantitative comparison of the number of apoptotic cells per crypt measured 
by H&E and TUNEL (A) Quantitative comparison of the number of apoptotic cells per crypt 
measured by H&E and TUNEL in the distal colon in saline versus AOM injected mice (12 hr). 
(B) Association between the number of apoptotic cells per crypt in TUNEL assay and H&E. (C) 
Representative image of AOM-induced apoptotic cells at 12 hr post AOM injection as seen by 
H&E. Refer to Figure 2 legend for statistics.  
 
 
Consistent with previous findings (Hu et al., 2002), H&E and TUNEL data were 
highly correlated (Figure 3B). GFPhigh cells preferentially exhibited AOM-
induced apoptosis, e.g., 4.7-fold higher levels (P<0.0001), compared to GFPneg 
cells at 12 hr (Figures 4). In contrast, apoptosis in GFPneg cells after exposure 
to carcinogen was more modest. Next, using linear regression analysis, we 
determined whether AOM-induced apoptosis was associated with the levels of 
A C 
B 
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DNA damage induced by AOM. As shown in Figure 4C, only GFPhigh cells 
exhibited proportionally increased apoptosis (slope=0.42, p=0.03) in response 
to DNA damage, whereas GFPneg cells were non-responsive. We subsequently 
quantified the number of damaged Lgr5+ stem cells that were targeted for 
apoptotic deletion, i.e., GFPhigh, TUNEL+, H2AX+ triple positive cells, since the 
selective deletion of damaged Lgr5+ stem cells by promoting apoptosis could 
mitigate the clonal expansion of DNA-damaged Lgr5+ stem cells. As shown in 
Figure 4D, no statistically significant differences between GFPhigh cells and 
GFPneg cells (p=0.54) were observed in terms of targeted apoptosis (TUNEL+, 
H2AX+ cells) both at 12 and 24 hr. However, H2AX-, GFPhigh cells exhibited a 
7.7-fold higher induction of apoptosis (non-targeted apoptosis - TUNEL+, 
H2AX- cells) as compared to H2AX-, GFPneg cells at 12 hr (p=0.001) (Figure 
4D right).  These data indicate that the majority (63%) of induced apoptosis in 
GFPhigh cells was non-targeted. Specifically, 28% of GFPhigh cells exhibited non-
targeted apoptosis (12 hr, Figure 4D right) and 13% exhibited targeted 
apoptosis (12 hr, Figure 4D left).   
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Figure 4. Comparison of AOM-induced apoptosis in stem cells and differentiated cells. 
(A) Representative images (objective, 40×) of GFP+ (GFP high stem cells, green), 
H2AX+ (DSBs, white) and TUNEL+ (apoptotic body, red) cells are shown. For comparative 
purposes, immunofluorescence staining of colonic crypts in the distal colon in saline (control) 
and AOM injected mice is shown. (B) % TUNEL+ (apoptotic) stem cells and differentiated cells 
per crypt. (C) Association between the % of AOM-induced apoptotic cells and % of 
H2AX+ cells per crypt in stem and differentiated (Diff) cells. Each point represents an individual 
animal. The P value was calculated using an F test. Correlation computes the value of the 
Pearson correlation coefficient, r, ranges from −1 to +1. The linear regression was fitted using 
GraphPad Prism 6.0. Apoptotic index = # of TUNEL+ stem or differentiated cells/total # of stem 
or differentiated cells per crypt X 100 at 12 and 24 hr post-AOM injection; Damage index = # 
of H2AX+ stem or differentiated cells/total # of stem or differentiated cells per crypt X 100 at 
12 and 24 hr post-AOM injection. Slope where the difference from zero is statistically significant 
is marked in red (Stem, 12 hr). (D) (left panel) % targeted apoptosis (double positive 
TUNEL+ and H2AX+ stem or differentiated cells/H2AX+ stem or differentiated cells) at 12 and 
24 hr post-AOM injection; (right panel) % nontargeted apoptosis (TUNEL+ and H2AX− stem or 
differentiated cells/H2AX − stem or differentiated cells) at 12 and 24 hr post-AOM injection. 
Different letters or * indicate significant differences between treatment groups (p < 0.05). Refer 
to Figure 2 legend for animal numbers. 
A B 
C 
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2.3.3 AOM exposure promotes an apoptosis-bystander effect (BE) in Lgr5+ 
stem cells. 
In order to further shed mechanistic insight into the cause of the non-
targeted apoptosis stem cell phenotype (TUNEL+, H2AX-, Lgr5+, Figure 4D), 
we defined BE-dependent apoptosis as apoptotic cells without DNA damage 
adjacent to damaged or apoptotic/damaged cells. In comparison, BE-
independent apoptosis was defined as apoptotic cells with no adjacent 
damaged cells (Figure 5A, left). Our findings indicate that TUNEL+, H2AX-, 
Lgr5+ stem cells were predominantly (70%) localized to regions adjacent to 
H2AX+ cells (Figure 5B, left).  The proximity of H2AX+ cells to TUNEL+, 
H2AX- Lgr5+ stem cells suggest the involvement of AOM-induced BE (Figures 
5A&B, right). 
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Figure 5. Bystander effect. (A) Representative image of direct BE (apoptotic cell located one 
or two cells away from damaged cell) and indirect BE (apoptotic cells with no damaged cells in 
the field of interest) at 12 hr post-AOM injection. An apoptotic cell immediately adjacent to a 
damaged cell is defined as P1; an apoptotic cell located one cell away from a damaged cell is 
defined as P2 (right). Representative images (objective, 40×) of TUNEL+ (apoptotic body, red) 
cells next to H2AX+ (DSBs, white) cells are shown counter-stained with DAPI (blue). (B) 
Percentage of BE-dependent and BE-independent apoptotic Lgr5+ stem versus differentiated 
cells (left) and percentage of BE-dependent apoptotic cells in relation to its proximity to a 
damaged cell. 
 
A 
B 
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2.3.4 Lgr5+ stem cells up-regulate DNA repair enzyme expression in response 
to carcinogen. 
The major pathway for the repair of the O6meG is via the MGMT 
mechanism (Pegg and Byers, 1992). Because this alkyltransferase is induced 
by alkylating agents, quantitative immunohistochemical analysis can be used 
to estimate MGMT activity upon AOM injection (Zaidi et al., 1996).  As shown 
in Figure 6A&B, MGMT expression in GFPhigh cells in the distal colon was 
increased by 18.5-fold 24 hr after AOM injection, whereas in GFPneg cells, no 
induction was detected. Using linear regression analysis, both GFPhigh cells 
(slope=1.08, p=0.03) and GFPneg cells (slope=0.87, p=0.006) at 24 hr exhibited 
an induction of MGMT expression that was associated with the amount of DNA 
damage induced by AOM (Figure 6C), whereas at 12 h, no statistical 
differences were detected both in Lgr5+ stem and differentiated cells. Next, we 
quantified the number of damaged cells expressing MGMT, i.e., exhibiting 
targeted repair (GFPhigh, H2AX+ and MGMT+ triple positive), since the removal 
of mutagenic and cytotoxic adducts via induced-MGMT expression is 
negatively associated with G to A mutations in K-ras in colorectal tumorigenesis 
(Esteller et al., 2000). With respect to the H2AX+ cell compartment, only 
H2AX+ cells exhibited a statistically induced MGMT expression in GFPhigh cells 
at 24 hr, whereas no significant changes were detected in GFPneg cells (Figure 
6D left).  In comparison, MGMT expression in H2AX- cells was negligible both 
in GFPhigh and GFPneg cells (Figure 6D right).  
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DSBs can be repaired by at least four independent pathways including, 
homologous repair (HR), non-homologous end joining (NHEJ), alternative-
NHEJ (alt-NHEJ), and single-strand annealing (SSA) (Ciccia and Elledge, 
2010). Therefore, we used BRCA1 and Rad51 as markers of HR to define 
AOM-induced post-replicative repair process of Lgr5+ stem cells. BRCA1 and 
Rad51 are well known markers for post-replication repair, especially HR in the 
presence of radiation Rad51 (Hua et al., 2012). However, we were not able to 
detect an induction of HR marked by BRCA1 and Rad51 (Figure 7). 
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Figure 6. Comparison of AOM-induced MGMT expression in stem cells and differentiated 
cells. (A) Representative images (objective, 40×) of GFP+ (Lgr5 + stem cells), H2AX+ (DSBs) and 
MGMT+ (repair enzyme) cells are shown. For comparative purposes, immunofluorescence staining 
of colonic crypt in the distal colon in saline (control) and AOM injected mice is shown. (B) % 
MGMT+ stem cells and differentiated cells per crypt. (C) Association between the % of AOM-
induced MGMT+ (DNA repair) cells and % of H2AX+ cells per crypt in stem and differentiated 
(Diff) cells. Repair index = # of MGMT+ stem or differentiated cells/total # of stem or differentiated 
cells per crypt X 100 at 12 and 24 hr post-AOM injection; DNA damage index = # of H2AX+ stem 
or differentiated cells/total # of stem or differentiated cells per crypt X 100 at 12 and 24 hr post-
AOM injection. Slope where the difference from zero is statistically significant is marked in red 
(Stem, 24 hr) or blue (Diff, 24 hr). (D) (left panel) % of H2AX+ cells expressing MGMT (both 
H2AX+ and MGMT+ stem or differentiated cells/H2AX + stem or differentiated cells) at 12 and 24 
hr (right) post-AOM injection; (right panel) % of H2AX− cells expressing MGMT (both H2AX− and 
MGMT+ stem or differentiated cells/H2AX− stem or differentiated cells) at 12 and 24 hr post-AOM 
injection. Different letters or * indicate significant differences between treatment groups (p < 0.05). 
Refer to Figure 2 legend for animal numbers. 
A 
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Figure 7. Breast cancer genes 1 (BRCA1) and RAD51 recombinase (RAD51) expression 
in mouse colonic crypts at 12 and 24 hr post AOM injection. Representative images 
(objective, 40X) of BRCA1+ (white) and RAD51+ (red) cells are shown counter-stained with 
DAPI (blue).  Saline represents control sections.   
 
 
2.3.5 Lgr5+ cells exhibit increased proliferation following AOM exposure 
Elevated crypt epithelial cell proliferation is considered a risk factor for 
colon cancer (Chapkin and Lupton, 1999). For example, assessment of colonic 
crypt cell proliferation, including detection of an increased proliferative state 
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and expansion of the proliferative zone, are considered putative intermediate 
markers of colon cancer risk (Colussi et al., 2001). Furthermore, it has been 
shown that alkylating agent exposure results in increased colonic crypt 
cellularity, colonic crypt cell proliferation and the crypt proliferative zone 
(Richards, 1977). Therefore, we determined whether AOM injection results in 
increased GFPhigh cell proliferation in the presence of AOM in the distal colon.  
As shown in Figures 8A&B, no reduction in cell cycle was observed immediately 
following AOM injection (12 hr) both in GFPhigh and GFPneg cells. However, a 
significant increase in cell proliferation (EdU labeling) was detected in GFPhjgh 
cells at 24 hr (Figure 8B) and the increase in proliferation was associated with 
the induction of DNA damage (slope=0.98, p=0.01) as assessed by linear 
regression analysis (Figure 8C).  In contrast, this association was not detected 
in GFPneg cells. Figure 8D (left) also shows that the percentage of GFPhjgh, 
H2AX+, EdU+ triple positive Lgr5+ stem cells increased overtime.  This is 
consistent with the fact that Lgr5+ cells are actively cycling and have a greater 
chance of accumulating DNA double breaks as compared to differentiated cells 
(Staszewski et al., 2008). The percentage of H2AX-, EdU+ cells did not exhibit 
a cell type or temporal response (Figure 8D right). 
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Figure 8. Comparison of AOM-induced proliferation in stem cells and differentiated cells. 
(A) Representative images (objective, 40×) of GFP+ (Lgr5+ stem cells), H2AX+ (DSBs) and 
EdU+ (proliferation) cells are shown. For comparative purposes, immunofluorescence staining 
of colonic crypts in the distal colon in saline (control) and AOM injected mice is shown. (B) % 
EdU+ stem cells and differentiated cells per crypt. (C) Association between the % of AOM-
induced proliferating cells and % of H2AX+ cells per crypt in both stem and differentiated (Diff) 
cells. Proliferating index = # of EdU+ stem or differentiated cells/total # of stem or differentiated 
cells per crypt X 100 at 12 and 24 hr post-AOM injection; DNA damage index = # of 
H2AX+ stem or differentiated cells/total # of stem or differentiated cells per crypt X 100 at 12 
and 24 hr post-AOM injection. Slope where the difference from zero is statistically significant is 
marked in red (stem, 24 hr). (D) (left panel) % of H2AX+ cells also positive for EdU (both 
H2AX+ and EdU+ stem or differentiated cells/H2AX+ stem or differentiated cells) at 12 and 24 
hr post-AOM injection; (right panel) % of H2AX− cells positive for EdU (both H2AX− and 
EdU+ stem or differentiated cells/H2AX− stem or differentiated cells) at 12 and 24 hr post-AOM 
injection. Different letters or * indicate significant differences between treatment groups (p < 
0.05). Refer to Figure 1 legend for animal numbers. 
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2.4 Discussion 
Historically, alkylating agents are known to produce gastrointestinal 
tumors in rodents (Hawks and Magee, 1974; James and Autrup, 1983), and to 
cause cancer in humans as a result of lifetime environmental exposures (Hall 
et al., 1991). Of the spectrum of adducts produced by AOM, O6MeG accounts 
for ~8% of the total DNA methyl adducts, is stable and persists in the absence 
of the DNA repair enzyme MGMT (Kondo et al., 2010).  If left unrepaired, this 
adduct remains in the genome, triggering a futile repair loop which can 
eventually result in highly toxic double-strand breaks (DSBs), which are 
intermediates in apoptotic and DSB repair pathways (Karran and Bignami, 
1992). DSBs are the most dominant cytotoxic effect generated by AOM (Kondo 
et al., 2010), and are typically detected at 12 hr following exposure (Hong et 
al., 2000). This form of alkylation-induced DNA damage is clinically relevant 
because AOM hyper-activates -catenin and K-ras signaling, which are 
dysregulated in sporadic colorectal cancer in humans (Hata et al., 2004; 
Takahashi and Wakabayashi, 2004).  In addition, this preclinical model 
recapitulates the pathogenesis of human sporadic colon cancer (Deschner and 
Long, 1977).  
Colon cancer has been suggested to follow a cancer stem cell (CSC) 
hierarchical model (Barker et al., 2009; Chandler and Lagasse, 2010).  Several 
studies have monitored DNA damage in stem cells, including MNNG-induced 
(Tominaga et al., 1997) and radiation-induced (Asfaha et al., 2015; Bhanja et 
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al., 2009) mouse stem cells, and small intestinal Lgr5+ stem cells at the initiation 
stage of tumorigenesis (Metcalfe et al., 2014). Moreover, the transformation of 
actively cycling, long-lived intestinal Lgr5+ stem cells drives intestinal cancer 
(Barker et al., 2007). Overexpression of Lgr5 has been shown to occur in 
human colorectal adenomas and cancers (Fan et al., 2010), as well as in other 
solid tumors (McClanahan et al., 2006). However, to date, no investigation has 
determined the in vivo effect of AOM exposure with respect to colonic Lgr5+ 
stem cells.  In the present study, we report for the first time the biological 
properties of AOM-damaged colonic Lgr5+ stem cells at the initiation stage of 
tumorigenesis. For this purpose, the relationship between DNA damage, 
apoptosis, repair, and cell cycle arrest was examined in Lgr5+ stem cells versus 
differentiated cells within the colonic crypt at 12 and 24 hr following the 
administration of carcinogen.                                                                          
We have previously demonstrated that (a) AOM induces DNA damage 
to a greater degree in actively proliferating cells at the base of the crypt (Hong 
et al., 1999); (b) AOM-induced apoptosis is primarily targeted to the base of the 
crypt (Hong et al., 1999); and (c) AOM-induced MGMT protein expression 
increases over time in the bottom one-third of the crypt as compared to the 
differentiated cell compartment (Hong et al., 2000). In the present study, we 
extend these findings by demonstrating that: DNA damage occurs to a greater 
degree in Lgr5+ stem cells (located at the base of the crypt) as compared to the 
differentiated cell compartment (Figure 2). It is assumed that AOM induced 
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H2AX phosphorylation occurs during DNA replication in rapidly cycling Lgr5+ 
stem cells before the damage has been repaired, i.e., restored to normal 
(O'Neill, 2000). This finding is consistent with the fact that alkylating agent-
induced H2AX foci are selectively formed in proliferating cells (Staszewski et 
al., 2008). In addition, we also demonstrate that colonic Lgr5+ stem cells 
uniquely respond to AOM by inducing preferential apoptosis (Figure 4B), which 
is positively associated with induced H2AX (Figure 4C), whereas differentiated 
cells do not exhibit this response. These findings are consistent with the fact 
that stem cells exhibit a rapid apoptotic response due to mitochondrial priming 
in a p53 dependent manner (Liu et al., 2013). It is noteworthy that AOM-induced 
apoptosis is p53-dependent whereas spontaneous apoptosis is p53-
independent (Hu et al., 2005). However, it remains to be determined whether 
the induced apoptosis in Lgr5+ stem cells is promoted due to p53-dependent 
mitochondrial priming.  
Interestingly, “untargeted” apoptosis (TUNEL+, H2AX-) in Lgr5+ stem 
cells (Figure 4D right) was 2.2-fold higher than “targeted” apoptosis (TUNEL+, 
H2AX+) (Figure 4D left), implying an inefficient removal of damaged Lgr5+ stem 
cells via programmed cell death. Apoptotic cell death might be considered 
protective, because it selectively eliminates damaged cells that can contribute 
to carcinogenesis. However, untargeted cell death in the presence of residual 
DNA damage could promote cell proliferation and generate defective progenitor 
cells, which is potentially a tumor-promoting factor (Hua et al., 2012). It has also 
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been demonstrated that untargeted apoptosis can mediate DNA damage and 
induce chromosomal instability in neighboring cells (Coquerelle et al., 1995; 
Yang et al., 2013). Therefore, primary prevention strategies resulting in a 
favorable enhancement of apoptosis in damaged Lgr5+ stem cells would be 
expected to reduce colon cancer risk.  
Data in Figure 4D indicate that the majority of apoptosis occurs in 
undamaged GFPhigh Lgr5+ stem cells following AOM exposure. Based on the 
proximity of H2AX+ cells to TUNEL+, H2AX- Lgr5+ stem cells, we have 
proposed the involvement of an AOM-induced BE (Figure 5).  This unexpected 
outcome suggests that undamaged ‘bystander’ Lgr5+ stem cells are being 
indirectly influenced by the intestinal niche. For example, numerous studies 
have shown that irradiated/damaged colonic cells can induce secondary 
apoptosis (Furlong et al., 2013) and H2AX foci in non-irradiated cells via 
bystander effects (Dickey et al., 2011). This process, in part, may be mediated 
by lipid rafts (Burdak-Rothkamm et al., 2007) via the absorption of exosomes 
by naïve bystander cells (Al-Mayah et al., 2012) or intestinal commensal 
bacteria by triggering macrophages (Yang et al., 2013). It is noteworthy that 
bystander cells exhibit a significant pro-apoptotic gene expression profile 
compared to cells directly impacted by radiation (Furlong et al., 2013). From a 
mechanistic perspective, soluble mediators induced by AOM such as PGE2 
may partly mediate this process (Riehl et al., 2006; Zhou et al., 2005). 
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Additional studies are required to further elucidate the mechanism of the 
alkylation-induced bystander effects.  
With respect to cell proliferation, we also determined that Lgr5+ stem 
cells exhibiting DNA damage were actively cycling (Figure 8D left), and that 
proliferation was positively associated with DNA damage (Figure 8C), implying 
that Lgr5+ stem cells have a high potential to accumulate mutations which 
enhance the risk of tumorigenesis. These findings provide a model for future 
therapeutic studies designed to ameliorate the effects of DNA damage in Lgr5+ 
stem cells. Importantly, the level of H2AX+, GFPhigh cells (56%) per crypt was 
4.1-fold higher (Figure 2) than EdU+, GFPhigh cells (14%) per crypt (Figure 8B) 
at 12 hr. This implies that DSBs may also be formed independently of cell 
division. H2AX induced by bystander effects might explain the relatively high 
number of H2AX+, GFPhigh cells compared to H2AX+, GFPhigh. This may in 
part be mediated by apurinic (AP) sites generated from release of N-
methylpurines which can be converted into DSBs by the activity of the AP 
endonuclease (Coquerelle et al., 1995).  
A goal of the present study was to assess the localization of the MGMT 
repair enzyme in both the Lgr5+ stem cell and differentiated cell compartments, 
which is not possible when using scraped mucosa for enzyme assays. MGMT 
methylation status has been shown to influence the risk of colon cancer 
development (Kycler et al., 2012) and it is known that MGMT expression is 
regulated by p53 in human astrocytic cells (Blough et al., 2007) and human 
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brain tumors (Russell et al., 1995). This is noteworthy because p53 in Lgr5+ 
stem cells is a critical regulator of AOM/DSS induced tumorigenesis 
[unpublished data] and MGMT has been shown to function similarly in humans 
and rats (Gerson et al., 1995). Therefore, it was interesting to note that Lgr5+ 
stem cells preferentially induced MGMT in response to DNA damage as 
compared to differentiated cells. It is possible that this increased expression 
may represent both an increase in protein expression and also an accumulation 
of inactive protein targeted for degradation, a distinction that would have to be 
further evaluated by measuring enzyme activity. Our findings also indicate that 
Lgr5+ stem cells can modulate cancer risk by promoting DNA repair (Figures 
6B&C) and by promoting targeted apoptosis (Figure 5D left). Interestingly, we 
did not detect evidence of an AOM-induced post-replicative repair process in 
Lgr5+ stem cells (Figure 7). Collectively these results help clarify the 
homeostatic responses of Lgr5+ stem cells at the initiation stage of 
tumorigenesis.  
In summary, we demonstrate for the first time that colonic Lgr5+ stem 
cells actively induce repair enzyme following AOM-induced DNA damage. This 
phenotype is consistent with the enhanced xenobiotic resistance reported in 
normal stem cells, attributed in part to a more efficient DNA repair response 
(Kenyon and Gerson, 2007). Importantly, the stem-like state is deeply linked to 
resilience and stress response, a relationship that appears to hold for their 
neoplastic counterpart, the cancer stem cell (CSC) (Dean et al., 2005; 
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Donnenberg and Donnenberg, 2005; Medema, 2013; Pisco and Huang, 2015). 
Thus, we propose that the monitoring of Lgr5+ stem cell targeting responses 
provides a powerful tool to interrogate primary prevention strategies, e.g., diet 
and exercise, to specifically eradicate damaged Lgr5+ stem cells. Ultimately, 
this strategy will provide a better understanding of the origin of colon cancer 
and the development of diagnostic tests that can detect cancer development at 
its earliest stages, which will improve overall survival.  
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3. EFFECT OF n-3 PUFA AND CURCUMIN ON TARGETING DNA DAMAGED 
LGR5+ STEM CELL* 
 
3.1      Introduction 
Numerous epidemiological studies have established strong evidence 
that many cancers including colon cancer have substantial risk proportions 
attributed to extrinsic factors such as diet, smoking and obesity (Kesse et al., 
2006; Potter, 1999; Wu et al., 2016). High fat diet (HFD)-induced obesity 
augments stemness and tumorigenicity of intestinal progenitors (Beyaz et al., 
2016; Schulz et al., 2014). In addition, epithelial colonic G protein-coupled 
receptor 5 (Lgr5)+ stem cells respond to HFD (DeClercq et al., 2015) and 
genotoxic carcinogen, e.g., azoxymethane (AOM) (Kim et al., 2016a), during 
the cancer initiation stage. It has been also demonstrated that colonic Lgr5+ 
stem cells are preferentially damaged by AOM compared to differentiated cells 
(Kim et al., 2016a). A functional consequence of this status could enhance 
tumorigenesis. Thus, induction of apoptosis in DNA damaged Lgr5+ stem cells 
is likely to be a useful marker for successful cancer prevention, and may hold  
*This chapter is reprinted with permission from “Rapidly cycling Lgr5+ stem cells are exquisitely sensitive 
to extrinsic dietary factors that modulate colon cancer risk” by Eunjoo Kim; Laurie A Davidson; Roger S 
Zoh; Martha E Hensel; Michael L Salinas; Bhimanagouda S Patil; Guddadarangavvanahally K 
Jayaprakasha; Evelyn S Callaway; Clinton D Allred; Nancy D Turner; Brad R Weeks & Robert S Chapkin. 
Cell Death and Disease 2016, 7(11):e2460. doi: 10.1038/cddis.2016.269. Copyright (2016) by Nature 
Publishing Group. 
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promise for identifying novel and improved cancer chemo-preventive agents. 
For example, it has been shown that nonsteroidal anti-inflammatory drugs 
(NSAIDs) can induce apoptosis in Lgr5+ stem cells and suppress adenoma 
formation in APCMin/+ mice (Leibowitz et al., 2014; Qiu et al., 2010). Long-term 
use of NSAIDs, in particular COX-2-specific inhibitors, is associated with side 
effects, which has stimulated the development of new targets and combination 
strategies for cancer chemoprevention (Meyskens et al., 2008). 
It is clear that select extrinsic bioactives, e.g., n-3 polyunsaturated fatty 
acids (n-3 PUFA) and curcumin (Cur), independently reduce aberrant crypt foci 
(ACF) and polyp formation in humans (Carroll et al., 2011; West et al., 2010) 
and combinations of the two have been reported to exert synergistic effects 
related to the suppression of chronic inflammation and cell proliferation and the 
promotion of apoptosis in breast and pancreatic cancers (Altenburg et al., 2011; 
Jia et al., 2011; Saw et al., 2010; Siddiqui et al., 2013; Swamy et al., 2008). 
From a mechanistic perspective, the combination of n-3 PUFA and curcumin 
has been shown to suppress NFB activation in mouse colonic mucosa (Jia et 
al., 2011) in part by altering plasma membrane composition (Kim et al., 2009), 
which is required for activation of the apoptotic pathways (Beneteau et al., 
2008; Gajate and Mollinedo, 2011). The suppression of inflammatory mediators 
such as COX-2, inducible nitric oxide synthase (iNOS), prostaglandin E2 
(PGE2), 5-lipoxygenase (5-LOX) and cytosolic phospholipase A2 (cPLA2) has 
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also been linked to the synergistic action of curcumin and n-3 PUFA, e.g., 
docosahexaenoic acid (DHA) (Saw et al., 2010; Swamy et al., 2008).  
DHA and curcumin synergistically induce p53 activation (Altenburg et 
al., 2011; Siddiqui et al., 2013), a well-known tumor suppressor (Stracquadanio 
et al., 2016; Vogelstein et al., 2000).  This is noteworthy, because p53 functions 
in part to inhibit NFB activity, thereby inducing apoptosis in human colon 
cancer cells (Shao et al., 2000) (Puszynski et al., 2009). In contrast, the loss of 
p53 during tumor progression promotes an NFB dependent inflammatory 
microenvironment (Schwitalla et al., 2013b), which is a critical event in the 
commitment of stem cells to apoptosis following DNA damage (Davidson et al., 
2015; Dumitru et al., 2012). Unfortunately, the properties of extrinsic chemo-
protective natural compounds known to enhance the p53 signaling pathway in 
colonic adult stem cells from the perspective of cancer initiation and 
progression have not been determined.  
 In this study, we assessed the chemo-protective effects of diet on Lgr5+ 
stem cell homeostasis in the context of AOM-induced tumorigenesis at both the 
initiation and pre-tumor stages. Our novel data provide evidence that curcumin 
combined with n-3 PUFA synergistically reduces AOM-induced nuclear 
catenin levels in ACF in part by promoting p53-dependent signaling and 
targeted apoptosis in damaged Lgr5+ stem cells at the initiation stage. We also 
provide evidence that DNA damaged Lgr5+ stem cells are highly responsive to 
the combination diet compared to DNA damaged differentiated cells. Our 
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findings demonstrate for the first time that rapidly cycling Lgr5+ stem cells are 
exquisitely sensitive to extrinsic dietary factors which modulate colon cancer 
risk.  
 
3.2 Material and methods 
3.2.1 Animals and study design 
The animal use protocol was approved by the University Animal Care 
Committee of Texas A&M University and conformed to NIH guidelines. Lgr5-
EGFP-IRES-CreERT2 knock-in mice (Barker et al., 2009), 6-7 wk old, were 
acclimated for 1 wk and then maintained on a semi-purified diet (Figure 9A) for 
3 wks prior to injection with AOM (Sigma, St. Louis, MO, 10 mg/kg body weight). 
Mice were injected with AOM once a week for 6 wks and euthanized by CO2 
asphyxiation at 17 wks (n=7~8 per group) after the last AOM injection (Figure 
9B). In complementary experiments, mice were injected with a single dose of 
AOM and euthanized 12 (n=8) or 24 hr (n=8) later (Figure 9C). Control mice 
(n=3) received a single saline injection. Mice were injected with EdU (Life 
Technologies) 2 h prior to sacrifice. Immediately after termination, the distal 
colon was rapidly removed, flushed with ice-cold saline and a longitudinal 
section of the distal colon was immediately fixed in 4% paraformaldehyde for 
hematoxylin and eosin (H&E) staining and immunofluorescence analyses. 
Figure 9B&C shows the timeline of the treatments and the experimental design. 
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3.2.2 Diets 
Diet sources have been previously reported (Kim et al., 2009).  A 
complete diet containing 5% corn oil (containing n-6 PUFA) was used as a 
baseline control, i.e., contained no n-3 PUFA or curcumin. The control diet was 
supplemented with 1% (w/w) curcumin (n-6 PUFA + Cur) to determine the effect 
of curcumin. A diet containing 4% (w/w) Menhaden fish oil (enriched in n-3 
PUFA) was used to assess the effect of n-3 PUFA alone, while a fish oil + 
curcumin (n-3 PUFA + Cur) diet was used to determine the additive/synergistic 
effects of these dietary bioactives. Both n-3 PUFA and n-3 PUFA + Cur diets 
contained 1% corn oil (w/w) to ensure that essential fatty acid requirements 
were met (Figure 9A). Mice were provided with fresh diet every day and the 
feeders were removed and washed daily. Animals had free access to food and 
water at all times and 24 hr food intakes were measured after 1 week of 
receiving the diets (Figure 9D). Body weights were recorded each week (Figure 
9E) and weight gain was not affected by the experimental diets. The fatty acid 
composition of the diets was analyzed by gas chromatography and the level of 
curcumin was quantified by 1H NMR (Jayaprakasha et al., 2013). The fatty acid 
composition of the crypt was quantified by gas chromatography (Fan et al., 
2003) and the level of curcumin was quantified by HPLC (Cuomo et al., 2011; 
Jayaprakasha et al., 2013). 
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3.2.3 In vivo DNA damage and repair measurement 
Longitudinal sections of paraffin-embedded colon sections (4 m) were 
deparaffinized, rehydrated through graded ethanol and stained with antibodies 
using standard procedures. DNA double strand breaks were measured by 
immunofluorescence using a rabbit monoclonal phospho-gamma H2AX 
(H2AX) Ser139 antibody (9718, Cell Signaling; dilution 1:200). Lgr5+ stem cells 
were labeled using goat polyclonal GFP antibody (ab6673, Abcam; dilution 
1:400) and O6meG DNA adduct removal was estimated by the induction of O6-
methylguanine-methyl transferase (MGMT) expression using a mouse 
monoclonal MGMT antibody (ab54306, Abcam; prediluted). Secondary 
antibodies were anti-rabbit Alexa 647 (711-605-152, Jackson 
ImmunoResearch: dilution 1:400) for H2AX, anti-goat 488 (705-545-147, 
Jackson ImmunoResearch) for GFP and anti-mouse Alexa 546 (A10036, Life 
Technologies) for MGMT.  Negative control slides were incubated without 
primary antibody. The DNA damage (or repair) index was determined by 
dividing the number of H2AX+ (or MGMT+) cells by the total number of cells in 
each crypt column and multiplying by 100. 
 
3.2.4 Slide scoring of in vivo apoptosis 
To investigate whether alkylating agent-induced DNA damage resulted 
in apoptotic cell death in colonic Lgr5+ stem cells, free 3'OH DNA termini were 
labeled using the TUNEL procedure according to the manufacturer’s 
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recommendations using the TACS 2 TdT-Fluor in situ apoptosis detection kit 
(4810-30-K and 4810-30-R, Trevigen) and detected with Streptavidin-CY3 
(438315, Life Technologies). Negative control slides were incubated without 
TdT enzyme. The apoptotic index was determined by dividing the number of 
apoptotic cells by the total number of cells in the crypt column and multiplying 
by 100. To corroborate the frequency of epithelial cells undergoing apoptosis, 
paraffin-embedded sections were also assessed by H&E staining by a blinded 
pathologist with both assays showing similar results.  
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Figure 9. Timeline of treatments and the experimental design. (A) Experimental diet 
composition. Timeline of the treatments at pre-tumor stage (B) and initiation stage (C) of 
tumorigenesis. (D) Food intake and (E) body weight gain. (F) Amount of fatty acids and 
curcumin in colonic crypts (n=4). n-6: n-6 PUFA, n-6+Cur: n-6 PUFA + curcumin, n-3: n-3 
PUFA, and n-3+Cur: n-3 PUFA + curcumin.  
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D 
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3.2.5 In vivo measurement of cell proliferation 
To investigate the effects of alkylating agent-induced DNA damage on 
cell cycle activity in colonic epithelial cells, proliferating cells were measured 
using the Click-iT EdU Alexa Fluor 555 Imaging kit (Life Technologies) as per 
manufacturer’s instructions. Negative control slides were incubated without 
Alexa Fluor. The proliferation index was determined by dividing the number of 
proliferating cells by the total number of cells in the crypt column and multiplying 
by 100. 
 
3.2.6 In vivo measurement of Bax expression 
To measure the chemo-protective effect of diet and carcinogen on Bax 
expression in the colon, Lgr5+ stem cells were labeled using goat polyclonal 
GFP antibody (ab6673, Abcam; dilution 1:400) and rabbit monoclonal total Bax 
antibody (14796, Cell Signaling; dilution 1:400). Secondary antibodies were 
anti-goat 488 (705-545-147, Jackson ImmunoResearch) for GFP and anti-
rabbit Alexa 647 (711-605-152, Jackson ImmunoResearch: dilution 1:400) for 
Bax. Negative control slides were incubated without Alexa Fluor.  For each high 
power field (objective, 40X), GFP positive crypts were assessed by defining 
regions of interest for analysis. GFP staining was used to define the region of 
interest and to assess differentiated cells and stem cells within a crypt. The ratio 
of Bax expression in Lgr5+ stem/differentiated cells was determined using NIS 
Image software, version 3.2 (Nikon).  
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3.2.7 Image acquisition and analysis 
All immunofluorescent images of colonic crypts were captured using an 
inverted TE 300 Nikon Eclipse fluorescence microscope equipped with 
40X/1.30 Nikon Plan Fluor oil immersion objective and a Photometrics Cool 
Snap EZ digital CCD camera and a SOLA external light source. Images were 
processed using NIS Image software, version 3.2 (Nikon). Greater than 40 GFP 
positive crypts per animal in each treatment group were examined by one 
reader. The number of animals used for each assay is described in each figure 
legend.  
 
3.2.8 Lgr5+ stem cell isolation from colonic crypt using fluorescence activated 
cell sorting (FACS) 
Colonic crypts were isolated by the method of Sato et al (Sato et al., 
2009) with minor modification. 3 cm of the distal colon was removed and flushed 
with Ca/Mg free PBS containing P/S. After opening longitudinally, it was placed 
into 30 mL PBS and vigorously vortexed. The colon is then incubated with 2 
mM EGTA in PBS at 37 °C for 15 min followed by another incubation with the 
20 mM EGTA in PBS at 37° C for 15 min. Following transfer to chilled Ca/Mg 
free PBS, colons were vigorously vortexed to release crypts. The crypts were 
then incubated with 50 L of DNase (stock concentration- 20 units/mL) in 10 
mL of 0.25% trypsin solution at 37 °C for 10 min and single cells were then 
passed through a 40 m cell strainer. The cells were counted and resuspended 
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to a final cell density of 2 x106 cells/mL. To examine the global transcriptome in 
stem  vs differentiated cells, isolated colonocytes from the distal colon were 
sorted based on GFP expression using a Beckman Coulter MoFlo Astrios as 
previously described (Fan et al., 2014). Approximately 12,000 GFPhigh cells 
(stem cells) and 275,000 GFPneg cells (differentiated cells) were sorted for each 
treated mouse. Cells from wild type mice were used to set the gates for sorting.  
 
3.2.9 RNA sequencing 
Total RNA from isolated cells was isolated using RNA nanoprep kit 
(Zymo Research, R1050) following the manufacturer’s protocol. RNA quantity 
and quality were measured by nanodrop and Agilent 2100 Bioanalyzer (Agilent 
Technologies, CA) respectively. Isolated total RNA (2 ng) from each sample 
was subsequently prepared for sequencing using the NuGen Ovation® Single 
Cell RNA-Seq System (0342HV). Samples were sequenced for 75 cycles with 
single index reads on the NextSeq 500 (Illumina). Following the removal of all 
genes with CPM (counts-per-million reads) values less than 1, publicly 
available R software, EdgeR, was used to identify differentially expressed 
genes. In total, 15,043 genes were queried to detect differentially expressed 
genes. 
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3.2.10 Ingenuity pathway analysis (IPA) 
Genes differentially expressed (FDR < 0.05) in GFPhigh versus GFPneg 
cells were included in pathway and function analyses (Shah et al., 2011; Triff 
et al., 2013) using Ingenuity software (IPA; Ingenuity® Systems, 
http://www.ingenuity.com). Statistical significance of the association between 
each data set and the canonical pathway was determined based on two 
parameters: (1) A ratio of the number of genes from the data set that map to 
the pathway divided by the total number of genes that map to the canonical 
pathway, and (2) P-values calculated using Fischer's exact test determining the 
probability that the association between the genes in the data set and the 
canonical pathway is due to chance alone. The upstream regulator analysis 
function of IPA was subsequently used to identify potential transcriptional 
regulators that could explain the observed changes in gene expression. The 
activation z-score was calculated to predict activation or inhibition of 
transcriptional regulators based on published findings accessible through the 
Ingenuity knowledge base. Regulators with a z-score greater than 1.96 or less 
than -1.96 were considered to be significantly activated or inhibited. Functions 
and pathways with P-value < 0.05 (Fischer’s exact test) were considered to be 
statistically significant. 
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3.2.11 ACF quantification 
Paraffin-embedded, H&E stained distal colon sections (4 m) were 
examined for ACF by a veterinary pathologist. Photomicrographs were taken at 
40X. ACF were defined as crypts with more than one of the following features: 
loss of polarity, nuclear atypia (enlarged nuclei, vesiculated chromatin, 
crowding), mucin depletion, and crypt multiplicity. Emphasis was placed on 
aberrant crypt multiplicity as a cardinal change. The presence of ACF adjacent 
to lymphoid follicles were not considered true ACF because proximity to 
lymphoid tissue may promote changes related to inflammation. For this study, 
only crypts with criteria matching Group C (dysplastic microadenomas, with 
enlarged, elongated and sometimes stratified nuclei with loss of polarity, mucin 
depletion and dysplasia) as defined by (Di Gregorio et al., 1997) were 
considered aberrant crypt foci. The number of ACF per section was quantified 
and the location mapped using mm measurements from the slide corner. In 
addition, complementary immunohistochemistry was performed to assess co-
labeling with -catenin.  
 
3.2.12 -catenin subcellular localization in nucleus and cytoplasmic ACF 
Serial sections were used to measure the subcellular localization of -
catenin in ACF. To measure the ratio of nuclear to cytosolic -catenin in ACF, 
tissue was labeled using a mouse monoclonal -catenin antibody (610154, BD 
Transduction; dilution 1:500) (Hata et al., 2004; Yamada et al., 2001). 
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Secondary antibody was anti-mouse Alexa 546 (A10036, Life Technologies). 
Nuclear staining was detected by counterstaining cells with 4', 6-Diamidino-2-
phenylindole, DAPI (P36935, Life Technologies). Negative control slides were 
incubated without primary antibody. For each high power field (objective, 40X), 
ACF areas stained with -catenin and DAPI were assessed by defining regions 
of interest for analysis. DAPI staining was used to define the nuclear region of 
interest and to separate nuclear and cytoplasmic staining within a cell. The ratio 
of nuclear to cytosolic -catenin was measured using NIS Image software, 
version 3.2 (Nikon).  
 
3.2.13 Statistics 
Data were analyzed using two-way analysis of variance and the 
estimated mean groups were subsequently compared using simple t-tests. A 
Tukey approach was used to adjust the resulting p-values for multiple 
comparisons. The significant comparisons were obtained based on the 
adjusted p-values<0.05.  
 
3.3 Results 
3.3.1 n-3 PUFA and curcumin synergize to promote targeted apoptosis of 
damaged Lgr5+ stem cells at the tumor initiation stage 
To elucidate the unique properties of colonic Lgr5+ stem cells in terms of 
their response to bioactive compounds in the presence of carcinogen, we 
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utilized mice carrying a gene for enhanced green fluorescent protein (EGFP) 
knocked into the Lgr5 genomic locus (Barker and Clevers, 2007). Mice were 
fed with n-3 PUFA and curcumin alone or in combination for 3 wks, injected 
with AOM, and analyzed to measure DNA damage (H2AX), apoptosis 
(TUNEL), damage repair (O6-methylguanine-methyl transferase, MGMT) and 
proliferation (EdU) in crypts 12 and 24 hr later as previously described (Kim et 
al., 2016a). Because the integration cassette in this mouse model is 
epigenetically silent in about 60%–70% of crypts (Barker et al., 2007), we 
analyzed only GFP positive crypts using fluorescence microscopy. No 
differences between GFPhigh and GFPneg crypts in response to carcinogen and 
bioactive compounds were observed (data not shown). In a separate 
experiment, levels of n-3 PUFA, n-6 PUFA and curcumin incorporated into 
colonic crypts were assessed following a 3 wks feeding period (Figure 9F). The 
data demonstrate that these bioactives were readily incorporated into the target 
site. 
It has been demonstrated that Lgr5+ stem cells are preferentially 
damaged by AOM in the distal colon compared to differentiated cells (Kim et 
al., 2016a) and n-3 PUFA reduce AOM-induced DNA adducts (Hong et al., 
2000) which cause double strand breaks (DSBs) (Karran and Bignami, 1992). 
Therefore, to determine the chemo-protective effects of combinatorial 
bioactives on AOM-induced DNA damage in Lgr5+ stem cells as compared to 
differentiated cells in vivo, we measured H2AX, a marker of the double strand 
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breaks (Kuo and Yang, 2008). As shown in Figure 10A, the level of DNA 
damaged stem cells at 12 hr in both n-3 PUFA and n-3 PUFA + Cur treatments 
was 50% lower than the n-6 PUFA. In comparison, DNA damage in n-6 PUFA 
+ Cur was 33% lower compared to n-6 PUFA fed mice. Strikingly, by 24 hr, the 
n-3 PUFA + Cur group maximally decreased damaged Lgr5+ stem cells, i.e., 
the level was not different from the saline-injected mice. 
The deletion of damaged Lgr5+ stem cells, the cells of origin of colon 
cancer (Barker et al., 2009), is a critical mechanism to prevent tumorigenesis 
in the intestine (Leibowitz et al., 2014). Since n-3 PUFA (Hong et al., 2003; 
Hong et al., 2000) and curcumin (Xu et al., 2010) promote apoptosis in 1,2-
dimethylhydrazine (DMH) or AOM injected rats, we next investigated the 
synergistic effects of n-3 PUFA + Cur on the Lgr5+ stem cell acute DNA damage 
response. Figure 10B shows representative co-localization images of DNA 
damaged (H2AX, white) Lgr5+ stem cells (GFP, green) with apoptosis 
(TUNEL, red), DNA repair (MGMT, red) or cell proliferation (EdU, red). As 
shown in Figure 11A, immediately following AOM exposure, n-3 PUFA and 
curcumin either alone or in combination increased apoptosis greater than 1.5 
fold in Lgr5+ stem cells (open symbols) at 12 hr compared to n-6 PUFA, 
whereas the apoptotic response was significantly lower in differentiated cells 
across all groups (filled symbols). 
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Figure 10. Effect of n-3 PUFA ± curcumin on AOM-induced DNA double strand breaks in 
mouse colonic crypts at 12 and 24 hr post AOM injection. (A) Comparison of H2AX+ (DNA 
damaged) stem and differentiated cells in the distal colon of saline (control) and 12 and 24 hr 
post AOM injected mice (left). GFP+ crypts from n=8-9 mice at 12 hr, and n=3 for saline and 24 
hr were counted. Statistically significant differences between diets and treatments were 
determined using two-way ANOVA followed by Tukey’s multiple comparison test adjustment. 
Different letters indicate significant differences between treatment groups in each time 
(p<0.05). Means and standard errors of the mean (SEM) in different cell types, diets and 
treatments are listed in the table (right). Diets are labeled with different symbols and the open 
symbols refer to stem cells whereas filled symbols refer to differentiated cells. (B) 
Representative images (objective, 40X) of GFP+ (GFP positive Lgr5 stem cells, green), H2AX+ 
DNA double strand breaks, white) and TUNEL+ (apoptotic body, red) cells 12 hr after AOM. 
Representative images of MGMT+ (damage repairing cells, red) and EdU+ (proliferating cells) 
cells 24 hr following AOM exposure. Saline injected animals serve as the control.  
A 
B 
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Next, using a simple linear regression analysis, we determined whether 
there is any association between AOM-induced apoptosis and AOM-induced 
damage. As shown in Figure 11B (left), n-3 PUFA + Cur (slope=0.65) and n-6 
PUFA (slope=0.61) exhibited a significant proportional increase in apoptosis in 
Lgr5+ stem cells in response to DNA damage at 12 hr. However, n-3 PUFA + 
Cur exhibited less than 40% of damaged (H2AX+) Lgr5+ stem cells per crypt 
(DNA damage index) whereas n-6 PUFA had 40-80% of damaged Lgr5+ stem 
cells per crypt. These data suggest that Lgr5+ stem cells responded efficiently 
to n-3 PUFA + Cur treatment in the presence of DNA damage by inducing 
apoptosis, whereas differentiated cells were not responsive (small symbols 
within the dotted line). We subsequently quantified the number of damaged 
Lgr5+ stem cells that were targeted for apoptotic deletion, i.e., GFP+, TUNEL+, 
H2AX+ triple positive cells, since the selective deletion of damaged Lgr5+ stem 
cells through apoptosis could mitigate the clonal expansion of damaged Lgr5+ 
stem cells. As shown in Figure 11C (right), 62% of DNA damaged Lgr5+ stem 
cells were deleted by apoptosis in n-3 PUFA + Cur treated mice at 12 hr, which 
was 5-fold higher than the n-6 PUFA group. Importantly, n-3 PUFA and 
curcumin interaction was only detected in Lgr5+ stem cells (p=0.025) and not in 
differentiated cells (p=0.526) (Tables 3A&B). These novel findings demonstrate 
that DNA damaged Lgr5+ stem cells uniquely respond to n-3 PUFA and Cur, 
and n-3 PUFA and Cur synergize to promote the deletion of DNA damaged 
Lgr5+ stem cell. 
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Figure 11. Effect of n-3 PUFA ± curcumin on AOM-induced apoptosis in mouse colonic 
crypts at 12 and 24 hr post AOM injection. (A) Comparison of TUNEL+ (apoptotic) stem and 
differentiated cells in the distal colon of saline, and 12 and 24 hr post AOM injected mice (left). 
Refer to Figure 1A legend for animal number and statistical details. Different letters indicate 
significant (p<0.05) differences between treatment groups at each time point.  (B) Association 
between AOM-induced apoptotic cells and H2AX+ cells in stem and differentiated cells at 12 
hr (left) and 24 hr (right). Each point represents an individual animal and diets are labeled with 
different symbols as indicated in the Table in A. Slopes shown are found to be significantly 
different from 0 at a significant level of 0.05 (n-3 PUFA + Cur and n-6 PUFA stem cells, 12 hr). 
Data from differentiated cells (12 and 24 hr) and stem cells (24 hr) are highlighted within the 
dotted lines and solid lines, respectively, instead of showing slope, since none of the slopes 
differed from zero. Linear regression was performed using GraphPad Prism 6.0. Values 
represent Pearson correlation coefficients, r, ranges from -1 to +1. P-values were calculated 
using an F test. Apoptotic index = # of TUNEL+ stem or differentiated cells / total # of stem or 
differentiated cells per crypt x100 at 12 and 24 hr post AOM injection; Damage index = # of 
H2AX+ stem or differentiated cells / total # of stem or differentiated cells per crypt x100 at 12 
and 24 hr post AOM injection. (C) Percentage of non-targeted apoptosis (# of TUNEL+ and 
H2AX- stem or differentiated cells / total # of H2AX- stem or differentiated cells x100) at 12 hr 
post AOM injection (left). Percentage of targeted apoptosis (# of double positive TUNEL+ and 
H2AX+ stem or differentiated cells / total # of H2AX+ stem or differentiated cells x100) at 12 
hr post AOM injection (right). Refer to Figure 10A legend for animal numbers and statistics. 
Different letters indicate significant (p<0.05) differences between treatment groups at each time 
point. n-6: n-6 PUFA, n-6 + Cur: n-6 PUFA + curcumin, n-3: n-3 PUFA, and n-3 + Cur: n-3 
PUFA + curcumin.  
A 
B 
C 
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Table 3. n-3 PUFA and curcumin interaction. Assessment of statistical interaction between 
dietary n-3 PUFA and curcumin with respect to the induction of apoptosis in Lgr5+ stem cells 
by Tukey’s HSD test (A&B) and in stem and differentiated cells by two-way ANOVA (C). 
 
 
 
 
A 
B 
C 
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3.3.2 AOM-induced MGMT expression is enhanced by n-3 PUFA and/or 
curcumin I n damaged Lgr5+ stem cells and differentiated cells. 
The major pathway to remove AOM-induced O6-methylguanine 
(O6meG) DNA adducts is via MGMT (Pegg and Byers, 1992). Therefore, the 
expedited elimination of O6meG by increasing MGMT activity is likely to be a 
successful chemoprevention strategy (Niture et al., 2007). Because curcumin 
induces MGMT protein expression in colon cancer cells (Niture et al., 2007), 
we estimated MGMT activity using quantitative immuno-histochemical analysis 
(Zaidi et al., 1996). As shown in Figure 12A, MGMT expression in Lgr5+ stem 
cells was maximally induced by curcumin with either PUFA diet or the n-3 PUFA 
treatment at 24 hr as compared to saline treatment.  However, only n-3 PUFA 
+ Cur fed animals exhibited an induction in MGMT associated with DNA 
damage in Lgr5+ stem cells at 24 hr using a simple linear regression analysis 
(Figure 12B right). In contrast, in differentiated cells (filled symbol), no 
significant induction was detected at 24 hr (Figure 3A). As shown in Figure 12B 
(left), at 12 hr post AOM exposure, n-3 PUFA and n-6 PUFA + Cur 
proportionally increased MGMT expression in Lgr5+ stem cells (n-3 PUFA: 
slope=2.07, r=0.92 and n-6 PUFA + Cur: slope=0.83, r=0.90), compared to n-
3 PUFA and n-3 PUFA + Cur treatment induction of MGMT in differentiated 
cells (GFPneg) (Figure 12B middle). We subsequently quantified the number of 
damaged Lgr5+ stem cells that were targeted for damage repair, i.e., GFP+, 
MGMT+, H2AX+ triple positive cells, since the deletion of O6meG in Lgr5+ stem 
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cells by MGMT could mitigate the clonal expansion of DNA-damaged Lgr5+ 
stem cells. As shown in Figure 13B (12 hr) and Figure 3C (right, 24 hr), n-3 
PUFA + Cur and n-3 PUFA induced MGMT expression in damaged Lgr5+ stem 
cells as compared to n-6 PUFA. Additionally, damaged differentiated cells also 
induced MGMT expression, similar to damaged Lgr5+ stem cells both at 12 and 
24 hr (Figure 13B and Figure 12C). 
 
 
 
 
 
 81 
 
 
Figure 12. Effect of n-3 PUFA ± curcumin on AOM-induced MGMT expression in mouse 
colonic crypts at 12 and 24 hr post AOM injection. (A) Comparison of MGMT+ (damage 
repairing) stem and differentiated cells in the distal colon of saline and 12 and 24 hr post AOM 
injected mice (left). GFP+ crypts were scored from n=3 per diet in saline treated mice, n=5~6 
per diet in AOM injected mice at 12 and 24 hr. Refer to Figure1A legend for statistical details. 
Different letters indicate significant (p<0.05) differences between treatment groups at each time 
point. (B) Association between AOM-induced MGMT expressing cells and H2AX+ cells in stem 
and differentiated cells at 12 hr (left and middle) and 24 hr (right). Each point represents an 
individual animal and diets are labeled with different symbols as indicated in the Table in A. 
Slopes shown are found to be significantly different from 0 at a significant level of 0.05. Data 
from differentiated cells (24 hr) are highlighted within the dotted line instead of showing slope 
because none of the slopes differed from zero. DNA repair index = # of MGMT+ stem or 
differentiated cells / total # of stem or differentiated cells per crypt x100 at 12 and 24 hr post 
AOM injection; Damage index = # of H2AX+ stem or differentiated cells / total # of stem or 
differentiated cells per crypt x100 at 12 and 24 hr post AOM injection. Refer to Figure 2B legend 
for statistical details. (C) Percentage of undamaged cells expressing MGMT (# of MGMT+ and 
H2AX- stem or differentiated cells / total # of H2AX- stem or differentiated cells x100) at 24 hr 
post AOM injection (left). Percentage of cells expressing MGMT in damaged cells (# of double 
positive MGMT+ and H2AX+ stem or differentiated cells / total # of H2AX+ stem or 
differentiated cells x100) at 24 hr post AOM injection (right). Refer to Figure 1A legend for 
statistical details. Different letters indicate significant (p<0.05) differences between treatment 
groups at each time point. n-6: n-6 PUFA, n-6+Cur: n-6 PUFA + curcumin, n-3: n-3 PUFA, and 
n-3+Cur: n-3 PUFA + curcumin.  
A 
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Figure 13. Effect of n-3 PUFA ± curcumin in mouse colonic crypts at 12 and 24 hr post 
AOM injection (A) Percentage of non-targeted apoptosis (# of TUNEL+ and H2AX- stem or 
differentiated cells / total # of H2AX- stem or differentiated cells x 100) at 24 hr post AOM 
injection (left). Percentage of targeted apoptosis (# of double positive TUNEL+ and H2AX+ 
stem or differentiated cells / total # of H2AX+ stem or differentiated cells x100) at 24 hr post 
AOM injection (right). Refer to Figure 1A legend for animal number and statistical details. 
Different letters indicate significant (p<0.05) differences between treatment groups. (B) 
Percentage of undamaged cells expressing MGMT (# of MGMT+ and H2AX- stem or 
differentiated cells / total # of H2AX- stem or differentiated cells x100) at 12 hr post AOM 
injection (left). Percentage of damaged cells expressing MGMT (# of double positive MGMT+ 
and H2AX+ stem or differentiated cells / total # of H2AX+ stem or differentiated cells x100) at 
12 hr post AOM injection (right). Refer to Figure 1A legend for statistical details and Figure 3A 
for animal numbers. Different letters indicate significant (p<0.05) differences between treatment 
groups. (C) Percentage of undamaged proliferating cells (# of EdU+ and H2AX- stem or 
differentiated cells / total # of H2AX- stem or differentiated cells x100) at 12 hr post AOM 
injection (left). Percentage of damaged proliferating cells (# of double positive EdU+ and 
H2AX+ stem or differentiated cells / total # of H2AX+ stem or differentiated cells x100) at 12 
hr post AOM injection (right). GFP+ crypts (n=5 per diet for saline and n=5-6 per diet for 12 and 
24 hr post AOM injection) were counted. Refer to Figure 1A legend for statistical details. 
Different letters indicate significant (p<0.05) differences between treatment groups. n-6: n-6 
PUFA, n-6+Cur: n-6 PUFA + curcumin, n-3: n-3 PUFA, and n-3+Cur: n-3 PUFA + curcumin. 
A 
B 
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3.3.3 Crypt regeneration following AOM exposure. 
 As shown in Figure 10B, proliferating cells were predominantly located 
at the bottom of crypt where Lgr5+ stem cells and transit amplifying (TA) cells 
reside, together referred to as the stem cell clonogen (SCC) compartment (Hua 
et al., 2012). To assess dietary effects on stem cell proliferation, a requirement 
for crypt regeneration following insult, EdU+ cells in the colonic crypt were 
quantified following AOM-induced DNA damage. The percentage of 
proliferating cells at 12 hr post AOM vs saline injection was not affected across 
all dietary treatments (Figure 14A). An increase in cell division at 24 hr was only 
associated with Lgr5+ stem cells, i.e., not in differentiated TA cells (Figure 14A). 
These findings indicate that colonic Lgr5+ stem cells uniquely respond to cues 
associated with tissue homeostasis. Surprisingly, there was no significant 
association between the proliferative index and the level of DNA damage 
(Figure 14B) and no diet effects were observed with regard to cell proliferation 
in damaged Lgr5+ stem cells at 12 hr (Figure 13C) and 24 hr (Figure 14C). 
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Figure 14. Effect of n-3 PUFA ± curcumin on AOM-induced proliferation in mouse colonic 
crypts at 12 and 24 hr post AOM injection. (A) Comparison of EdU+ (proliferating) stem and 
differentiated cells in the distal colon of saline, and 12 and 24 hr post AOM injected mice (left). 
GFP+ crypts (n=5 per diet for saline and n=5-6 per diet for 12 and 24 hr post AOM injection) 
were counted. Refer to Figure 1A legend for statistical details. Different letters indicate 
significant (p<0.05) differences between treatment groups. (B) Association between the AOM-
induced proliferating cells and H2AX+ cells in stem and differentiated cells at 12 hr (left) and 
24 hr (right). Each point represents an individual animal and diets are labeled with different 
symbols as indicated in the Table in A. Data from stem cells and differentiated cells not 
significantly different from 0 are within the area of the square solid lines and dotted lines, 
respectively, instead of showing slope since none of the slopes were different from zero. 
Proliferation index = # of EdU+ stem or differentiated cells / total # of stem or differentiated cells 
per crypt x100 at 12 and 24 hr post AOM injection; Damage index = # of H2AX+ stem or 
differentiated cells / total # of stem or differentiated cells per crypt x100 at 12 and 24 hr post 
AOM injection. Refer to Figure 2B legend for statistical details. (C) Percentage of undamaged 
proliferating cells (# of EdU+ and H2AX- stem or differentiated cells / total # of H2AX- stem or 
differentiated cells x100) at 24 hr post AOM injection (left). Percentage of damaged proliferating 
cells (# of double positive EdU+ and H2AX+ stem or differentiated cells / total # of H2AX+ stem 
or differentiated cells x100) at 24 hr post AOM injection (right). Refer to Figure 1A legend for 
statistical details. Different letters indicate significant (p<0.05) differences between treatment 
groups. n-6: n-6 PUFA, n-6+Cur: n-6 PUFA + curcumin, n-3: n-3 PUFA, and n-3+Cur: n-3 PUFA 
+ curcumin.  
A 
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3.3.4 Lgr5+ stem cells markers are enhanced by carcinogen exposure 
To further elucidate the effects of n-3 PUFA + Cur in the presence of 
AOM on Lgr5+ stem cells, global transcriptional differences in early response 
genes between sorted GFPhigh (Lgr5+) and GFPneg (differentiated) cells were 
assessed by RNA sequencing. Mice were fed with the combination of n-3 PUFA 
and curcumin or control diet (n-6 PUFA) for 3 wks, injected with AOM and 
euthanized 12 hr later. Table 4 demonstrates that GFPhigh cells expressed high 
levels of Lgr5 and other stem cell markers, e.g., Ascl2 and CD44, whereas 
GFPneg cells expressed progenitor cell markers, e.g., Reg4 and Muc2 as well 
as Krt20 and Slc26a3, markers highly expressed at the crypt top (Dalerba et 
al., 2011) (Table 4). Surprisingly, mRNA levels of crypt base columnar cell 
(CBC) marker genes (Jiao et al., 2008) were rapidly altered by extrinsic factors 
(Table 5). For example, CD44 mRNA levels in GFPhigh cells were increased by 
5.41-fold (in n-6 PUFA) and 2.88-fold (in n-3 PUFA + Cur) upon AOM exposure, 
and the enhancement was significantly higher (1.87-fold) in n-6 PUFA versus 
n-3 PUFA + Cur fed mice. Interestingly, Agr3 mRNA levels in GFPhigh cells were 
increased by 108.51-fold by AOM in n-6 PUFA fed mice as compared to 21.10-
fold (FDR<0.1) to the n-3 PUFA + Cur group.  
Differentiated cell markers were also modulated by extrinsic factors. Alpi, 
an absorptive enterocyte marker, was mainly found in GFPneg cells (Table 4) 
and its levels in GFPneg cells were increased by AOM both in n-6 PUFA (1.87-
fold FDR) and n-3 PUFA + Cur (1.85-fold FDR) treated mice (Table 5). In 
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GFPhigh cells, Alpi levels were increased by AOM only in n-6 PUFA (2.61-fold) 
(Table 5). This is interesting because Alpi is expressed at the crypt base where 
cells dedifferentiate into Lgr5 stem cells following targeted depletion of Lgr5 
cells (Tetteh et al., 2016), and contributes to intestinal tumorigenesis initiated 
by dedifferentiation (Schwitalla et al., 2013a). In addition, Kit/CD117, mainly 
expressed in goblet cells, was also increased by AOM (1.62-fold) only in 
GFPhigh cells in n-6 PUFA fed mice. This finding is consistent with the fact that 
Kit signaling promotes colonic tumor development (Chen et al., 2015). Finally, 
the colon cancer stem cell marker, Prom1/CD133 (Sahlberg et al., 2014; 
Snippert et al., 2009) was uniquely up-regulated by n-6 PUFA and AOM co-
treatment (Table 5). Specifically, Prom1/CD133 expression in GFPhigh cells 
increased following AOM exposure in n-6 PUFA not in n-3 PUFA + Cur treated 
mice.  
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Table 4. Differentially expressed marker genes in GFPhigh versus GFPneg colonocytes. 
Fold change of cell type marker gene expression by RNA sequencing of colonic GFPhigh and 
GFPneg cells at 12 h post saline exposure, n=8 mice per group. 
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Table 5. Marker genes transcriptionally modulated by extrinsic factors. Fold change of 
marker gene expression in colonic GFPhigh and GFPneg cells in the presence of (A) carcinogen 
(12 hr) and (B) bioactive treatments, n=4 mice per group. FDR values <0.05 are given three 
asterisks (***), FDR values <0.1 are given two asterisks (**), FDR values <0.2 are given one 
asterisk (*) and any FDR values >0.2 are marked with a dash (-).  
 
A 
B 
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3.3.5 Dietary fish oil and curcumin synergistically enhance p53 signaling in 
stem cells following AOM exposure 
RNA Seq was used to identify signaling pathways that were most 
significantly modulated by extrinsic cues. From a global transcriptome 
perspective, GFPhigh stem cells from n-3 PUFA + Cur versus n-6 PUFA (control) 
fed mice treated with AOM exclusively increased p53, BRCA1, and Polo-like 
kinase related pathways (z-score>1.96) (Figure 15A). This is relevant because 
rapid accumulation of p53 is associated with cell death in human colon cancer 
cells (Paek et al., 2016). A total of twenty-four p53 target genes were increased 
by extrinsic factors in GFPhigh and GFPneg cells (Figure 15B). Of the eleven 
genes uniquely increased by n-3 PUFA + Cur in GFPhigh cells, Bax was 
increased 3.53-fold (Figure 15C). This is noteworthy, because human 
embryonic stem cells have constitutively active Bax at the Golgi, and active Bax 
translocates from Golgi to mitochondria after DNA damage in a p53-dependent 
manner, triggering a rapid apoptotic response (Dumitru et al., 2012). To 
examine whether the increase in mRNA expression was accompanied by 
enhanced expression at the protein level, we quantified total Bax expression in 
Lgr5+ stem cells and differentiated cells in n-6 PUFA versus n-3 PUFA + Cur 
90 
GFPhigh/GFPneg cells was unresponsive at 12 hr, and increased 1.3-fold at 24 
hr post AOM injection. 
fed mice in the presence of AOM. As shown in Figure 15D, the relative 
expression of total Bax in GFPhigh/GFPneg cells was increased 1.3-fold by the 
administration of n-3 PUFA + Cur at 12 hr post AOM exposure and persisted 
for up to 24 hr (1.5-fold). In contrast, in n-6 PUFA fed mice, total Bax in 
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Figure 15. Lgr5+ stem cells exclusively enhance p53 signaling pathway by n-3 PUFA + 
curcumin in the presence of AOM. (A) Canonical pathways in cells induced by n-6 PUFA or 
n-3 PUFA + Cur in the presence of AOM. (B) p53-associated genes induced by different 
groups. (C) Genes downstream of p53 in GFPhigh cells uniquely increased by n-3 PUFA + Cur 
in the presence of AOM. (D) (left) Total Bax abundance in cells in n-6 PUFA and n-3 PUFA + 
Cur. Values were normalized to each respective saline (control) group. * Indicates significant 
difference between treatment groups (p<0.05). (right) Representative image of Bax positive 
(red) cells at 12 hr and 24 hr post AOM exposure. Green dots indicate the location of GFP 
positive Lgr5 stem cells.  Saline injected animals serve as the control.  
A 
B 
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3.3.6 n-3 PUFA and curcumin combination reduces nuclear -catenin levels 
in ACF 
Intestinal ACF formation is a surrogate marker of colon cancer both in 
rodent preclinical models and patients (Hata et al., 2004; Iwamoto et al., 2000). 
Nuclear to cytoplasmic -catenin levels are associated with higher mortality in 
selected groups of colorectal cancer patients (Wanitsuwan et al., 2008) and -
catenin accumulated crypts serve as a premalignant biomarker (Hao et al., 
2001; Mi et al., 2009; Mori et al., 2004). As shown in Figure 16A (left), n-3 PUFA 
± Cur groups exhibited a significant reduction in the number of ACF per mouse 
compared to n-6 PUFA and n-3 PUFA + Cur treated mice exhibited a significant 
reduction (75%) in the incidence of ACF as compared to n-6 PUFA (100% ACF 
incidence). Figure 16B shows representative images of cross-sectioned ACF 
(yellow boxes) and Figure 16C shows -catenin expression (red) in serial cross 
sections of the same ACF. Subsequently, nuclear to cytosolic -catenin 
expression was measured as a biomarker of cancer risk (Figures 16D). -
catenin was predominantly localized to the plasma membrane region of normal 
colonocytes and negligible nuclear β-catenin was detectable in colonic crypt 
cells in saline injected animals. In contrast, -catenin immunoreactivity was 
present in both the cytoplasm and the nucleus in ACF localized cells as 
expected (Hao et al., 2001; Mi et al., 2009) (Figure 16C). Surprisingly, only the 
n-3 PUFA + Cur combination treatment exhibited an inhibitory effect (Figure 
16D), i.e., reduced relative density of nuclear/cytosolic -catenin expression in 
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ACF (n-3 PUFA x curcumin interaction, p<0.05) (Table 3C). These data indicate 
that n-3 PUFA + Cur synergistically suppressed Wnt signaling in ACF, which 
may underlie the molecular mechanism of n-3 PUFA and curcumin action in the 
AOM-induced colon cancer model. Unfortunately, the percentage of GFP+ Lgr5 
cells within the ACF could not be determined due to the mosaic nature of 
expression in the Lgr5-EGFP-IRES-CreERT2 knock-in mouse (Schuijers et al., 
2014), i.e., a large fraction of ACF were GFP negative.  
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Figure 16. Chemo-protective effect of n-3 PUFA ± curcumin on ACF formation and 
subcellular localization of -catenin in ACF. (A) (left) Percentage of mice with colonic ACF 
as affected by diet and (right) the number of ACF per animal (half colon) in the presence of 
AOM. ACF from n= 7-8 mice were counted 17 wks after 6 AOM injections. Different letters 
indicate significant (p<0.05) differences between treatment groups at each time point.  (B) 
H&E stained tissues showing distinct colonic ACF in the center of the image with normal crypts 
at the periphery in the presence of AOM compared to saline. (C) Immunofluorescent images 
of -catenin (red) in serially sectioned ACF tissue. Nuclear staining was detected by 
counterstaining cells with DAPI (blue). (D) (left) Quantification of -catenin expression 
(staining density) in nucleus/cytoplasm in ACF from mice on the 4 different diets. Values were 
normalized to the n-6 PUFA (control) group. (right) Representative image of b-catenin (red) 
translocated into the nucleus in n-6 PUFA vs n-3 PUFA + Cur fed mouse.  Magnified image of 
-catenin in the nucleus (nuclear DAPI staining is circled). Refer to Figure 1A legend for 
statistical details. * Indicate significant difference between treatment groups (p<0.05). n-6: n-
6 PUFA, n-6+Cur: n-6 PUFA + curcumin, n-3: n-3 PUFA, and n-3+Cur: n-3 PUFA + curcumin.  
A 
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3.4 Discussion 
There is an impending chronic disease crisis in our country and it is 
predicted that if the current trends continue, the number of cancer cases 
diagnosed annually by 2050 is likely to double as a result of population aging 
(Vogelstein and Kinzler, 2012). Heading off this escalating burden of age-
related illnesses requires an emphasis on primary cancer prevention research 
and training in cancer-related lifestyle decisions, including diet and exercise 
(Vogelstein and Kinzler, 2012).  Here we describe the effect of beneficial dietary 
factors on DNA damage-induced responses in Lgr5+ stem cells in the colon. 
Further justifying our investigation is the fact that these bioactives do not exhibit 
the side effects such as gastrointestinal bleeding and myocardial complications 
associated with the administration of anti-cancer drugs (Meyskens et al., 2008; 
Psaty and Potter, 2006; Solomon et al., 2005; Zell et al., 2009).  
DNA damage induced by AOM is directly linked to colon tumorigenesis 
in the rodent model (Chang et al., 1998). To reduce the risk of tumorigenic 
transformation of cells, it is critical that DNA damaged cells be deleted (Chang 
et al., 1998; Rogers and Pegg, 1977) or repaired via MGMT (Zaidi et al., 1995). 
We have previously demonstrated that colonic Lgr5+ stem cells are highly 
impacted by AOM exposure, resulting in the promotion of apoptosis and 
induction of MGMT expression compared to differentiated cells during the first 
12-24 hr after AOM exposure (Kim et al., 2016a). In this study, we extend these 
findings by demonstrating for the first time that n-3 PUFA + Cur combination 
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maximally promotes targeted apoptosis (Figures 11C) and the induction of 
MGMT expression in DNA damaged Lgr5+ stem cells (Figure 12B). Consistent 
with this observation, it has been reported that n-3 PUFA enriched diets 
enhance targeted apoptosis during colon tumor initiation in part by 
downregulating Bcl-2 (Hong et al., 2003).  In addition, n-3 PUFA may prime 
colonocytes for damage-induced apoptosis by enhancing the unsaturation of 
mitochondrial phospholipids, resulting in an increase in oxidative stress and the 
initiation of the apoptotic cascade (Chapkin et al., 2002; Hong et al., 2002). 
Curcumin can also induce apoptosis by activating mitochondria-initiated 
apoptotic pathways (Guo et al., 2013). It has been demonstrated that both n-3 
PUFA and curcumin can induce MGMT (Hong et al., 2000; Niture et al., 2007), 
and MGMT expression is known to be associated with p53 in multiple cell types 
(Blough et al., 2007; Russell et al., 1995). Interestingly, the combination of DHA 
and curcumin has an additive effect with regard to the induction of apoptosis in 
breast cancer and pancreatic cell lines (Altenburg et al., 2011; Swamy et al., 
2008). With respect to Lgr5+ stem cell proliferation, only a mild increase was 
observed at 24 hr post AOM as compared to saline. This finding is consistent 
with the fact that the crypt must regenerate following the loss of cells in the crypt 
bottom after carcinogen and radiation exposure (Hong et al., 2015; Hua et al., 
2012). 
Only mice treated with the combination of n-3 PUFA + Cur exhibited an 
induction of p53 signaling exclusively in Lgr5+ stem cells in the presence of 
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AOM.  This was exemplified, in part, by the induction of Bax at the mRNA and 
protein levels, a major mediator of p53-mediated apoptosis.  These findings are 
relevant in view of the fact that human embryonic stem cells (hESCs) have 
constitutively active Bax at the Golgi and are primed to undergo rapid apoptosis 
in a p53 dependent manner (Dumitru et al., 2012; Gama and Deshmukh, 2012; 
Liu et al., 2013) and decreased mitochondrial priming determines chemo-
resistance of colon cancer stem cells (Colak et al., 2014). It has also been 
demonstrated that the absence of an acute apoptotic response to AOM in p53-
deficient mice is associated with an increased tumor incidence (Davidson et al., 
2015; Hu et al., 2005). Further studies are needed to elucidate the 
combinatorial effects of diet on the translocation of active Bax from Golgi to 
mitochondria. Consistent with these observations, curcumin combined with n-3 
PUFA synergistically reduced AOM-induced nuclear -catenin levels in ACF at 
the pre-tumor stage. This is noteworthy because elevated nuclear -catenin 
levels are associated with higher mortality in selected groups of colorectal 
cancer patients (Hao et al., 2001; Takayama et al., 2001; Wanitsuwan et al., 
2008), and various attempts have been made to identify and characterize 
pharmacological inhibitors of β-catenin (Thakur and Mishra, 2013). Consistent 
with this notion, it has been shown that n-3 PUFA or curcumin reduce polyps 
or adenoma in APC mutated mice (Collett et al., 2001; Fini et al., 2010) and 
inhibit nuclear location of -catenin in colon cancer cells and breast cancer 
stem cells (Calviello et al., 2007; Mukherjee et al., 2014).  
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The potential benefits of using a combination of pleiotropic chemo-
protective compounds may also be linked to their combined ability to suppress 
NFB activation (Kim et al., 2009), which drives Cox-2 expression (Cai et al., 
2011; Charalambous et al., 2003; Cherukuri et al., 2005). In terms of disease 
progression, Cox-2 is capable of enhancing cell proliferation, angiogenesis, cell 
migration and invasion as well as inhibiting apoptosis and enhancing tumor 
growth via cross-talk between Frizzled and the epidermal growth factor receptor 
(EGFR) (Buchanan et al., 2007). In addition, both DHA and curcumin are 
capable of modulating plasma membrane structure and EGFR function (Soung 
and Chung, 2011; Turk et al., 2012), which regulates colon cancer stem cell 
proliferation (Feng et al., 2012). Curcumin can also inhibit the expression of 
EGFR in human colon cancer cells (Chen et al., 2006).  
In summary, our data broaden and redefine the phenotypic features of 
the colonic adult stem cell in the presence of external cues.  DNA damaged 
Lgr5+ stem cells uniquely respond to the combination of n-3 PUFA and 
curcumin, which promote targeted apoptosis in part by enhancing p53 signaling 
and maximally reducing nuclear -catenin in ACF. This is a critical area of 
research because long-lived Lgr5+ stem cells are responsible for maintaining 
and regenerating intestinal crypts (Kantara et al., 2015). These novel findings 
demonstrate that Lgr5+ stem cells are uniquely responsive to external dietary 
cues following the induction of DNA damage during tumor initiation and 
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progression, providing a therapeutic strategy for eliminating damaged stem 
cells and reducing colon cancer risk. 
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4. DOSE EFFECT OF n-3 PUFA AND CURCUMIN ON TARGETED      
APOPTOSIS 
 
4.1     Introduction 
Combination or multicomponent therapy, in which two or more drugs are 
used together, typically has one or more of the following goals: (i) reduce the 
frequency at which acquired resistance arises by combining drugs with minimal 
cross-resistance (ii) lower the dose of drugs with non-overlapping toxicity and 
similar therapeutic profiles so as to achieve efficacy with fewer side effects; and 
(iii) achieve enhanced potency by exploiting additivity, or better yet, greater-
than-additive effects in the biochemical activities of two drugs (Fitzgerald et al., 
2006). There is also a growing interest in drug combinations that might prevent 
cancer, as summarized in a recent Nature article by Gravitz (Gravitz, 2011).  
There is also an increasing awareness that the use of synergistic drug 
combinations in treating cancer can the lower dose of each constituent drug 
and consequently minimize adverse effects. Thus, to kill cancer cells, 
combination therapy can be more effective than individual drug use (DeVita et 
al., 1975).  
It has been demonstrated that AOM-induced DNA damaged Lgr5+ stem 
cells, the cells of origin if colon cancer (Barker et al., 2009), are efficiently 
removed by targeted apoptosis in mice fed a 4% fish oil (1% n-3 PUFA) + 1% 
curcumin combination diet as compared to fish oil or curcumin alone (Kim et 
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al., 2016b).  
We also demonstrated that curcumin combined with n-3 PUFA 
synergistically reduces AOM-induced nuclear β-catenin levels in aberrant crypt 
foci (ACF) (Kim et al., 2016b). In order to determine the clinical relevance of 
our findings, we extrapolated the animal dose to a human equivalent dose 
(HED) by applying a conversion based body surface area (BSA) normalization 
method (Reagan-Shaw et al., 2008). Using this approach, the HED of our 
experimental diet was 8.6g of n-3 PUFA + 8.5g of curcumin (Figure 17).  The 
FDA has established a generally regarded as safe (GRAS) level of 3g of n-3 
PUFA per day. Thus, the HED of the n-3 PUFA (8.6 g) diet used in our mouse 
study was higher than the FDA recommendation (3g per day).  In comparison, 
curcumin has not yet been approved as a therapeutic agent due to its relatively 
low bioavailability (Anand et al., 2007). 
In this study, we experimentally determined the median effective 
concentration (ED50) and the HED of n-3 PUFA + curcumin to remove DNA 
damaged Lgr5+ stem cells by targeted apoptosis. We assessed the dietary 
threshold for phenotypically significant responses by using lower doses of n-3 
PUFA and curcumin as described in Figure 17.  As part of this effort, we utilized 
FlowSight image-based flow cytometry. One of the biggest advantages of using 
the FlowSight system is that sample throughput is increased and potential bias 
in data analysis can be reduced compared to a traditional fluorescence 
microscopy. 
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Our novel data provide evidence that DNA-damaged Lgr5+ stem cells 
are highly responsive to a low dose of the combination curcumin + n-3 PUFA 
diet. We provide evidence that the low dose combination diet reduces AOM-
induced DNA damage in Lgr5+ stem cells, implying that a lower HED can 
utilized in human clinical trials.  
 
 
 
 
Figure 17. Design of n-3 PUFA and curcumin mouse diets and their human equivalent 
dose (HED). The animal dose was extrapolated to a HED by applying a conversion based on 
body surface area (BSA). Lower doses of n-3 PUFA and curcumin in animal diets and 
corresponding HEDs are listed (marked in red arrow). Daily dose of n-3 PUFA and curcumin 
from animal diets used in our previous study (Kim et al., 2016b) are marked in blue. 
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4.2 Material and methods 
4.2.1 Animals, diets and study design 
The animal use protocol was approved by the University Animal Care 
Committee of Texas A&M University and conformed to NIH guidelines. Lgr5-
EGFP-IRES-CreERT2 knock-in mice (Barker et al., 2009), 6-7 wk old, were 
acclimated for 1 wk and then maintained on a semi-purified diet (Table 6B) for 
3 wk prior to injection with AOM (Sigma, St. Louis, MO, 10 mg/kg body weight). 
Mice (n=7~8 per group) were injected with a single dose of AOM and 
euthanized 12 hr later. Control mice (n=5) received a single saline injection. 
Immediately after termination, the distal colon was rapidly removed, flushed 
with ice-cold saline and a longitudinal section of the distal colon was used for 
isolating colonocyte. Figure 18A shows the timeline of the treatments and the 
experimental design. For sample preparation, the profiles of sorted-live GFPhigh 
cells and sorted-fixed GFPhigh cells were assessed.  Since fixation was shown 
to alter the fluorescence signature, to avoid contamination of cell population 
after PFA fixing step, we initially sorted GFPhigh and GFPneg live cells using a 
MoFlow fluorescent cell sorter and then subsequently fixed cells with 4% PFA. 
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Table 6. Dose of n-3 PUFA and curcumin in the experimental mouse diets and their 
corresponding human equivalent dose (HED). (A) Design of experimental diet and (B) diet 
composition. (FO = fish oil; CO = corn oil; Cur = curcumin) 
 
 
4.2.2 Diets 
Diet sources have been previously reported (Kim et al., 2009). Complete 
diets containing 1.9~4.5% corn oil (containing n-6 PUFA) were used as a 
baseline controls, i.e., contained no n-3 PUFA or curcumin. Diets containing 
1.4~4.0% (w/w) Menhaden fish oil (containing n-3 PUFA) + 0.23~1% curcumin 
diets were used to determine the median effective dose (ED50). All fish oil (FO) 
+ curcumin (Cur) diets contained 0.5% corn oil (w/w) to ensure that essential 
fatty acid requirements were met (Table 6A&B). The four FO + Cur diets listed 
in Table 6 had different levels of total fat (%), thus the level of total fat (%) in 
each CO diet was matched to serve as a control. In addition, the ratio of FO : 
A 
B 
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Cur across all combination (FO + Cur) diets was maintained at a 4 : 1 ratio 
(Table 6A). Mice were provided with fresh diet every day and the feeders were 
removed and washed daily. Animals had free access to food and water at all 
times. The fatty acid composition of the diets was analyzed by gas 
chromatography and the level of curcumin was quantified by 1H NMR 
(Jayaprakasha et al., 2013). The fatty acid composition of isolated colonic 
crypts was quantified by gas chromatography (Fan et al., 2003) and the level 
of curcumin was quantified by HPLC (Cuomo et al., 2011; Jayaprakasha et al., 
2013).  
 
4.2.3 DNA damaged and apoptotic cell staining  
To quantify targeted apoptosis in stem cells, isolated colonocytes from 
the distal colon were sorted based on GFP expression using a Beckman 
Coulter MoFlo Astrios as previously described (Fan et al., 2014). Dead cells 
positive for Propidium Iodide (PI, 1g/mL) staining were excluded from sorting. 
GFPhigh cells (stem cells) and GFPneg cells (all cells combined) were sorted and 
subsequently fixed in 4% PFA for 20 min at room temperature followed by 
incubation in 100 mM glycine for 30 min to quench paraformaldehyde 
autofluorescence. After washing with PBS, cells were permeabilized in 70% 
EtOH for 24 hr at -20◦C followed by rehydration in PBS prior to immunostaining. 
Fixed and permeabilized cells were subsequently stained with phospho-
H2AX-Alexa Fluor 647 antibody (H2AX-AF 647, Cell Signaling, 20E3, 1:25 
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dilution), to detect DNA damaged cells and cleaved caspase3-Alexa Fluor 555 
(Cl.caspase-3-AF 555, Cell Signaling, D3E9, 1:50 dilution) antibody to detect 
apoptotic cells, for 24 hr at 4◦C followed by washing with PBS. Stained cells 
were counterstained with DAPI and quantified by FlowSight imaging flow 
cytometry. 
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Figure 18. Experimental design and validation. (A) Timeline of the treatments and 
experimental design. (B) Profile of sorted live GFPhigh cells (left), GFPlow cells (middle) and 
GFPneg cells (right). (C) Profile of sorted and fixed GFPhigh cells (left), GFPlow cells (middle) and 
GFPneg cells (right). 
 
 
4.2.4 FlowSight 
Samples were analyzed with the imaging flowcytometer FlowSight® 
(Amnis®, EMDMillipore). The 403, 488 and 647 nm lasers were used for 
excitation. On average, 18,225 events of GFPhigh cells (Lgr5+ stem cells) and 
A 
B 
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434,301 events of GFPneg cells (all population) per sample were collected. 
Bright field (430–480 nm), nucleus (405 nm), cleaved caspase-3 (555 nm) and 
H2AX (647 nm) channels were used to collect data.  Color compensation was 
not necessary as no overlapping emission spectra were observed. The IDEAS 
version 6.0 was used for analysis, and image based features and single gating 
control for each population was achieved.  
 
4.2.5 Statistics 
One-way ANOVA followed by Sidak’s multiple comparison test 
adjustment was used to determine the biological effect of FO + Cur dose as 
compared to each respective CO control diet. The significant comparisons were 
obtained based on adjusted P-values <0.05. 
 
4.3 Results 
4.3.1 Quantification of H2AX-labeled DNA damaged cells and cleaved 
caspase-3-labeled apoptotic cells  
To elucidate the dose response of colonic Lgr5+ stem cells to bioactive 
compounds in the presence of carcinogen, we utilized mice expressing 
enhanced green fluorescent protein (EGFP) knocked into the Lgr5 genomic 
locus (Barker and Clevers, 2007). Mice were fed with different doses of the 
combination diet (n-3 PUFA and curcumin) described in Table 6 for 3 wks, 
injected with AOM and euthanized 12 hr later. To examine the response of 
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Lgr5+ stem cells, represented by GFPhigh, Lgr5+ stem cells were sorted based 
on GFP expression using a Beckman Coulter MoFlo. Bulk (GFPneg) cells were 
also sorted as a control. Approximately 18,225 GFPhigh cells (Lgr5+ stem cells) 
and 434,301 GFPneg cells (all cells combined) were sorted for each treated 
mouse. Isolated GFPhigh cells and GFPneg cells were subsequently fixed in 4% 
PFA and analyzed for the purpose of quantifying DNA damage (H2AX-AF647) 
and apoptosis (cleaved caspase-3-AF 555, Cl.caspase-3-AF 555) and targeted 
apoptosis (both H2AX-AF647 and Cl. caspase-3-AF555) at 12 h post AOM 
injection. The 4% FO + 1% Cur diet was used to reproduce finding from the 
previous study and also as a comparison to the lower dose FO + Cur diets. 
Using the imaging flowcytometer, focused single cells were identified 
using gradient root mean square of the bright filed image (Figure 19A) and 
bright area and aspect ratio (Figure 19B), respectively. Single-labeled samples 
were prepared and served as serve a positive control for single staining of 
H2AX (Figure 20A, right) or Cl.caspase-3 (Figure 20B, right), respectively. As 
additional negative antibody controls, samples not incubated with antibodies 
were used for gating cells negative for H2AX (Figure 20A, left) or Cl.caspase-
3 (Figure 20A, left). Figure 20C shows representative images of H2AX+ and 
H2AX- cells and Figure 20D shows representative images of Cl.caspase-3+ 
and Cl.caspase-3- cells. 
The fluorescence intensities of H2AX-AF 647 and Cl.caspase-3-AF 
555, % of DNA damage, apoptosis and targeted apoptosis were determined as 
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demonstrated in Figure 21A. To provide biological negative controls, colonic 
cells from saline injected mice (Figure 21B) were used to gate cells negative 
for H2AX-AF 647 and Cl.caspase-3-AF 555. Less than 5% of H2AX+ and/or 
Cl.caspase-3+ events were detected following the processing of samples. As 
shown in Figure 21C&D, AOM-induced H2AX+ and/or Cl.caspase-3+ were 
detected in both in mice fed FO + Cur and CO diets. Figure 21E shows 
representative images of cells negative for H2AX and Cl.caspase-3, as well 
as cells staining positive for Cl.caspase-3 and/or H2AX.  
 
 
 
 
 
Figure 19. Gating strategy to identifying focused and single cell populations. 
Fluorescence intensities and image features were analyzed to identify (A) focused cells, (B) 
single cells by using a gradient root mean square of the bright field image or bright field area 
and aspect ratio, respectively. 
 
 
 
 
A B 
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Figure 20. Illustration of cell gating and representative images of DNA damaged and 
apoptotic cells. The fluorescence intensity of H2AX-AF647 and Cl.caspase3-AF555 were 
used to identify (A, left) H2AX- and (A, right) H2AX+ population and (B, left) Cl.caspase3- and 
(B, right) Cl.caspase3+ population. Cells from mice injected with AOM (12 hr) were used to 
detect DNA damage and apoptosis. Cells that are not incubated with antibody were used for 
gating of H2AX- population and Cl.caspase3- population. Representative images of (C) 
H2AX+ (#546) and H2AX- (#1) cells and (D) Cl.caspase3+ (#600) and Cl.caspase3- (#50) 
cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
C 
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Figure 21. Gating strategy for distinguishing cells double positive (DNA damaged and 
apoptotic) cells. (A) Schematic illustration showing the gating strategy of the assay. (B) 
Fluorescence intensity of H2AX-AF647 and Cl.caspase3-AF555 of cells from mice injected 
with saline (control) used to identify double negative cells. Cells from mice fed 4.5% CO diet, 
(C) and 4% FO + 0.5% CO + 1% Cur diet, (D) injected with AOM (12 hr) used to identify DNA 
damaged (H2AX+), apoptotic (Cl.caspase3+) and targeted apoptotic (H2AX+, Cl.caspase3+) 
cells. (E) Representative images of double negative cells (#1849), apoptotic cells (#147), DNA 
damaged cells (#963) and DNA damaged and apoptotic (#1830) GFPhigh cells.  
 
 
4.3.2 Lgr5+ stem cells respond to n-3 PUFA and curcumin in a dose-
dependent manner in the presence of AOM 
In our previous study, we demonstrated that 56%, 18% and 13% of Lgr5+ 
stem cells were DNA damaged, apoptotic and targeted apoptotic cells, 
respectively in mice fed 5% CO (control) in the presence of AOM, as compared 
to 22%, 30% and 62% of DNA damaged, apoptotic and targeted apoptotic cells, 
D 
A B C 
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respectively, in mice fed 4% FO + 1% CO + 1% Cur in the presence of AOM 
(Kim et al., 2016b). In comparison, using image-based flow cytometry in this 
study, 23%, 20% and 35% of Lgr5+ stem cells were DNA damaged, apoptotic 
and targeted apoptotic cells, respectively, in mice fed 4.5% CO, whereas 5%, 
14% and 69% of Lgr5+ stem cells were DNA damaged, apoptotic and targeted 
apoptotic cells, respectively, in mice fed 4% FO + 0.5% CO + 1% Cur in the 
presence of AOM (Figure 22). Overall, these cross study trends are consistent 
and demonstrate that mice fed the chemo-protective diets exhibit lower levels 
of DNA damaged Lgr5+ stem cells and higher levels of targeted apoptotic Lgr5+ 
stem cells as compared to control (Figure 22) (Kim et al., 2016b).  
Next, we determined the dose effects of n-3 PUFA + curcumin on the % 
of DNA damaged (H2AX+), apoptotic (Cl.caspas-3+) and targeted apoptotic 
(H2AX+; Cl.caspas-3+) in Lgr5+ stem cells (GFPhigh) in the presence of AOM. 
As shown in Figure 22A, mice fed 2.8% FO + 0.5% CO + 0.69% Cur and 1.9% 
FO + 0.5% CO + 0.46% Cur exhibited a marked suppression (5-fold) in DNA 
damaged (H2AX+) cells as compared to the control groups. However, no 
statistically significant chemo-protective effect was detected in mice fed 1.4% 
FO + 0.5% CO + 0.35% Cur diet as compared to control. In a previous study, 
the 4% FO + 1% CO + 1% Cur diet increased apoptosis >1.5-fold in Lgr5+ stem 
cells as compared to control in the presence of AOM (Kim et al., 2016b), 
however, no statistically significent chemo-protective diet effect was detected 
in terms of the % of apoptosis (Cl.caspas-3+) cross all groups as shown in 
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Figure 22B. 
The deletion of damaged Lgr5+ stem cells, the cells of origin of colon 
cancer (Barker et al., 2009), is a critical mechanism to prevent tumorigenesis 
in the intestine (Leibowitz et al., 2014). We therefore quantified the % of 
damaged Lgr5+ stem cells that are targeted for apoptotic deletion, i.e., H2AX+, 
Cl.caspas-3+ double-positive cells, as the selective deletion of damaged Lgr5+ 
stem cells through apoptosis could mitigate the clonal expansion of damaged 
Lgr5+ stem cells. As shown in Figure 22C, mice fed 2.8% FO + 0.5% CO + 
0.69% Cur and 1.9% FO + 0.5% CO + 0.46% Cur had markedly increased 
numbers of targeted apoptotic (H2AX+, Cl.caspas-3+) Lgr5+ stem cells as 
compared to its control group (2~3-fold). However, no statistically significant 
chemo-protective effect was detected in mice fed 1.4% FO + 0.5% CO + 0.35% 
Cur diet as compared to control.   
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Figure 22. Dose response of GFPhigh cells to n-3 PUFA + curcumin in the presence of 
AOM (12 hr). (A) Comparison in % of H2AX+ (DNA damaged) GFPhigh cells from mice fed 
varying doses of FO + Cur relative to CO (control) diets. % of DNA damaged cells = # of H2AX+ 
cells / total # of gated single cells x100. (B) Comparison in % of Cl.caspase3+ (apoptotic) 
GFPhigh cells from mice fed different doses of FO + Cur relative to CO diet. % of apoptotic cells 
= # of Cl.caspase3+ cells / total # of gated single cells x100. (C) Comparison in % of H2AX+ 
Cl.caspase3+ (targeted apoptotic, double positive) GFPhigh cells from mice fed different doses 
of FO + Cur relative to CO (control) diets. % targeted apoptotic cells = # of double positive cells 
(H2AX+ Cl.caspase3+) / # of H2AX+ cells x100. GFPhigh cells were isolated from n=7-8 mice 
per group and on average 9,000 single cell events per sample were collected. Statistically 
significant differences between diets were determined using one-way ANOVA followed by 
Sidak’s multiple comparison test adjustment. * Indicates significant difference between 
treatment groups (p<0.05). n.s. indicates not significant.  
 
 
 
GFPneg cells represent all populations of colonocytes including Lgr5+ 
stem cells, progenitor cells and differentiated cells due to the mosaic nature of 
GFP expression in Lgr5-EGFP-IRES-CreERT2 knock-in mice (Schuijers et al., 
2014). In GFPneg cells, only mice fed the 1.9% FO + 0.5% CO + 0.46% Cur diet 
had reduced DNA damage as compared to control (Figure 23A) and mice fed 
4.5% FO + 0.5% CO + 1% Cur diet exhibited enhanced apoptosis as compared 
A B C 
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to control (Figure 23B). However, no other statistically significant chemo-
protective effects were detected. This may reflect the dilution of the DNA 
damaged and apoptotic cell population in crypts, as the majority of AOM 
induced DNA damaged and apoptotic cells are present in the base of the crypt 
where Lgr5+ stem cells and transit-amplifying (TA) cells reside (Kim et al., 
2016a). With respect to the % of targeted apoptotic (H2AX+, Cl.caspas-3+) 
cells, statistically significent chemo-protective diet effects were detected  
across all groups compared to control as shown in Figure 23C. These findings 
indicate that DNA damaged cells (mostly Lgr5+ stem cells and transit-amplifying 
cells) are highly responsive to FO + Cur treatment. 
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Figure 23. Dose response of GFPneg cells to n-3 PUFA + curcumin in the presence of 
AOM (12 hr). (A) Comparison in % of H2AX+ (DNA damaged) GFPneg cells from mice fed 
different doses of FO + Cur relative CO (control) diets. % of DNA damaged cells = # of H2AX+ 
cells / total # of gated single cells x100. (B) Comparison in % of Cl.caspase3+ (apoptotic) GFPneg 
cells from mice fed different doses of FO + Cur relative CO (control) diets. % of apoptotic cells 
= # of Cl.caspase3+ cells / total # of gated single cells x100. (C) Comparison in % of H2AX+ 
Cl.caspase3+ (targeted apoptotic, double positive) GFPneg cells from mice fed different doses 
of FO + Cur relative to CO (control) diets. % of targeted apoptotic cells = # of double positive 
cells (H2AX+ Cl.caspase3+) / # of H2AX+ cells x100. GFPneg cells were isolated from n=7~8 
mice per group and on average 434,301 single cell events per sample were collected. 
Statistically significant differences between diets were determined using one-way ANOVA 
followed by Sidak’s multiple comparison test adjustment. * Indicates significant difference 
between treatment groups (p<0.05). n.s. indicates not significant.  
 
 
The median effective dose (ED50), i.e., the dose that produces a chemo-
protective effect in 50% of the subjects (Singh et al., 1999) was calculated to 
be 16 mg of n-3 PUFA and 15.9 mg of curcumin (Figure 24).  This corresponds 
to a daily HED of 3.0 g of n-3 PUFA and 3.0 g of curcumin. 
 
A B C 
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Figure 24. Dose response curves. ED50 is indicated in blue arrow. 
 
 
4.4      Discussion 
Drug synergism is of clinical significance when one uses both drugs at 
lower concentrations to produce better efficacy with lower toxicity than the 
single drug alone.  In our previous mouse study, we demonstrated that AOM-
induced DNA damaged Lgr5+ stem cells were effectively deleted by targeted 
apoptosis using a 4% fish oil (1% n-3 PUFA) + 1% curcumin combination diet. 
This diet also reduced AOM-induced nuclear β-catenin levels in ACF as 
compared to fish oil or curcumin alone (Kim et al., 2016b). However, the effects 
of a lower dose of fish oil + curcumin combination diet was not investigated. 
Therefore, in the present study, we investigated the potential synergistic 
chemo-protective effects of low dose curcumin and n-3 PUFA combination in 
the presence of AOM.  
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The daily dose of the experimental chemo-protective diet (4% fish oil + 
1% curcumin) in our previous study (Kim et al., 2016b) was 46 mg of n-3 PUFA 
and 45 mg of curcumin as described in Figure 17. Therefore, we compared 
several doses (32 mg n-3 PUFA + 31.7 mg Cur, 21.3 mg n-3 PUFA + 21.1 mg 
Cur and 16.0 mg n-3 PUFA + 15.9 mg Cur), with an HED of 6.0 g n-3 PUFA + 
6.0 g Cur, 4.0 g n-3 PUFA + 4.0 g Cur and 3.0 g n-3 PUFA + 3.0 g Cur, 
respectively (Figure 17). 
Analysis of the impact of the allometric exponent on the conversion of 
an animal dose to human equivalent dose (HED) utilizes BSA for dose 
calculations (Reagan-Shaw et al., 2008). The Food and Drug Administration 
has suggested that the extrapolation of animal dose to human dose is correctly 
performed only through normalization to body surface area (BSA), which often 
is represented in mg/ m2 (Reagan-Shaw et al., 2008). Accordingly, the 
approach of converting animal doses to an HED based on BSA is standard for 
estimating starting doses for initial studies in health volunteers. Thus, we 
extrapolated n-3 PUFA and curcumin dosages in the mouse diet to HED based 
on BSA (Reagan-Shaw et al., 2008) as shown in Figure 17. In this study, we 
demonstrated that a significant enhancement in the % of targeted apoptotic 
Lgr5+ stem cells (GFPhigh) is still observed at a dose of 21.3 mg n-3 PUFA + 
21.1 mg Cur (Figure 22), corresponding to an HED of 4.0 g n-3 PUFA + 4.0 g 
Cur. This is noteworthy, because in human subjects, treatment with 2 g of EPA 
for 6 months was associated with a 22% reduction in polyp number (West et 
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al., 2010) and a 40% reduction in ACF number following treatment with a 4 g 
dose of curcumin (Carroll et al., 2011).   In addition, 2.5 g of n-3 PUFA (1.4 g 
EPA + 1.1 g DHA) significantly reduced proliferative indices in patients with 
colonic polyps (Anti et al., 1994). With regard to curcumin dose, numerous 
studies have been conducted to address the pharmacokinetics, safety, and 
efficacy of curcumin in human subjects. According to the search results on 
ClinicalTrials.gov, a number of clinical trials utilizing curcumin are underway or 
have been completed (Li and Zhang, 2014).  Curcumin C3 Complex (Sabinsa 
Corporation, NJ, USA) is known to be well tolerated when taken at high doses 
(12 g/day) (Cheng et al., 2001; Ireson et al., 2002). 
As shown in Figure 22C, 1.9% FO + 0.5% CO + 0.46% Cur diet is the 
lowest dose that exhibits chemo-protective effects in terms of promoting 
targeted apoptosis in Lgr5+ stem cell. This corresponds to a dose of 21.3 mg 
n-3 PUFA in combination with 21.1 mg Cur /day or an HED equal to 4.0 g of n-
3 PUFA and 4.0 g of curcumin (Figure 17).  In summary, the present study 
provides strong evidence for translating the observed synergistic chemo-
protective effects to human trials utilizing a daily dose equivalent to 4.0 g n-3 
PUFA + 4.0 g Cur. Although the results from this study are encouraging, the 
efficacy of n-3 PUFA and curcumin in preventing colon cancer must still be 
evaluated in prospective controlled trials using ACF or adenoma recurrence as 
the intermediated end point.   
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In summary, our data broaden and redefine the physiological dose of n-
3 PUFA and curcumin by using mice fed relatively low dose n-3 PUFA and 
curcumin diets.  A daily dose of 21.3 mg of n-3 PUFA in combination with 21.1 
mg of curcumin promotes targeted apoptosis in DNA damaged Lgr5+ stem 
cells.  This corresponds to a HED of 4.0 g n-3 PUFA + 4.0 g Cur per day and a 
human ED50 equivalent to 3.0 g n-3 PUFA + 3.0 g Cur. These novel findings (i) 
demonstrate that Lgr5+ stem cells are very responsive to low dose dietary cues 
following the induction of DNA damage, and (ii) provide a therapeutic strategy 
for eliminating damaged stem cells and reducing colon cancer risk in humans.  
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5. CHOLESTETOL HOMEOSTASIS IN TUMORIGENESIS 
 
5.1     Introduction 
It has been demonstrated that free cholesterol and esterified cholesterol 
are 1.5~2 fold higher in tumor tissue as compared to uninvolved (normal) tissue 
in human colon cancer patients (Dessi et al., 1994). Mounting evidence indicates 
that statins, i.e., cholesterol synthesis inhibitors which selectively target 3-
hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), significantly reduce 
risk and mortality in colorectal cancer (Cardwell et al., 2014; Lakha et al., 2012; 
Poynter et al., 2005). In addition, epidemiologic studies suggest that statins may 
prevent certain malignancies (Hindler et al., 2006), including melanoma (Downs 
et al., 1998), breast (Boudreau et al., 2004; Cauley et al., 2003) and prostate 
cancer (Shannon et al., 2005).  
Cholesterol serves a structural roles in cell membranes where it forms 
lipid rafts (liquid ordered domains) (Bloch, 1983). As an important membrane 
component, cholesterol helps to generate a semipermeable barrier between 
cellular compartments and to regulate membrane fluidity. Cholesterol also 
modulates the functions of membrane proteins and participates in several 
membrane trafficking and transmembrane signaling processes, as exemplified 
by G protein-coupled receptor signaling (Cherezov et al., 2007; Simons and 
Vaz, 2004). 
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Approximately, 90% of free cholesterol is estimated to reside in the 
plasma membrane (Kim et al., 1991; Lange et al., 1989; Ueland et al., 1986) 
and membrane cholesterol levels are positively correlated with membrane 
order (decreased membrane fluidity) (Montero et al., 2008). Highly ordered lipid 
rafts are increased in many types of cancer (Li et al., 2006b; Patra, 2008) and 
some drug resistant cancers (Yi et al., 2013). Numerous studies indicate that 
elevated mitochondrial cholesterol is associated with cancer cell (Montero et 
al., 2008), can promote increased death resistance and thus malignant cell 
transformation (Smith and Land, 2012), as well as contribute to chemotherapy 
resistance (Montero et al., 2008). In addition, there is evidence suggesting that 
disruption of lipid rafts in cancer can lead to increased responsiveness to anti-
cancer therapies (Irwin et al., 2011). For this reason, there is considerable 
interest in identifying alternative strategies for lowering cholesterol. We have 
recently demonstrated that n-3 PUFA and curcumin reduce 
nuclear/cytoplasmic -catenin in aberrant crypt foci (ACF) (Kim et al., 2016b), 
and both DHA and curcumin are capable of modulating plasma membrane 
structure and EGFR function (Soung and Chung, 2011; Turk et al., 2012), 
which regulates colon cancer stem cell proliferation (Feng et al., 2012). With 
respect to its membrane targeting properties, curcumin associates with the 
head group region of the phospholipid bilayer (Barry et al., 2009; Hung et al., 
2008), whereas n-3 PUFA interact with the tail group region within rafts (Shaikh 
et al., 2004; Shaikh et al., 2015; Shaikh et al., 2009a).   
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Approximately, 80% of human colon cancers have biallelic Apc 
mutations (Kinzler and Vogelstein, 1996; Sparks et al., 1998), often with 
complete lack of expression from one allele along with expression of a 
truncated from the other.  In addition, approximately 40% of colon cancers 
express a mutated form of Kras (Amado et al., 2008; Di Fiore et al., 2007; Kim 
et al., 2016c). In cell lines, Apc knock-out increases genes involved in the de 
novo synthesis of cholesterol (Dow et al., 2015; Halvey et al., 2012). The 
intracellular accumulation of cholesterol promotes increased deposition of free 
cholesterol in the plasma membrane (Kellner-Weibel et al., 1999; Tulenko et 
al., 1998). However, the link between colon cancer (aberrant Wnt signaling) 
and membrane biology has not been investigated to date. 
We hypothesized that oncogenic Apc and Kras alter plasma membrane 
order in part by perturbing cholesterol homeostasis. In order to determine the 
effect of oncogenic Apc and Kras on plasma membrane order, we used 
tamoxifen (TAM)-regulated Cre transgenic mice, e.g., CDX2P-CreERT2-
Apc580S/+; KrasLSL-G12D/+ mice, which express Cre in epithelial cells in terminal 
ileum, cecum, colon and rectum. In this study, we have delineated a 
mechanism by which oncogenic Apc and Kras modulates plasma membrane 
order. We also assessed the ability of dietary effect (n-3 PUFA and curcumin) 
to modulate cholesterol levels and plasma membrane order. 
Our novel data provide evidence that oncogenic Apc and Kras directly 
modulate membrane cholesterol homeostasis, thereby perturbing plasma 
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membrane order which is positively modulates cell proliferation in our mouse 
model. Also, we provide evidence that select chemo-protective dietary 
bioactive compounds (n-3 PUFA and curcumin) can reverse the membrane 
modifying effects of cancer causing genes. 
 
5.2 Material and methods 
5.2.1 Animals 
KrasLSL-G12D/+ mice have been described previously (Jackson et al., 
2001). To study effects of inactive Apc (Apc 580D/+) and Kras activation 
(KrasG12D/+) in the large intestine, we crossed KrasLSL-G12D/+ mice with CDX2P-
CreERT2-Apc 580S/+ (Shibata et al., 1997) transgenic mice to generate CDX2P-
CreERT2- Apc 580S/+; KrasLSL-G12D/+ mice. To study the effects of inactive Apc 
(Apc 580D/+) and Kras activation (KrasG12D/+) in Lgr5+ stem cells, we crossed 
CDX2P-CreERT2-Apc 580S/+; KrasLSL-G12D/+ mice and Lgr5-EGFP-IRES-CreERT2 
mice (Barker et al., 2007) to generate Lgr5-EGFP-IRES-CDX2P-CreERT2-
Apc580S/+; KrasLSL-G12D/+ mice. The resultant mice were injected intraperitoneally 
three times (daily) with tamoxifen (100 mg/kg weight; Sigma-Aldrich, St. Louis, 
MO) dissolved in corn oil.  
 
5.2.2 Diets 
Mice were provided with a Teklad 4% fat rodent diet (Envigo, 7001) to 
see assess the effect of inactive Apc and oncogenic Kras on cholesterol 
 126 
 
homeostasis. In addition, the chemo-protective effect of n-3 PUFA and 
curcumin, 4% fish oil + 1% curcumin (n-3 PUFA + Cur) diet was examined. 
Dietary details have been previously reported (Kim et al., 2016b). A complete 
diet containing 5% corn oil (containing n-6 PUFA) was used as a baseline 
control, i.e., contained no n-3 PUFA or curcumin. A diet containing 4% (w/w) 
Menhaden fish oil (enriched in n-3 PUFA) + curcumin diet was used to 
determine the chemo-protective effects of these dietary bioactives. n-3 PUFA 
+ Cur diet contained 1% corn oil (w/w) to ensure that essential fatty acid 
requirements were met. Mice were provided with fresh diet every day and the 
feeders were removed and washed daily. Animals had free access to food and 
water at all times and 24 hr food intake was measured after 1 week of receiving 
the diets. The fatty acid composition of the diets was analyzed by gas 
chromatography and the level of curcumin was quantified by 1H NMR 
(Jayaprakasha et al., 2013). The fatty acid composition of the crypt was 
quantified by gas chromatography (Fan et al., 2003) and the level of curcumin 
was quantified by HPLC (Cuomo et al., 2011; Jayaprakasha et al., 2013). 
 
5.2.3 Total RNA isolation and PCR 
DNA from isolated crypts was extracted using RNA miniprep kit (Zymo 
Research, R1054) following the manufacturer’s protocol. Analysis for APC 
alleles (ApcWT, Apc580D, Apc580S) and KRAS alleles (KrasWT, KrasLSL-G12D, 
KrasG12D) were performed by multiplex PCR using primers as described in 
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Figure 26. Annealing sites for PCR primers used for the detection of each allele 
are indicated in Figure 26. 
 
5.2.4 RNA sequencing 
Total RNA from isolated crypts was isolated using the RNA miniprep kit 
(Zymo Research, R1054) following the manufacturer’s protocol. RNA quantity 
and quality were measured by nanodrop and Agilent 2100 Bioanalyzers 
(Agilent Technologies, CA), respectively. Isolated total RNA (250 ng) from each 
sample was subsequently prepared for sequencing using the TruSeq RNA 
Library Preparation Kit v2 (RS-122-2002, Illumina). Samples were sequenced 
for 50 cycles with single index reads on the HiSeq 2500 Sequencing system 
(Illumina). Following the removal of all genes with CPM (counts-per-million 
reads) values less than 1, publicly available R software, EdgeR, was used to 
identify differentially expressed genes.  
 
5.2.5 Ingenuity pathway analysis (IPA) 
Genes differentially expressed (FDR < 0.05) were included in pathway 
and function analyses (Shah et al., 2011; Triff et al., 2013) using Ingenuity 
software (IPA; Ingenuity® Systems, http://www.ingenuity.com). Statistical 
significance of the association between each data set and the canonical 
pathway was determined based on two parameters: (1) ratio of the number of 
genes from the data set that map to the pathway divided by the total number of 
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genes that map to the canonical pathway, and (2) p-values calculated using 
Fischer's exact test determining the probability that the association between 
the genes in the data set and the canonical pathway is due to chance alone. 
The upstream regulator analysis function of IPA was subsequently used to 
identify potential transcriptional regulators that could explain the observed 
changes in gene expression. The activation z-score was calculated to predict 
activation or inhibition of transcriptional regulators based on published findings 
accessible through the Ingenuity knowledge base. Regulators with a z-score 
greater than 1.96 or less than -1.96 were considered to be significantly 
activated or inhibited. Functions and pathways with P-value < 0.05 (Fischer’s 
exact test) were considered to be statistically significant. 
 
5.2.6 Fractionation and Western Blot (WB) 
Isolated crypts from colon samples were harvested and washed with 
PBS. The nuclear and cytoplasmic fractions were extracted using NE-PER 
Nuclear and Cytoplasmic Extraction Reagents (78833, ThermoFisher 
Scientific, USA) according to the manufacturer's manual. Total lysates were 
prepared using Pierce RIPA buffer (89901, ThermoFisher Scientific) according 
to manufacturer's protocol. Samples were quantified by Bradford analysis and 
measured at 595 nm with a microplate reader. Normalized amounts of the 
samples were denatured in SDS sample buffer for 10 min at 95°C before being 
separated by SDS-PAGE and blotted onto polyvinylidene (PVDF) membranes 
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(Millipore, IPVH00010). Membranes were blocked with 5% non-fat dry milk-
TBS at room temperature for 30 min followed by incubation with β-catenin 
antibody (BD, 610154) at 4° C for overnight. β-actin (AbCam, Ab8227) antibody 
was used to generate loading controls. After being washed with 0.1% Tris-
buffered saline and Tween 20 (TBST), membranes were incubated with 
horseradish peroxidase labeled Goat anti-rabbit conjugated (HRP) IgG (H+L) 
(SeraCare, 074-1516) or horseradish peroxidase labeled Goat anti-mouse 
conjugated (HRP) IgG (H+L) (SeraCare, 074-1806). 
SuperSignalWestFemtoTrial kit (ThermoFisher, 34094)) was used to detect 
chemiluminescence, and blots were imaged using a ChemiDoc MP Imaging 
system (Bio-Rad, USA). 
 
5.2.7 Single cell sorting-ACKG 
Lgr5-EGFP-IRES-CreERT2-CDX2P-CreERT2 (CG, n=3) and Lgr5-
EGFP- IRES-CreERT2-CDX2P-CreERT2- Apc 580S/+; KrasLSL-G12D/+ mice (ACKG, 
n=3) mice were terminated at 8 wks after 3 daily Tamoxifen (TAM, 100 mg/kg 
body weight) injections. CG mice were used as a control for the ACKG mice. 
To examine effects of inactive Apc (Apc580D/+) and mutant Kras activation 
(KrasG12D/+) in Lgr5+ stem cells compared to all cells, isolated colonocytes from 
the colon were sorted based on GFP expression using a Beckman Coulter 
MoFlo Astrios as previously described (Fan et al., 2014). GFPhigh cells (Lgr5+ 
 130 
 
stem cells) and GFPneg cells (all cells combined) were sorted for each mouse 
and used for measuring plasma membrane order and levels of cholesterol.  
 
5.2.8 Membrane order 
Live isolated single cells or sorted GFPhigh cells (Lgr5+ stem cells) and 
GFPneg cells were used for quantifying plasma membrane order. The stock 
solution of di-4-ANEPPDHQ (ThermoFisher, D36802, 5 M in DMSO) was 
stored in a 200 L aliquots wrapped in aluminum foil at -20° C. Di-4-
ANEPPDHQ was mixed with cells (at a final concentration of 1 M) immediately 
before imaging to avoid internalization of dye.  Cells were transferred onto Cell 
Imaging Coverglass (8 chamber) slides (Eppendorf, 0030742036) for 
microscopic analysis using a laser confocal microscope (Leica DMi8 S Platform 
EII). A 40× oil immersion objective (NA = 1.15) was used with an excitation of 
488 nm, and detection ranges for the two channels were set to 500–580 nm 
and 620–750 nm. Identical microscope settings were maintained for 
quantitative imaging of membrane components, including the laser power, PMT 
voltage, and the offset values. After the confocal imaging process, general 
polarization (GP)-images were generated as previously described (Owen et al., 
2011). The image J macro provided by Owen et al. was downloaded and 
applied.  
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5.2.9 Filipin III 
Isolated single cells or sorted GFPhigh cells (Lgr5+ stem cells) and GFPneg 
cells were fixed in 1.5% paraformaldehyde for 20 min at room temperature. 
Cells are rinsed with PBS followed by incubation with Filipin III (Sigma, F4767) 
at a final concentration of 50 g/mL for 45 min at room temperature. Cells were 
washed with PBS and images were captured using an inverted TE 300 Nikon 
Eclipse fluorescence microscope equipped with 40X/1.30 Nikon Plan Fluor oil 
immersion objective, a Photometrics Cool Snap EZ digital CCD camera and a 
SOLA external light source. Images were acquired using a 405 nm laser with 
10 ms exposure time to avoid photobleaching. Images were subsequently 
processed using NIS Image software, version 3.2 (Nikon). 
 
5.2.10 Organoid cultures 
Lgr5-EGFP-CreERT2 mice were used to isolate a cell population 
expressing GFPhigh. Sorted GFPhigh single cells were embedded in Matrigel on 
ice and seeded in 12-well plates (200 cells/30 L of Matrigel per well). The 
Matrigel was polymerized for 10 min at 37◦C, and 500 L /well basal medium 
was overlaid for each well. Basal medium contained advanced Dulbecco's 
modified Eagle medium/F12 supplemented (Gibco, 12634-010) with PenStrep 
(P/S) (Gibco, 15140-122), 10 mM HEPES (Gibco, H0887), Glutamax glutamax 
(Gibco, 35050-061), 50 ng/mL murine EGF (LifeTech, PMG8041), 0.2 M LDN 
(Noggin replacement) Cellagen Tech, 0.5 g/mL R-Spondin (Peprotech, 315-
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32), 1× N2 (LifeTech, 17502-048), 1× B27 (LifeTech, 12587-010), 1 M N-
acetylcysteine (Sigma, A9165), 30 ng/mL Wnt (TimeBioscience, rmW3aL-002). 
Media was changed every 48 hr and organoids were passage every 5 days.  
 
5.2.11 Cholesterol loading 
Exogenous cholesterol was delivered to cells as a Chol: methyl-β-
cyclodextrin (MβCD) complex purchased from Sigma as “water-soluble 
cholesterol” (Sigma, C4951) containing 40 mg of cholesterol/g solid. All 
treatment concentrations involving Chol: MβCD were based on cholesterol 
mass. For this purpose, cholesterol was mixed in a Chol: MβCD molar ratio of 
1:7.4, and solubility was increased by adding 351 mg of extra uncomplexed 
MβCD to produce a molar ratio of 1:10 (Zidovetzki and Levitan, 2007). Cells 
incubated with media for 24, 48 and 72 hr with 250 M MβCD (Sigma, C4555) 
treatment served as control experiments. 
 
5.2.12 Proliferation assay using organoids 
To determine whether cholesterol enhanced cell proliferation, organoids 
were incubated with Chol: MβCD (12.5~100 M) in organoid complete media 
for 24, 48 and 72 hr. Media was changed every 24 hr to prevent cholesterol 
oxidization. To test for proliferation, 10 M EdU were incubated for 1.5 hr before 
harvest organoids and the assay was done using the Click-iT Plus EdU Alexa 
Fluor 647 Imaging kit (Life Technologies, C10640) according to manufacturer's 
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protocol. Cells incubated with media for 24, 48 and 72 hr with MβCD (125~1000 
M) and cells with no treatment served as control experiments. To quantify 
EdU+ cells, imaging is achieved with the imaging flowcytometer FlowSight® 
(Amnis®, EMDMillipore). Bright field (595-642 nm) and EdU AF647 (632-740 
nm) channels were used to collect data. Cells not incubated with AF647 was 
used for gating EdU negative cells. To quantify EdU+ cells IDEAS version 6.0 
was used.     
 
5.2.13 Cell proliferation assay 
Young adult mouse colonic epithelium (YAMC) cells and 
Immortomouse/Min colon epithelial (IMCE) cells were treated with cholesterol 
and MβCD for 24, 48 and 72 hr. Rates of cell proliferation were assessed using 
the CellTiter Blue Cell Viability Assay kit (Promega, G8080), a fluorescent 
method that is based on the ability of living cells to convert a redox dye 
(resazurin) into a fluorescent end product (resorufin). Briefly, cells were seeded 
into 24-well cell-culture plates (3 × 104 per well) and at 0, 24, 48 and 72 hr and 
cell proliferation was determined.  
 
5.2.14 Measurement of plasma membrane order and cholesterol levels using 
imaging flow cytometry.  
YAMC cells and IMCE cells were seeded into 6-well cell-culture plates 
(5 × 104 per well) and treated with cholesterol and MβCD for 0, 24, 48 and 72 hr. 
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Cells were harvested at 0, 24, 48 and 72 hr and harvested cells were used to 
measure plasma membrane order and cholesterol levels. Analyses were 
performed using an imaging FlowSight® flowcytometer (Amnis®, 
EMDMillipore) immediately after adding Di-4-ANEPPDHQ (at a final 
concentration of 1 M) to live single cells. A 488 nm laser was used for 
excitation. Bright field (430-480 nm), ordered (505-560 nm) and disordered 
(642-740 nm) channels were used to collect data. After collecting images, GP-
values were generated (Owen et al., 2011) using IDEAS version 6.0.      
Imaging flowcytometry was also used to measure cholesterol levels in 
the plasma membrane.  For this purpose, harvested single cells were fixed in 
1.5% PFA for 30 minutes at 4°C, followed by labeling with Filipin III (50 g/mL) 
for 45 minutes at room temperature in the dark and washing with PBS.  A 403 
nm laser was used for excitation. Bright field (560-595 nm) and Filipin III (430-
505 nm) channels were used to collect data. Filipin III intensity from the plasma 
membrane was quantified using the IDEAS feature analysis software.  Masks 
were drawn around each cell to identify the plasma membrane (whole cell – 
cytoplasm).  
 
5.3 Results 
5.3.1 Validation of CDX2P-CreERT2-Apc580D/+; Kras LSL-G12D/+ mouse model 
 Tamoxifen (TAM)-regulated inducible CDX2P-CreERT2-Apc580S/+; 
KrasLSL-G12D/+ (referred to as ACK) were utilized to express Cre in epithelial cells 
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in terminal ileum, cecum, colon and rectum. Following TAM injection, Cre 
expression induced deletion of exon 14 from the Apc580S transcripts, resulting 
in a frame-shift mutation, Apc580D. Concurrently, Cre-mediated recombination 
removed transcriptional stop elements and activated a latent oncogenic 
KrasLSL-G12D/+ allele resulting in the expression KrasLSL-G12D/+ under control of its 
endogenous regulatory promoter. CDX2P-CreERT2 (referred to as Control or 
WT) mice were used as a control.  
Mice were terminated at 4, 8 and 24 wks after 3 TAM injections (Figure 
25B) and samples collected as described in Figure 25B. Somatic inactivation 
of the Apc580S allele and activation of the KrasLSL-G12D/+ allele in the colonic crypt 
of ACK compared to control mice were assessed using PCR. For both 
genotype and Cre activity purposes, allele-specific primers were as described 
is Figure 26 A&B. In control mice, only wild type Apc allele and wild type Kras 
allele were present across all time points, whereas in ACK mice, mutated allele 
of Apc and Kras were detected as expected.  Animal body weights in ACK 
compared to control mice were not different (Figure 27A). Since recombinase 
activity is not 100%, allele carrying floxed region Apc (Apc580D) and Kras 
(KrasG12D) was also detected. We measured the body weight in the mice every 
week and no difference in ACK compared to control mice (Figure 27A).  
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Figure 25.  Experimental design and sample preparation. (A) Timeline of the treatments 
and experimental design. (B) Sample preparation.  
A 
B 
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combined, there was a statistically significant change in β-catenin with respect 
to its nuclear/cytoplasmic distribution in ACK mice compared to control mice 
(Figure 27D, right). 
We then applied a cell fractionation protocol, which separated the 
nuclear compartment from the cytoplasm of isolated crypts as revealed by 
western blot analysis to verify the effect of inactive Apc (Apc580D) in ACK mice 
on Wnt-downstream signaling.  As expected, β-catenin was detected in both 
the nuclear and cytosol fractions in both ACK and control mice across all time 
points. The relative density of nuclear / cytosolic β-catenin per group was 
determined and there was no statistically significant change in β-catenin in 
nuclear/cytoplasmic distribution in ACK mice compared with control mice 
across all time points (Figure 27D, left).  However, when all time points were 
 138 
 
 
 
 
 
Figure 26. PCR strategy and primers. Positions of Allele-specific primers for Apc (A) and 
Kras (B) and estimated size (bp). ApcWT: Apc wild type allele, KrasWT: Kras wild type allele, bp: 
base pair, N.A.: not amplified.   
 
 
 
 
 
B 
A 
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Figure 27.  Validation of inactivation of Apc and activation of oncogenic Kras in the ACK 
mouse model. (A) Animal weight post TAM treatment per group. (B) Molecular analysis of Apc 
and Kras alleles in isolated crypts. CDX2P-CreERT2 (Control, n=3 per group) and CDX2P-
CreERT2-Apc580S/+; KrasLSL-G12D/+ (ACK, n=3 per group) mice were terminated at 4, 8 and 24 
wks after 3 daily Tamoxifen (TAM, 100 mg/kg body weight) injections. The wild-type Kras allele 
(Kras+) is represented by a 700 base pair (bp) fragment. The floxed Kras allele (KrasLSL-G12D) is 
represented by a band of 570 bp, whereas the Cre-targeted allele (KrasG12D) is represented by 
a band of 720 bp. The wild-type Apc (Apc +) is represented by a 226 bp fragment. Floxed Apc 
allele (Apc 580S) is represented by a 314 bp fragment, whereas the Cre-targeted allele (Apc580D) 
is represented by a band of 258 bp. (C) The expression of cytosol and nuclear forms of β-
catenin was examined by Western blotting. β-actin served as a loading control. Crypts from 
control and ACK mice were isolated at 4, 8 and 24 wks post 3 TAM injection and fractionated 
into nuclear and cytosolic compartments. N = nuclear fraction and C = cytosolic fraction. (D) 
The relative density of nuclear / cytosolic β-catenin of ACK compared to control at 4, 8 and 24 
wks post TAM injection (left). The relative density of nuclear / cytosolic β-catenin of ACK 
compared to control (all time points combined, right) is shown. Values are normalized to the 
control group. * Indicate significant difference between treatment groups (p<0.05). 
 
 
5.3.2 Dysplastic foci are increased in ACK mice  
As a functional validation of our animal model, we 
immunohistochemically quantified dysplastic foci, polyps and adenoma 
phenotypes (Di Gregorio et al., 1997; Naini and Odze, 2013; Suzui et al., 2013) 
A B 
C D 
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as shown in Figure 28A. Paraffin-embedded, H&E stained colon sections (4 
m) were examined for aberrant crypt foci (ACF) by a blinded veterinary 
pathologist. Representative images of dysplastic foci, polyps and adenoma are 
shown in (Figure 28B). (i) Dysplastic foci were defined as regions with an 
increased nuclear to cytoplasm ratio, loss of apical differentiation, crowding of 
cells (hyperplasia), and/or irregular lumen diameter with tortuous branching. 
The lamina propria and submucosa contained a mixed inflammatory infiltrate 
composed of small numbers of neutrophils with fewer macrophages, 
lymphocytes and plasma cells. Crypts sometimes contained sloughed 
degenerate epithelial cells and acellular debris. (ii) Polyps contained a short 
stalk with a raised, nodular foci of hyperplastic epithelium. They share many of 
the cellular features of dysplasia but are more nodular and elevated above the 
surrounding epithelium. (iii) Adenomas were nodular, raised, circumscribed foci 
of neoplastic epithelial cells arising from the mucosa. Epithelial cells formed 
irregularly branching tortuous glands that did not extend beyond the muscularis 
mucosa. The stroma contained a small number of neutrophils, lymphocytes (Di 
Gregorio et al., 1997; Naini and Odze, 2013; Suzui et al., 2013). Substantial 
amounts of dysplastic foci were present in ACK mice across all time points 
(Figure 28C) and polyps and adenomas were detected at 8 and 24 wks, 
respectively (Figure 28A). In contrast, none of sequential abnormalities were 
detected in control mice.  
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Figure 28.  Number of dysplastic foci, polyps and adenomas per animal were increased 
in ACK mice as compared to control mice.  (A) Number of dysplastic foci, polyps and 
adenoma per animal in different group. CDX2P-CreERT2 (Control, n=3 per group) and CDX2P-
CreERT2-Apc580S/+; KrasLSL-G12D/+ (ACK, n=3 per group) mice were terminated at 4, 8 and 24 
wks after 3 Tamoxifen (TAM, 100 mg/kg body weight) injections. (B) Representative images of 
dysplastic foci, polyps and adenoma and description of it. (C) Comparison of number of 
dysplastic foci per group. Two-way ANOVA followed by the Tukey’s multiple comparison test 
to compare between groups. Bars with different letters are significantly different, P < 0.05.  
 
 
5.3.3 Proliferation is increased in ACK mice as compared to control mice 
In familial adenomatous polyposis (FAP), which is associated with germline 
mutations in APC, the earliest visible change before the development of small, 
dysplastic adenomas is an upward shift in the proliferative compartment (Potten 
A B 
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et al., 1992). To determine whether the proliferative compartment in the colonic 
crypt is elongated, the proliferating zone was determined as the distance from 
the base of the crypt to the highest proliferating cell (EdU+) cell within in the crypt. 
For this purpose, the number of EdU+ cells per crypt, proliferating zone and 
length of crypt in ACK mice were quantified at 4, 8 and 24 wks after 3 TAM 
injections. Representative images of Swiss rolls labeled with EdU and 
counterstained with DAPI are shown in Figure 29D.  As expected, the number of 
EdU+ cells per crypt (Figure 29A), proliferating zone (Figure 29B) and length of 
crypt were increased in ACK mice as compared to control across all time points. 
None of the sequential abnormalities were detected in control mice. 
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Figure 29. Proliferation is increased in ACK compared to control mice.  (A) Number of 
proliferating cells (EdU+) per crypt in the distal colon. CDX2P-CreERT2 (Control, n=3 per group) 
and CDX2P-CreERT2-Apc580S/+; KrasLSL-G12D/+ (ACK, n=3 per group) mice were terminated at 4, 8 
and 24 wks after 3 Tamoxifen (TAM, 100 mg/kg body weight) injections. (B) Length of the crypt 
proliferative zone in the distal colon. (C) Length of crypts in the distal colon. (D) Swiss roll labeled 
with DAPI (cyan, nucleus) and EdU (red, proliferating cells). Two-way ANOVA followed by the 
Tukey’s multiple comparison test to compare between groups. Bars with different letters are 
significantly different, P < 0.05. 
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5.3.4 Apc580D/+ and KrasG12D/+ increases cholesterol and plasma membrane 
order and is positively associated with increased proliferation 
Increased free cholesterol (1.5-fold) and esterified cholesterol (2-fold) in 
tumor tissue as compared to normal tissue has been reported in human colon 
cancer patients (Dessi et al., 1994). Statin, a cholesterol antagonist, 
significantly reduces risk of colorectal cancer (OR=0.33-0.50) and mortality in 
colorectal cancer patients (Cardwell et al., 2014; Lakha et al., 2012; Poynter et 
al., 2005) implying an important role for cholesterol in cancer biology.  This is 
noteworthy, because plasma membrane cholesterol is highly correlated with 
membrane order (Montero et al., 2008), and cholesterol-rich highly ordered lipid 
rafts are increased in many types of cancer (Li et al., 2006b; Patra, 2008) and 
some drug resistant cancers (Yi et al., 2013). From a mechanistic perspective, 
changes in plasma membrane structure alter receptor-mediated cell signaling 
(Gawrisch et al., 2008).  
It has been demonstrated that Apc knock-out mice increase 
hydroxymethylglutaryl coenzyme A reductase (HMGCR) genes which drive 
cholesterol synthesis in the colonocyte (Dow et al., 2015).  In addition, mutant 
Kras promotes Wnt signaling through LRP6 phosphorylation (Lemieux et al., 
2015), which promotes stemness and malignant transformation. It also has 
been shown that oncogenic Kras induces cholesterol synthesis (SREBP1/2 and 
Sqle.1) gene expression in murine lung adenocarcinoma cells (Gouw et al., 
2017). However, to date, it has not been determined whether disrupted Wnt 
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and EGFR signaling pathways modulate colonocyte cholesterol homeostasis 
in vivo. Thus, we hypothesized that levels of free cholesterol increased by 
inactive Apc (Apc580D) and oncogenic Kras (KrasG12D) will perturb colonic crypt 
plasma membrane order.  
In order to visualize the distribution of plasma membrane free 
cholesterol, isolated fixed cells from ACK and control mice were labeled with 
Filipin III (a sterol-binding fluorescent polyene) which selectively binds free 
cholesterol (Kruth and Vaughan, 1980). Representative images of Filipin III 
stained cells are shown in Figure 30A and fluorescence intensity of Filipin III 
from cells was determined using the NIS Image software. Fluorescence 
microscopy images of cells isolated from ACK mice exhibited an increased 
staining with Filipin III when compared to cells from control mice (Figure 30B).  
From a functional perspective, the cholesterol/phospholipid composition 
of cellular membranes is known to influence plasma membrane biology and the 
ability of plasma membrane receptors/signaling proteins to function properly 
(Griffie et al., 2015; Hou et al., 2016; Phillips et al., 2009). From a biophysical 
perspective, cholesterol in the plasma membrane increases plasma 
membrane order (decrease plasma membrane fluidity) (Montero et al., 
2008), thus, we examined the effect of cholesterol enrichment on plasma 
membrane order using colonic epithelial cells isolated from ACK mice as 
compared to control mice. Representative images of di-4-ANEPPDHQ stained 
cell are shown in Figure 31A. As expected, plasma membrane order of cells 
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from ACK mice were increased as compared to control mice across all time 
points (Figure 31B).  
 
 
 
 
 
Figure 30.  Plasma membrane free cholesterol levels are increased in ACK mice as 
compared to control mice.  (A) Representative images of free cholesterol as indicated by 
Filipin III fluorescence in colonocyte from each group.  (B) Mean Filipin III fluorescence in 
colonocyte from each group.  CDX2P-CreERT2 and CDX2P-CreERT2-Apc580S/+; KrasLSL-G12D/+ 
mice were terminated at 4, 8 and 24 wks after 3 daily Tamoxifen (TAM, 100 mg/kg body weight) 
injections. Isolated single cells were fixed in 1.5% PFA for 30 minutes at 4°C, followed by 
labeling of cholesterol with Filipin III (50 g/mL) for 45 minutes at room temperature in the dark.  
Images were acquired using a Nikon wide field microscope with 40x oil objective using the 
DAPI_2 (dedicated DAPI filter, not the quad 4 cube) filter. Images were acquired using the 
same exposure time (10 ms) to compare relative fluorescence.  Intensity of Filipin III was 
determined using NIS Image software, version 3.2. Two-way ANOVA followed by the Tukey’s 
multiple comparison test to compare between groups. Bars with different letters are significantly 
different, P < 0.05. 
 
 
A 
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Figure 31. Membrane order of colonocyte is increased in ACK mice compared to control.  
(A) Representative confocal images of colonocyte in the liquid ordered phase (green line) and 
liquid disordered phase (red line). (B) Plasma membrane order of colonocyte isolated from 
ACK and control mice.  CDX2P-CreERT2 and CDX2P-CreERT2-Apc580S/+; KrasLSL-G12D/+ mice 
were terminated at 4, 8 and 24 wks after 3 daily Tamoxifen (TAM, 100 mg/kg body weight) 
injections.  Imaging was achieved with a Nikon confocal microscope immediately after adding 
Di-4-ANEPPDHQ to isolated single cells.  Generalized Polarization (GP) images were 
calculated using a custom plugin for ImageJ using the intensity of the ordered phase image (IO) 
and a red-shifted image (ID) from the disordered phase according to the equation, GP=(IO-
ID)/(IO+ID).  The GP values ranged from −1 (when all the fluorescence emission is collected in 
the disordered, long-wavelength channel) to +1 (when all the fluorescence is collected in the 
ordered, short wavelength channel).  IO: Intensity of the ordered phase image (shorter 
wavelength, 508-544 nm); ID: Intensity of the disordered phase image (long-wavelength, 651-
695 nm).  Statistically significant differences between time were determined using one-way 
ANOVA followed by Tukey’s multiple comparison test adjustment. Bars with different letters are 
significantly different, P < 0.05. 
 
 
 
Using a simple linear regression analysis, we determined whether 
there was any association between the number of EdU+ cells per crypt, 
membrane cholesterol levels (Figure 32A). In addition, the relationship 
A 
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between the number of EdU+ cells per crypt and plasma membrane order was 
investigated (Figure 32B). As shown in Figure 32, cholesterol and plasma 
membrane order exhibited a significant proportional increase dependent on 
the number of EdU+ cells per crypt. This finding implies that Apc580S and 
KrasG12D play a role in increasing free cholesterol, thereby affecting plasma 
membrane order, which is associated with increased cell proliferation.  
 
 
 
 
Figure 32. Plasma membrane order and cell proliferation are positively correlated.  
Association between the number of EdU positive cells and membrane order. (A) The 
association between EdU positive cells and cell cholesterol levels.  (B)  The association 
between EdU positive cells and cell membrane order.  Each point represents an individual 
animal and wks post Tmx are labeled with different symbols as indicated.  Slopes shown 
are found to be significantly different from 0 at a significant level of 0.05.  
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5.3.5 Cholesterol directly enhances proliferation – in vitro and ex vivo  
Our findings raise the possibility that changes in membrane 
cholesterol status may directly regulate cell proliferation in the colon.  
Because proliferating cells, such as cancer cells, are believed to have 
increased requirements for cholesterol (Menendez and Lupu, 2007), we 
further elucidated the association of Apc580D and KrasG12D mutation-mediated 
changes in membrane cholesterol to cell proliferation. To measure the direct 
effects of cholesterol on cell proliferation, we quantified the proliferation rate 
following exogenous cholesterol incubation using a model of (i) conditionally 
immortalized mouse colon epithelial cell lines (in vivo): YAMC (with two wild 
type Apc alleles) (Whitehead and Robinson, 2009), (ii) IMCE (with one wild 
type Apc and one mutant ApcMin allele) (Whitehead and Joseph, 1994) and 
(iii) mouse colonic organoids (ex vivo).  Proliferation was determined by the 
fluorescent CellTiter-Blue method, which is based on the ability of living cells to 
convert redox dye (resazurin) into a fluorescent end product (resorufin). 
Nonviable cells rapidly lose metabolic capacity and thus do not generate a 
fluorescent signal. Cells were either treated with varying concentrations of 
cholesterol combined with MCD (water soluble cholesterol) or MCD as 
described in Figures 33 and 34.  Cells not incubated with cholesterol and MCD 
were used as a baseline control. In addition, cholesterol was incubated with 
media containing lipoprotein depleted serum. Cell viability was monitored every 
24 hr over a 72 hr period. YAMC cells increased proliferation in the presence 
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of 100 M cholesterol at 72 hr (Figure 33B) whereas, MβCD treated cells 
exhibited a significant decrease in proliferation as compared to cells with no 
treatment (cells only) as shown in Figure 33A.  Data showing cholesterol 
incubated cells are separately shown in Figure 33B along with statistical 
results. As a consequence of cholesterol incubation, levels of cholesterol 
(Figure 33C) and plasma membrane order (Figure 33D) were also increased 
as compared to MCD (alone) incubated cells.  In IMCE cells, cholesterol 
incubation for 72 hr increased proliferation as compared to cells with no 
treatment in a dose-dependent manner (Figure 34B), in contrast to MβCD 
treated cells (Figure 34A). These preliminary findings demonstrate that cells 
increase proliferation in a dose dependent manner, implying a direct role of 
cholesterol in cell division.  
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Figure 33. Cholesterol increases proliferative rate in YAMC cells.  (A) Proliferation rate of 
YAMC cells upon incubation with different concentrations of cholesterol and MCD (n=3).  (B) 
Statistical summary of cholesterol effects on YAMC cell proliferation (n=3).  (C) Levels of 
plasma membrane cholesterol in YAMC cells were exposed to increasing concentrations of 
cholesterol and MCD (n=1). Imaging flowcytometry (FlowSight®, Amnis®, EMD Millipore) was 
used to measure membrane cholesterol levels. For this purpose, harvested single cells were 
fixed in 1.5% PFA for 30 minutes at 4°C, followed by labeling with Filipin III (50 mg/mL) for 45 
minutes at room temperature in the dark followed by washing with PBS. Bright field (560-595 
nm) and Filipin III (430-505 nm) channels were used to collect data. Filipin III intensity from cell 
plasma membranes were quantified using the IDEAS feature analysis software. * Indicates 
significant difference from cells only. Media was changed every 24 hr to avoid oxidization. No 
data presented indicates non-viable cultures. Cells not incubated with cholesterol and MCD 
were used as a baseline control. (D) Plasma membrane order of YAMC cells following 
incubation with different concentrations of cholesterol and MCD (n=1). Imaging was achieved 
immediately after adding Di-4-ANEPPDHQ (at a final concentration of 1 M) to live single cells. 
Cells were excited using a 488 nm laser. Bright field (430-480 nm), ordered (505-560 nm) and 
disordered (642-740 nm) channels were used to collect data. Confocal images were processed 
to generate GP-values (Owen et al., 2011) using IDEAS version 6.0.     
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Figure 34. Cholesterol increases proliferative rates in IMCE cells.  (A) Proliferation rate of 
IMCE cells upon cholesterol and MCD incubation (n=3).  (B) Effect of cholesterol dose on 
IMCE cell proliferation rates (n=3). (C) Levels of plasma membrane cholesterol in IMCE cells 
following incubation with increasing concentrations of cholesterol and MCD (n=1). Plasma 
membrane cholesterol levels were quantified as described in Figure 34. (D) Plasma membrane 
order of IMCE cells was also quantified using an imaging flowcytometer FlowSight® (Amnis®, 
EMDMillipore) immediately after adding Di-4-ANEPPDHQ (at a final concentration of 1 M) to 
live single cells as described in Figure 33.   
 
 
We also investigated the effects of exogenous cholesterol on the number 
of proliferating cells in organoids.  For this purpose, organoids were grown 
using sorted Lgr5 stem cells (GFPhigh) isolated from Lgr5-EGFP-IRES-CreERT2 
mice and incubated in media (Table 7) either with 100M cholesterol or 1000 
M MCD for 72 hr. A predetermined cholesterol (100M) dose was selected 
A B 
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based on our cell line proliferation data (Figure 33B and 34B). MβCD (1 mM) 
was used as a control (Figure 33A and 34A). Proliferating cells were labeled 
using EdU assay and the % of EdU positive cells were quantified using a 
Millipore FlowSight imaging flow cytometer. As shown in Figure 35A, less than 
5% of EdU positive cells were found in organoids incubated without cholesterol 
(no Chol, 72 hr), whereas 25% of EdU positive cells were detected in organoids 
incubated with cholesterol (Chol, 72 hr), further demonstrating the ability of 
cholesterol to directly modulate colonocyte proliferation. Consistent with these 
findings, membrane cholesterol levels and plasma membrane order were 
increased upon cholesterol incubation for 72 hr as expected (Figure 35B and 
35C). In summary, our data demonstrate a direct effect of cholesterol on 
enhancing proliferation and plasma membrane order in vitro (Figure 33A and 
34A) and ex vivo (Figure 35A). These findings support our hypothesis that 
cholesterol mediated changes in plasma membrane order may modulate cell 
proliferation.     
 
 
 
Table 7. Organoid culture media. 
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Figure 35. Cholesterol increases the percentage of proliferating cells in organoids.  (A) 
% EdU positive cells in organoids incubated with 100 M cholesterol for 72 hr. Organoids were 
derived from sorted GFPhigh cells isolated from Lgr5-EGFP-CreERT2 crypt cells. To quantify 
EdU+ cells, FlowSight® (Amnis®, EMDMillipore) images were obtained following excitation with 
647 nm. Bright field (595-642 nm) and EdU AF647 (632-740 nm) channels were used to collect 
data. Cells not incubated with AF647 were used for gating EdU negative cells. Cholesterol (B) 
and plasma membrane order (C) in organoids incubated with 100 mM cholesterol for 72 hr.  * 
Indicates significant difference between groups.  Refer to Figure 30 and 31 for additional 
details. 
 
 
 
5.3.6 Apc580D/+ and KrasG12D/+ regulate a canonical cancer driver gene 
associated with cholesterol homeostasis 
To further elucidate the effect of Apc580D/+ and KrasG12D/+ on modulating 
cholesterol homeostasis, global transcriptional profiles in ACK mice and control 
mice were assessed by RNA sequencing on isolated crypt cells. Mice were 
terminated at 4, 8 and 24 wks after 3 daily TAM injections and samples were 
collected as described in Figure 25B. ACK mice terminated at 4, 8 and 24 wks 
post TAM were compared with control mice terminated at 4, 8 and 24 wks, 
respectively. IPA was subsequently used to identify potential transcriptional 
A B C 
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regulators inferred from differentially expressed genes.  Interestingly, Myc was 
the number one ranked upstream regulator (highest z-score) in ACK mice at 4 
and 8 wks as compared to control mice, and was the second highest ranked 
upstream regulator at 24 wks (Table 8). This is highly relevant, since Myc is a 
well-known marker gene associated with inactive Apc and is overexpressed in 
approximately 70% of colorectal tumors (Erisman et al., 1985). Oncogenic Myc 
is known to regulate the expression of HMGCR in esophageal epithelial cells 
(SHEE) cells (Zhong et al., 2014), thereby increasing cholesterol. Cholesterol is 
synthesized from acetyl-CoA, which is condensed to form HMG-CoA and is 
subsequently reduced to mevalonate by HMGCR. HMGCR is rate-limiting in 
the cholesterol synthesis pathway; hence, HMGCR is essential for Myc-driven 
cancer as it mediates the phosphorylation and transactivation of Myc (Cao et 
al., 2011). In summary, our novel findings indicate that Apc580D/+ and KrasG12D/+ 
regulate a canonical cancer driver gene associated with cholesterol 
homeostasis. 
 Using bioinformatic analysis, we have identified a total of 66 Myc target 
genes that were differentially expressed in ACK mice as compared to control 
mice across all time points. Myc target genes expressed in at 4, 8 and 24 wks 
are listed in Table 8. Many of these genes  regulate the cell cycle and mitotic 
regulation including Cyclin A2 (CCNA2) (Pagano et al., 1992), cyclin B1 
(CCNB1) (Wang et al., 1997), cyclin E (CCNE) (Bondi et al., 2005), cyclin D2 
(CCND2) (Mermelshtein et al., 2005), cyclin-dependent kinase 1 (CDK1) 
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(Castedo et al., 2002), and cyclin-dependent kinase 4 (CDK4) (O'Leary et al., 
2016)  (marked with green) (Tables 8 & 9). 
Proliferation of epithelial crypt cells is Wnt dependent (Schuijers et al., 
2015) and Wnt-driven target gene expressed in colon cancer and in crypts has 
been categorized (Van der Flier et al., 2007). Among them ASCL2, CD44 and 
Myc (marked in orange), main Wnt target gene, are also shown in our ACK 
mouse model (Table 8 and Table9) implying activation of Wnt signaling by 
inactive Apc. It also implying that colonocyte in ACK mice are globally affected 
by inactive Apc because ASCL2, Myc and CD44 are is expressed highly 
restricted fashion in intestinal stem cells (Barker et al., 2007; Fevr et al., 2007; 
ten Kate et al., 1989).  
Other notable Myc target genes include Solute carrier family 2 member 1 
(SLC2A1, GLUT1, marked in violet) (Tables 8 & 9). SLC2A1 is a glucose 
transporter expressed in colorectal carcinoma from patients (Haber et al., 1998).  
This finding is consistent with  the link between Myc and metabolic 
reprogramming, a hallmark of cancer (Hanahan and Weinberg, 2011).  
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Table 8. IPA upstream regulator analysis. Direct target genes of Myc that are differentially 
expressed in ACK mice as compared to control mice. CDX2P-CreERT2 (Control) and CDX2P-
CreERT2-Apc580S/+; KrasLSL-G12D/+ (ACK) mice were terminated at 4, 8 and 24 wks after 3 daily 
Tamoxifen (TAM, 100 mg/kg body weight) injections. n=3 mice per group.  
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Table 9. Myc target genes transcriptionally modulated in ACK mice as compared to 
control.  Fold change of gene expression in ACK mice as compared to control mice. CDX2P-
CreERT2 (Control) and CDX2P-CreERT2-Apc580S/+; KrasLSL-G12D/+ (ACK) mice were terminated 
at 4, 8 and 24 wks after 3 daily Tamoxifen (TAM, 100 mg/kg body weight) injections, n=3 mice 
per group.  FDR values less than 0.05 are noted by two asterisks (**), FDR values less than 
0.01 are noted by a single asterisk (*), and FDR values greater than 0.1 are marked with a 
dash (-). 
 
 
Since membrane free cholesterol levels and plasma membrane order 
are elevated in ACK mice, we looked at genes known to modulate cholesterol 
metabolism. Cells can increase their cholesterol content either via de novo 
synthesis (i.e., mevalonate pathway), by increasing uptake of extracellular 
cholesterol via the low-density lipoprotein receptor, or by decreasing 
expression of a rate-limiting cholesterol exporter, e.g., ATP binding cassette 
transporter A1 (ABCA1) (Ikonen, 2008).  As shown in Table 10, Low-density 
lipoprotein (LDL) receptor (Ldlr) was increased by 1.4-fold in ACK mice as 
compared to control mice at 4 wks. Also, Very Low Density Lipoprotein 
Receptor (Vldlr) and Proprotein convertase subtilisin/kexin type 9 (Pcsk9) were 
increased in ACK mice as compared to control mice at 8 and 24 wks. Ldlr, Vldlr 
Comparison
Wks post TAM injection
Target gene Fold change FDR Fold change FDR Fold change FDR
Ccna2 0.8 - 1.6 ** 0.9 -
Ccnb1 0.8 - 1.6 ** 0.9 -
Ccnd2 1.6 ** 1.1 - 1.3 **
Ccne1 1.4 ** 1.3 * 1.6 **
Ccne2 1.1 - 1.6 ** 1.1 -
Cdk1 0.9 - 1.8 ** 1.0 -
Cdk4 1.1 - 1.3 * 1.4 **
Ascl2 1.3 - 1.0 - 1.8 **
Cd44 1.6 ** 1.5 ** 2.4 **
Myc 1.0 - 1.4 ** 2.8 **
Slc2a1 1.9 ** 1.5 ** 1.9 **
ACK/Control
4 8 24
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and Pcsk9 are known to increase cell cholesterol (Go and Mani, 2012; 
Takahashi et al., 1995; Tao et al., 2010).  These data imply that increases in 
cholesterol and plasma membrane order in ACK mice (Figure 30 and 31) were 
in part attributed to elevation in cholesterol uptake.  
 
 
Table 10.  Genes associated with cholesterol uptake that are transcriptionally modulated 
in ACK mice as compared to control.  See Table 9 for details. 
 
 
Examination of genes involved in the efflux of cholesterol were assessed 
in ACK mice. As shown in Table 11, only the ATP binding cassette transporter 
A1 (Abca1) was differentially expressed in ACK mice as compared to control 
mice. Abca1 mediates the transfer of cellular cholesterol across the plasma 
membrane to apolipo-protein A-I (ApoAI), the major apolipoprotein component 
of high-density lipoprotein (HDL) (Attie, 2007). The increased levels of Abca1 
(2.4-fold) in ACK mice at 24 wks suggests that cholesterol efflux does not 
Comparison
Wks post TAM injection
Target gene Fold change FDR Fold change FDR Fold change FDR
Ldlr 1.427 ** 1.014 - 0.959 -
Lrp10 1.140 - 0.797 - 0.884 -
Lrp12 1.121 - 1.172 - 1.086 -
Lrp6 0.874 - 0.675 ** 0.797 -
Olr1 2.867 - 4.733 - 4.382 -
Stab1 1.025 - 1.449 - 1.464 -
Stab2 5.404 - 0.878 - 3.201 -
Vldlr 1.142 - 1.299 * 1.799 **
Lrpap1 0.839 - 0.827 - 0.754 **
Pcsk9 1.239 - 1.940 ** 2.264 **
Snx17 1.039 - 0.893 - 1.044 -
Ankra2 0.731 * 1.292 - 0.938 -
Colec12 0.388 - 2.062 - 0.634 -
Nccrp1 0.313 ** 0.215 ** 0.138 **
Scarf1 0.690 - 0.435 ** 0.333 **
Sorl1 1.119 - 0.752 - 1.152 -
Apoa1 2.767 - 3.532 - 2.535 -
Apod 0.853 - 1.809 - 2.230 -
ACK/Control
4 8 24
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contribute to increased cholesterol and plasma membrane order observed in 
ACK mice (Figure 30 and 31).  
 
 
Table 11.  Abca1 associated with cholesterol export is transcriptionally modulated in 
ACK mice as compared to control.  See Table 9 for details. 
 
 
Lastly, we examined genes involved in cholesterol de novo synthesis. 
Interestingly, hydroxymethylglutaryl coenzyme A reductase (HMGCR) was 
increased by1.4-fold in ACK mice as compared to control at 8 wks (Table 12). 
HMGCR catalyzes the conversion of HMG-CoA to mevalonate, a rate-
determining step in the synthesis of cholesterol (Goldstein and Brown, 1990) 
and is regulated by Myc in esophageal epithelial cells (Zhong et al., 2014).  
CCHC-type zinc finger nucleic acid binding protein (CNBP, also named ZNF9) 
was also increased by 1.7-fold in ACK mice as compared to control at 8 wks 
(Table 12). CNBP was originally identified as a transcription factor bound to the 
sterol regulatory element (SRE) of the hydroxymethylglutaryl coenzyme A 
(HMGCOA) gene (Rajavashisth et al., 1989). Also, peroxisome proliferator-
activated receptor (PPAR), known to lower the synthesis of cholesterol (Konig 
et al., 2007), was reduced by 0.5-fold in ACK mice at 8 wks as compared to 
Comparison
Wks post TAM injection
Target gene Fold change FDR Fold change FDR Fold change FDR
Abca1 0.533 ** 0.604 ** 2.422 **
Abcg1 0.774 - 0.701 - 0.618 *
Apoe 0.806 - 0.720 - 0.794 -
Pltp 0.940 - 0.644 - 1.172 -
Stard3 0.926 - 0.782 ** 0.960 -
Npc1l1 0.634 - 0.840 - 1.545 -
Osbpl5 0.986 - 0.819 - 0.837 -
ACK/Control
4 8 24
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control mice (Table 12). Overall, our RNAseq data provide evidence that the 
elevated colonocyte membrane cholesterol level and plasma membrane order 
in ACK mice is the result a perturbation in cholesterol homeostasis.  
 
 
Table 12. Genes associated with cholesterol synthesis are transcriptionally modulated 
in ACK mice as compared to control.  See Table 9 for details. 
 
Comparison
Wks post TAM injection
Target gene Fold change FDR Fold change FDR Fold change FDR
Cyp39a1 0.811 - 0.958 - 0.624 **
Trerf1 1.345 - 1.550 - 0.799 -
Ldlrap1 1.598 ** 1.551 ** 2.547 **
Acaa2 0.838 - 0.965 - 0.944 -
Cnbp 0.944 - 1.690 ** 1.250 -
Cyb5r3 1.361 * 0.996 - 1.334 *
Cyp51 0.684 - 1.167 - 1.005 -
Dhcr24 1.223 - 0.958 - 1.991 ***
Dhcr7 1.030 - 0.616 ** 0.928 -
Ebp 1.376 ** 0.996 - 0.863 -
Fdft1 1.540 ** 1.441 ** 1.313 *
Fdps 1.161 - 1.273 * 1.070 -
Ggps1 0.778 - 1.435 - 1.025 -
Hmgcr 1.212 - 1.389 ** 1.244 -
Hmgcs1 1.133 - 1.139 - 0.911 -
Hmgcs2 0.682 ** 0.677 ** 0.804 -
Idi1 0.715 - 1.669 * 1.187 -
Mvd 1.209 - 1.122 - 1.345 **
Mvk 0.995 - 1.170 - 1.265 -
Nsdhl 0.939 - 1.175 - 1.357 **
Pmvk 0.686 ** 0.880 - 0.824 -
Prkaa1 0.995 - 1.008 - 1.131 -
Prkaa2 0.875 - 0.996 - 1.147 -
Prkag2 0.917 - 1.009 - 1.093 -
Sc5d 1.046 - 1.038 - 0.935 -
Scd1 0.673 ** 0.922 - 1.048 -
Tm7sf2 0.984 - 1.041 - 1.158 -
Abca2 1.421 - 1.059 - 1.103 -
Apob 1.393 ** 0.988 - 1.801 **
Cyp11a1 2.579 - 1.017 - 3.467 -
Cyp7b1 0.955 - 1.596 - 1.186 -
Hdlbp 1.331 - 0.971 - 1.014 -
Il4 0.593 - 1.336 - 1.487 -
Insig1 0.942 - 1.491 - 1.053 -
Insig2 0.812 - 1.237 - 0.951 -
Lipe 1.061 - 0.633 ** 0.841 -
Mbtps1 1.231 - 0.913 - 1.127 -
Nr1h4 0.613 ** 1.117 - 0.567 **
Osbpl1a 0.729 - 1.194 - 1.179 -
Ppara 0.845 - 0.500 ** 0.779 -
Ppard 0.931 - 0.628 * 0.612 **
Pparg 0.881 - 1.329 - 1.453 **
Scap 1.309 - 0.973 - 1.437 *
Soat2 0.439 ** 1.265 - 1.330 -
Srebf1 1.113 - 0.801 - 1.259 -
Srebf2 1.200 - 0.939 - 1.291 -
4 8 24
ACK/Control
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Sphingolipid enriched plasma membrane domains (Pike, 2005) are also 
known to increase plasma membrane order (Brown and London, 2000; 
Simons and Sampaio, 2011). Therefore, we also examined genes involved in 
sphingolipid metabolism. As shown Table 13, no sphinogolipid metabolism 
related genes were modulated in ACK mice as compared to control mice across 
all time points. This finding suggest that increases in plasma membrane order 
are associated with perturbations in cholesterol homeostasis.  
 
 
 
Table 13. Genes associated with sphingolipid synthesis are transcriptionally modulated 
in ACK mice as compared to control.  See Table 9 for details. 
 
 
5.3.7 Proliferation induced by compound Apc580D and KrasG12D mutations is 
ameliorated by n-3 PUFA + curcumin feeding. 
Highly ordered lipid rafts are increased in many types of cancer (Li et al., 
2006b; Patra, 2008) and some drug resistant cancers (Yi et al., 2013). There is 
also evidence suggesting that disruption of lipid rafts in cancer can lead to 
increased responsiveness to anti-cancer therapies (Irwin et al., 2011). With 
respect to diet and membrane therapy, it has been demonstrated that DHA 
suppresses EGFR-mediated cell proliferation by translocating EGFR from lipid 
Comparison
Wks post TAM injection
Target gene Fold change FDR Fold change FDR Fold change FDR
Cerk 1.001 - 0.802 - 0.768 -
Sgpp1 0.653 ** 1.029 - 0.770 **
Sgpp2 0.972 - 0.797 - 0.706 -
Sphk2 0.886 - 0.697 ** 1.023 -
Xbp1 0.713 ** 1.041 - 0.714 **
ACK/Control
4 8 24
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raft to non-lipid raft domains in the plasma membrane (Turk et al., 2012). 
Curcumin and n-3 PUFA are also known to modulate plasma membrane order: 
the ordering effect of curcumin is strongest in the head group region of the 
phospholipid bilayer (Barry et al., 2009; Hung et al., 2008), whereas n-3 PUFA 
acyl chains impact the organization of the tail group region within rafts (Shaikh 
et al., 2004; Shaikh et al., 2015; Shaikh et al., 2009a) implying a synergistic 
effect. For this reason, we evaluated the effects of n-3 PUFA combined with 
curcumin on plasma membrane order in colonocyte harvested from ACK mice.  
For this purpose, we examined whether increased plasma membrane order 
due to Apc580D and KrasG12D is reduced by dietary n-3 PUFA + curcumin 
enriched diet (4% fish oil + 1% corn oil + 1% curcumin). An n-6 PUFA enriched 
diet (5% corn oil diet) was used as a control (Figure 36B).  
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Figure 36.  Experimental design and sample preparation.  (A) Timeline of the treatments 
and experimental design.  (B) Experimental diets. 
 
 
ACK and control mice were fed either a n-3 PUFA + curcumin containing 
diet (referred to as n-3 PUFA + Cur) or a n-6 PUFA containing diet (referred to 
as the n-6 PUFA control diet), and terminated at 8 wks after 3 daily TAM 
injections (Figure 36A).  Samples were collected as described in Figure 25B. 
Initially, for validation purposes, the effect of n-3 PUFA + Cur on dysplastic foci 
in ACK mice was assessed. As shown in Figure 37, ACK mice fed n-3 PUFA + 
Cur diet exhibited a 50% reduction in the number of dysplastic foci as compared 
to ACK mice fed the control diet.  
 
A 
B 
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Figure 37.  ACK mice fed n-3 PUFA + Curcumin exhibit a reduced number of dysplastic 
foci. CDX2P-CreERT2 (WT or control, n=3 per group) and CDX2P-CreERT2-Apc580S/+; KrasLSL-
G12D/+ (ACK, n=4 per group) mice were fed n-3 PUFA + Curcumin (4% fish oil + 1% corn oil + 
1% curcumin diet) or n-6 PUFA (5% corn oil diet) for 3 wks prior to TAM injection.  Mice were 
terminated 8 wks following Cre induction.  Data from ACK mice fed n-6 PUFA and n-3 PUFA + 
Cur were normalized to control mice (WT) fed n-6 PUFA and n-3 PUFA + Cur, respectively.  
 
 
 
To determine the chemo-protective effect of n-3 PUFA + Cur in ACK 
mice, the number of EdU+ cells per crypt, proliferative zone and length of crypt 
were quantified.  As expected, n-3 PUFA + Cur feeding reduced the number of 
EdU+ cells per crypt (Figure 38A), proliferative zone (Figure 38B) and crypt 
length (Figure 38C) by 30%, 20% and 5 %, respectively, as compared to ACK 
mice fed the control diet.  For control mice (WT), no significant diet effect was 
detected.  
The location of colonic Lgr5 stem cells at the bottom of the crypt is well 
defined.  Sasaki et al. measured LGR5-GFP signal in Lgr5-EGFP-IRES-
CreERT2 derived live cells and demonstrated that the stem cell zone lies within 
35 µm of the bottom of the crypt (Sasaki et al., 2016). In a complementary 
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study, the Lgr5 stem cells zone in fixed tissue was found within 20 µm of the 
bottom of the crypt (Kim et al., 2016b).  Thus, we defined the stem cell zone as 
the cells located within 20 µm of the bottom of the crypt. To determine location-
specific diet effects, we measured the number of EdU+ cells in 20 m segments 
from the base to the top of crypts in the distal colon. As shown in Figure 38D, 
no location-specific diet effect in the stem cell zone was detected.  
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Figure 38.  Reduced cell proliferation in ACK mice fed n-3 PUFA + Curcumin.  (A) Number 
of proliferating cells (EdU+) per crypt in the distal colon.  (B) Length of proliferative zone per crypt 
in the distal colon.  (C) Length of crypts in the distal colon.  (D) Number of EdU+ cells in 20 µm 
intervals along the vertical crypt axis. Refer to Figures 30 and 31 for analytical details. 
 
 
 
5.3.8 Increased plasma membrane order associated with compound Apc580D 
and KrasG12D mice is ameliorated by n-3 PUFA + curcumin feeding. 
Next, we determined the effect of n-3 PUFA + Cur on plasma membrane 
properties in colonocytes isolated from ACK mice. As shown in Figure 39A, the 
increased free cholesterol associated with ACK mice compared to control mice 
C D 
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was reduced (by 50%) following n-3 PUFA + Cur feeding.  Figure 39B shows 
that ACK mice fed n-3 PUFA + Cur as are resistant to change in plasma 
membrane due to Apc580D and KrasG12D as compared to ACK mice fed a control 
diet. Changes in plasma membrane order in mice fed n-3 PUFA + Cur were 
significantly less than n-6 PUFA fed mice (Figure 39B).  
 
 
 
 
 
Figure 39. Chemo-protective diet effects on membrane parameters in ACK mice 
compared to control mice. (A) Cholesterol and (B) plasma membrane order of colonocyte 
from ACK and control mice fed with experiment diet. Mice were terminated at 8 wks after 3 
Tamoxifen (TAM, 100 mg/kg body weight) injections. Refer to Figures 30 and 31 for analytical 
details. 
 
 
 To determine whether n-3 PUFA + Cur diet reduces the positive 
association between EdU+ cell number per crypt and cholesterol level (Figure 
40A) and plasma membrane order (Figure 40B), we performed a simple linear 
regression analysis. As shown in Figure 40B, a positive association of plasma 
A B 
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membrane order and the number of EdU+ cells per crypt was found in n-6 PUFA 
fed mice with a p-value of 0.07.  In contrast, the n-3 PUFA + Cur group had a 
p-value of 0.41.   
 
 
 
 
Figure 40. Linear regression analysis.  Association between the number of EdU positive 
cells and cholesterol level (A) and association between EdU positive cells and membrane order 
(B).  Mice were terminated at 8 wks after 3 daily Tamoxifen (TAM, 100 mg/kg body weight) 
injections.  Each point represents an individual animal. n-3 PUFA + Cur containing diet is 
highlighted in green and n-6 PUFA containing diet is labeled with red.  ACK and control mice 
fed same diet were combined for this analysis. 
 
 
5.3.9 Increased cholesterol and plasma membrane order is not cell type 
specific effect. 
Lgr5-EGFP-IRES-CreERT2-CDX2P-CreERT2-Apc580S/+; KrasLSL-G12D/+ 
mice (ACKG, n=3) mice were used to measure the effect of Apc580S/+; KrasLSL-
G12D/+ on cholesterol and plasma membrane order homeostasis. Lgr5-EGFP- 
IRES-CreERT2 (CG, n=3) mice were used as a control (Figure 41A).  Mice were 
provided a Teklad 4% fat rodent diet (Envigo, 7001). ACKG and CG mice were 
A B 
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terminated at 8 wks following 3 daily Tamoxifen (TAM, 100 mg/kg body weight) 
injections. Live GFPhigh cells (stem cells) and GFPneg cells (all cells combined) 
from each mouse were sorted using a MoFlow fluorescent cell sorter. Half of 
sorted cells were used to measure plasma membrane order and the other half 
of cells were fixed cells with 4% PFA to measure cholesterol level. 
Di-4-ANEPPDHQ dye used for measuring plasma membrane order was 
excited at 488 nm. Since the EGFP signal from GFPhigh cells and it emission 
wave length overlap, 5% laser power was utilized for di-4-ANEPPDHQ dye 
excitation.  As shown in Figure 41B, only di-4-ANEPPDHQ signal is detected 
at this level.  EGFP signal was detectable only when laser power was increased 
to 50% (GFP-50%).  
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Figure 41. Experimental design and validation. (A) Timeline of the treatments and 
experimental design. (B) Representative confocal images of Lgr5+ cell (GFPhigh) in liquid 
ordered phase (green line) and liquid disordered phase (red line) using 5% or 50% laser power. 
 
 
Next, we determined plasma membrane properties of colonic stem cells, 
i.e., GFPhigh (Lgr5+), from ACK mice as compared to GFPhigh cells from control 
mice. GFPneg cell (all cells combined) from ACK mice were also compared to 
GFPneg cells from control mice. As shown in Figure 42, altered free cholesterol 
and plasma membrane order due to inactive Apc and active Kras do not appear 
to be stem cell (GFPhigh cell) specific.  
 
 
 
 
B 
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Figure 42. Cholesterol level and plasma membrane order of GFPhigh and GFPneg cells 
from ACK mice compared to control (CG) mice.  Lgr5-EGFP-CDX2P-CreERT2 (CG) and 
Lgr5-EGFP-CDX2P-CreERT2-Apc580S/+; KrasLSL-G12D/+ (ACKG) mice were terminated at 8 wks 
after 3 daily Tamoxifen (TAM, 100 mg/kg body weight) injections. Refer to Figures 31 and 32 
for analytical details. 
 
 
 
5.2 Discussion 
To our knowledge, this is the first time that the effect of Apc and Kras 
mutations on plasma membrane order in the context of colon tumorigenesis 
has been assessed. We utilized a novel mouse model, CDX2P-CreERT2-
Apc580S/+; KasLSL-G12D/+ (ACK), in which Cre expression induced by TAM 
injection results in the simultaneous deletion of Apc (Apc580D/+) and activation 
of KrasG12D/+. ACK mice does not develop tumors in 6 month window post TAM 
injection but develop dysplastic foci, polyps and some adenomas, indicating 
that it can be used to study chemo-prevention at the pre-tumor stage.  
The role of Apc and Kras mutation in promoting proliferation in colon 
cancer is well defined. In this study, that the Apc and oncogenic Kras mutations 
linked to increased cholesterol and plasma membrane order (Figure 30 and 
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31) are positively associated with cell proliferation (Figure 32). Global 
transcriptome data provide evidence that that genes involved in cholesterol 
synthesis (Table 12) and cholesterol uptake (Table 10) are increased in ACK 
mice as compared to control mice. It is noteworthy, that genes involved in 
sphingolipid metabolism are not modulated at the mRNA level, suggesting that 
the altered plasma membrane order observed in this study is in part mediated 
by effects on cholesterol homeostasis (Table 13). 
We next demonstrated that YAMC and IMCE cells respond to 
exogenous cholesterol by enhancing proliferation in a dose-dependent 
manner (Figure 33 and 34). Similar results were observed using mouse colonic 
organoids (Figure 35). These findings suggest that the elevated cell 
proliferation phenotype observed in ACK mice are in part mediated by 
increased membrane cholesterol levels. Clearly, further work is required to 
elucidate the mechanism(s) by which cholesterol modulates plasma 
membrane-mediated signaling in the presence of oncogenic Apc and Kras. 
Cell growth and division rely on new membrane synthesis, which 
requires energy. Fatty acids (FA) are the main components of phospholipids, 
which make up cell membranes and triglycerides, the major form of energy 
storage in the cell. Cholesterol, a lipid sterol derivative, maintains membrane 
integrity and regulates its fluidity. Given the importance of lipid in cell growth, 
fatty acid and cholesterol metabolism is strictly regulated in normal cells and 
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often upregulated in rapidly growing cancer cells (Clendening et al., 2010; 
Kuhajda et al., 1994; Santos and Schulze, 2012; Yoon et al., 2007).  
Early global mapping of Myc target genes has revealed that genes 
involved in fatty acid metabolism are regulated by Myc (Lin et al., 2012; Priolo 
et al., 2014; Zeller et al., 2006). Metabolomic analysis also suggests high levels 
of Myc are linked to elevated fatty acid synthesis (Priolo et al., 2014). In this 
study, we demonstrate that Myc is increasing cholesterol in part by induce 
mRNA levels of HMGCR. It is noteworthy because HMGCR is rate-limiting in 
the cholesterol synthesis pathway; hence, HMGCR has been documented to 
be essential for Myc-driven liver cancer as it mediates the phosphorylation and 
transactivation of Myc (Cao et al., 2011). Our data suggest that Myc is a major 
upstream transcription factor modulating cholesterol homeostasis thereby 
alters plasma membrane properties. 
We have demonstrated that a diet containing 4% fish oil (enriched in n-
3 PUFA) combined with 1% curcumin synergistically reduces nuclear/cytosolic 
-catenin in aberrant crypt foci (ACF) in the mouse colon (Kim et al., 2016b).  
Since n-3 PUFA acyl chains impact the organization of the tail group region 
within plasma membrane (Shaikh et al., 2004; Shaikh et al., 2015; Shaikh et 
al., 2009a) and curcumin can modify plasma membrane structure by targeting 
head group region of the phospholipid bilayer (Barry et al., 2009; Hung et al., 
2008), we determined whether these bioactives can modulate plasma 
membrane order. In our study, we found that plasma membrane order induced 
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by compound Apc580D and KrasG12D mutations is ameliorated by n-3 PUFA + 
curcumin feeding. Recent evidence further suggests that DHA can perturb lipid 
rafts (Chapkin et al., 2008; Kim et al., 2008; Shaikh et al., 2009b). DHA, due 
to its high degree of unsaturation, is sterically incompatible with cholesterol 
(Wassall et al., 2004), a major constituent of rafts. However, further work is 
required to pinpoint the mechanism by which n-3 PUFA and curcumin modulate 
cholesterol, plasma membrane order and plasma membrane-mediated 
signaling pathways. 
In conclusion, our novel data provide evidence that compound Apc580D 
and KrasG12D mutations mediate perturbations in cholesterol homeostasis, 
contributing to an increase in plasma membrane order and the promotion of 
cell proliferation (a colon cancer risk factor). The direct dose-dependent effect 
of exogenous cholesterol on membrane cholesterol, lipid order and cell 
proliferation was documented in multiple in vitro models (YAMC, IMCE and 
organoids).  In addition, we provide cogent evidence that dietary bioactive 
compounds (n-3 PUFA and curcumin) can modulate plasma membrane order.  
These findings imply that n-3 PUFA and curcumin may suppress tumorigenesis 
in part by targeting the plasma membrane.  
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6. SUMMARY AND CONCLUSIONS 
6.1     Summary 
We have demonstrated that Lgr5+ stem cells, the cells of origin of colon 
cancer, preferentially promote damage-induced apoptosis in response to 
carcinogen. n-3 PUFA and curcumin synergize to promote targeted apoptosis 
of damaged Lgr5+ stem cells in part by enhancing p53 signaling in Lgr5+ stem 
cells at the tumor initiation stage and reduce nuclear/cytoplasmic -catenin in 
ACF, surrogate marker of colon cancer at the pre-tumor stage. Lgr5+ stem cells 
also respond to low dose combination diet reducing carcinogen-induced DNA 
damage by enhancing apoptosis, which may lower HED ultimately. 
Additionally, we found that oncogenic Apc and Kras increase plasma 
membrane order (fluidity) by perturbing cholesterol homeostasis at pre-tumor 
stage. Myc was identified as an upstream regulator modulating genes 
associated with cholesterol homeostasis and cholesterol promotes cell 
proliferation in dose-dependent manner. We also demonstrated that the altered 
plasma membrane order and cholesterol homeostasis associated with 
oncogenic Apc and Kras is ameliorated by n-3 PUFA + curcumin feeding. 
 
6.2     Conclusions 
 
Historically, alkylating agents are known to produce gastrointestinal 
tumors in rodents (Hawks and Magee, 1974; James and Autrup, 1983) and to 
cause cancer in humans as a result of lifetime environmental exposures (Hall 
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et al., 1991). Notably, azoxymethane (AOM) - induced DNA damage is clinically 
relevant because AOM hyper-activates -catenin and Kras signaling, which are 
dysregulated in sporadic colorectal cancer in humans (Hata et al., 2004; 
Takahashi and Wakabayashi, 2004). Thus, the deletion of damaged cells at the 
tumor initiation stage is a critical mechanism to prevent tumorigenesis in the 
intestine (Leibowitz et al., 2014).  
Highly ordered lipid rafts (Li et al., 2006b; Patra, 2008) and cholesterol 
levels (Dessi et al., 1994) are increased in many types of cancer and some 
drug resistant cancers (Yi et al., 2013). Increased plasma membrane order 
(decreased membrane fluidity) is positively correlated with cholesterol levels 
(Montero et al., 2008) and altered membrane fluidity is associated with 
modulation of plasma membrane-mediated signaling pathways (Cherezov et 
al., 2007; Simons and Vaz, 2004). However, the link between plasma 
membrane order and cancer biology is poorly understood. 
The transformation of Lgr5+ stem cells drives intestinal neoplasia, 
indicating that Lgr5+ crypt stem cells are the cell-of-origin of cancer (Barker et 
al., 2009).  Thus, it is important to understand how Lgr5+ stem cells 
phenotypically respond to AOM (associated with DNA damage response). 
Because of the broad-acting effects of n-3 PUFA and curcumin on 
mammalian physiology, it has been postulated that these dietary fatty acids act 
at a fundamental level common to all cells from initiation to the pre-tumor stage 
of colon tumorigenesis, i.e., by promoting cell apoptosis and suppressing 
 178 
 
proliferation (Altenburg et al., 2011; Carroll et al., 2011; Jia et al., 2011; Saw et 
al., 2010; Siddiqui et al., 2013; Swamy et al., 2008; West et al., 2010) and by 
altering the physical properties of biological membranes (Barry et al., 2009; 
Chapkin et al., 2008; Hung et al., 2008; Shaikh et al., 2009b; Wassall et al., 
2004; Wassall and Stillwell, 2008). A wealth of published literature supports 
the hypothesis that n-3 PUFA and curcumin play an important role in 
modulating apoptotic genes as well as plasma membrane fluidity. Despite 
cogent scientific evidence indicating the protective effect of n-3 PUFA and 
curcumin, there is a lack of data regarding the additive/synergistic effects of 
these two dietary components in terms of colon tumorigenesis, especially with 
respect to Lgr5+ stem cell biology.  
In the absence of comprehensive human data, the AOM chemical 
carcinogenesis model serves as one of the most definitive means of assessing 
human colon cancer risk (Ahnen, 1985; Reddy, 1994). Therefore, the first 
portion of the study was designed to determine the response of Lgr5+ stem cells 
in mice exposed to AOM. We demonstrate that DNA damage occurs to a 
greater degree in Lgr5+ stem cells (located at the base of the crypt) as 
compared to differentiated cells. We also demonstrate that colonic Lgr5+ stem 
cells uniquely respond to AOM by inducing targeted apoptosis, which is 
positively associated with induced H2AX, whereas differentiated cells do not 
exhibit this response. Specifically, “untargeted” apoptosis (TUNEL+, H2AX-) in 
Lgr5+ stem cells was 2.2-fold higher than “targeted” apoptosis (TUNEL+, 
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H2AX+), implying an inefficient removal of damaged Lgr5+ stem cells via 
programmed cell death. These observations are important because the 
deletion of damaged cells is a critical mechanism to prevent tumorigenesis in 
the intestine (Leibowitz et al., 2014). 
To further elucidate the unique properties of colonic Lgr5+ stem cells in 
terms of their response to bioactive compounds in the presence of carcinogen, 
the second portion of the study was designed to determine the chemo-
protective effects of combinatorial bioactives in AOM-induced DNA damaged 
Lgr5+ stem cells as compared to differentiated cells. We demonstrate that DNA 
damaged Lgr5+ stem cells uniquely respond to n-3 PUFA and curcumin, and n-
3 PUFA and curcumin synergize to promote the deletion of DNA damaged 
Lgr5+ stem cell in part by enhancing p53 signaling pathway. This was 
exemplified, in part, by the induction of Bax at the mRNA and protein levels, a 
major mediator of p53-mediated apoptosis. These findings are relevant in view 
of the fact that the absence of an acute apoptotic response to AOM in p53-
deficient mice is associated with an increased tumor incidence (Davidson et 
al., 2015; Hu et al., 2005).  
Consistent with these observations, curcumin combined with n-3 PUFA 
synergistically reduces AOM-induced nuclear -catenin levels in ACF at the 
pre-tumor stage. This is noteworthy because elevated nuclear -catenin levels 
are associated with higher mortality in selected groups of colorectal cancer 
patients (Hao et al., 2001; Takayama et al., 2001; Wanitsuwan et al., 2008), 
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and various attempts have been made to identify and characterize 
pharmacological inhibitors of β-catenin (Thakur and Mishra, 2013). Consistent 
with this notion, it has been shown that n-3 PUFA or curcumin reduce polyps 
or adenoma in Apc mutated mice (Collett et al., 2001; Fini et al., 2010) and 
inhibit nuclear location of -catenin in colon cancer cells and breast cancer 
stem cells (Calviello et al., 2007; Mukherjee et al., 2014).  
The daily dose of the experimental chemo-protective diet (4% fish oil + 
1% curcumin) was 46 mg of n-3 PUFA and 45 mg of curcumin, which 
corresponds to an HED of 8.6 g n-3 PUFA + 8.5 g Curcumin.  In contrast, corn 
oil control diets contain only trace amounts of n-3 PUFA and no curcumin. In 
terms of human consumption, curcumin and n-3 PUFA intake vary greatly. 
Curcumin C3 Complex (Sabinsa Corporation, NJ, USA) is known to be well 
tolerated when taken at high doses (12 g/day) (Cheng et al., 2001; Ireson et al., 
2002) and the maximal tolerable dose for EPA and DHA is 17.6 g n-3 PUFA/day 
in humans (Skarke et al., 2015). Therefore, our experimental diets contain 
quantities of n-3 PUFA and curcumin well within the range that can be 
consumed in the human diet.  However, the HED of n-3 PUFA is higher than 
the FDA recommended (3g/day) level and curcumin has not yet been approved 
as a therapeutic agent because of relatively low bioavailability and intense 
staining color of curcumin (Anand et al., 2007).  
To address bioactive dose dependency, we assessed the dietary 
threshold for phenotypically significant responses by administering lower levels 
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of n-3 PUFA and curcumin. We demonstrate that the median effective dose 
(ED50), i.e., the dose that produces a chemo-protective effect in 50% of the 
subjects (Singh et al., 1999), is 16 mg of n-3 PUFA and 15.9 mg of curcumin.  
This corresponds to a daily HED of 3.0 g of n-3 PUFA and 3.0 g of curcumin. 
These finding provides a therapeutic strategy for eliminating damaged stem 
cells and reducing colon cancer risk in humans by using lower doses of n-3 
PUFA and curcumin. 
To further elucidate the biophysical properties of plasma membrane in 
pre tumor stage of colon tumorigenesis, we generated conditional CDX2P-
CreERT2-Apc580S/+; KrasLSL-G12D/+ transgenic mice to delineate the mechanism 
by which oncogenic Apc and Kras modulate colonocyte plasma membrane 
order. We demonstrate that oncogenic Apc and Kras perturb plasma 
membrane order (fluidity) by perturbing cholesterol homeostasis, which is 
associated with elevated levels of cell proliferation. We also analyzed gene 
expression datasets obtained from the RNAseq. The upstream regulator 
analysis function of IPA was used to identify potential transcriptional regulators 
which explain the observed changes in gene expression. Interestingly, Myc was 
the major upstream regulator modulating cholesterol homeostasis associated 
genes such as HMGCR and LDLR.  This is noteworthy because HMGCR is a 
rate-limiting step in the cholesterol synthesis pathway.  Overall, the knowledge 
obtained from our studies provides a solid mechanistic underpinning for the role 
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of Myc in increasing plasma membrane order by modulating cholesterol 
associated genes.  
Our findings raise the possibility that changes in membrane 
cholesterol status and plasma membrane order may directly regulate cell 
proliferation in the colon. This is supported by our data demonstrating that 
cholesterol dose-dependently promotes cell proliferation in YAMC, IMCE and 
mouse colonic organoid cultures.  
We also investigated the effects of chemo-protective dietary agents on 
cholesterol homeostasis, plasma membrane order and dysplastic foci in 
CDX2P-CreERT2-Apc580S/+; KrasLSL-G12D/+ transgenic mice. Our data 
demonstrate that perturbed plasma membrane order and cholesterol 
homeostasis as well as dysplastic formation due to compound Apc580D and 
KrasG12D mutations are ameliorated by n-3 PUFA + curcumin feeding. These 
findings indicate that n-3 PUFA combined with curcumin modulate plasma 
membrane order, thereby affecting plasma membrane-mediated signaling 
resulting in the suppression of dysplastic foci formation. These findings are 
consistent with the fact that DHA and curcumin are capable of modulating 
plasma membrane structure and EGFR function (Soung and Chung, 2011; 
Turk et al., 2012), which regulates colon cancer stem cell proliferation (Feng et 
al., 2012). 
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To further elucidate the unique properties of colonic Lgr5+ stem cells in 
response to oncogenic Apc and Kras in terms of cholesterol levels and plasma 
membrane order, Lgr5-EGFP-IRES-CreERT2-CDX2P-CreERT2-Apc580S/+; 
KrasLSL-G12D/+ mice were used. We demonstrate that altered cholesterol and 
plasma membrane order due to compound Apc580D and KrasG12D mutations do 
not appear to be Lgr5+ stem cell specific. 
In summary, our results indicate for the first time that fish oil plus 
curcumin synergistically protect Lgr5+ stem cells in part by modulating 
apoptosis during the initiation of tumorigenesis following carcinogen exposure. 
We have established an HED for curcumin and n-3 PUFA, and propose a novel 
membrane order related mechanism of action.  This body of work is important 
for overall human health, and will likely assist future researchers in 
understanding the role that dietary n-3 PUFA and curcumin play in chronic 
disease prevention. 
 
6.3      Future directions 
The research presented herein set the groundwork for a number of 
future studies that could further delve into the effects of DHA and curcumin on 
receptor signaling and function. 
 
6.3.1 DNA damage response of Lgr5+ stem cells 
We demonstrated that Lgr5+ stem cells preferentially promote damage-
 184 
 
induced apoptosis in response to carcinogen.  Human embryonic stem cells 
have constitutively active Bax at the Golgi, and active Bax translocates from 
Golgi to mitochondria after DNA damage in a p53-dependent manner, 
triggering a rapid apoptotic response (Dumitru et al., 2012). Additionally, AOM-
induced apoptosis is p53-dependent whereas spontaneous apoptosis is p53-
independent (Hu et al., 2005). Therefore, future studies should focus on 
whether the induced apoptosis in Lgr5+ stem cells is promoted due to p53-
dependent mitochondrial priming.  This type of study would help delineate how 
Lgr5+ stem cells uniquely respond to external cues. 
 
6.3.2 Mechanism of bystander effect in Lgr5+ stem cells 
We demonstrated that the majority of apoptosis occurs in undamaged 
GFPhigh Lgr5+ stem cells following AOM exposure.  Based on the proximity of 
H2AX+ cells to TUNEL+, H2AX- Lgr5+ stem cells, we have proposed the 
involvement of an AOM-induced bystander effect (BE). This unexpected 
outcome suggests that undamaged ‘bystander’ Lgr5+ stem cells are being 
indirectly influenced by the intestinal niche.  For example, numerous studies 
have shown that irradiated/damaged colonic cells can induce secondary 
apoptosis (Furlong et al., 2013) and H2AX foci in non-irradiated cells via 
bystander effects (Dickey et al., 2011).  This process, in part, may be mediated 
by lipid rafts (Burdak-Rothkamm et al., 2007) via the absorption of exosomes 
by naïve bystander cells (Al-Mayah et al., 2012) or intestinal commensal 
 185 
 
bacteria by triggering macrophages (Yang et al., 2013).  It is noteworthy that 
bystander cells exhibit a significant pro-apoptotic gene expression profile 
compared to cells directly impacted by radiation (Furlong et al., 2013).  From a 
mechanistic perspective, soluble mediators induced by AOM such as PGE2 
may partly mediate this process (Riehl et al., 2006; Zhou et al., 2005).  
Therefore, future studies should focus on molecules mediating BE to reduce 
propagation of DNA damage and undesired apoptosis in Lgr5+ stem cells. 
These proposed experiments would further elucidate the mechanism of the 
alkylation-induced bystander effects.  
 
6.3.3 Human study 
We demonstrated that 1.9% FO + 0.5% CO + 0.46% Cur diet is the 
lowest dose that exhibits chemo-protective effects in terms of promoting 
targeted apoptosis in Lgr5+ stem cells. This corresponds to a dose of 21.3 mg 
n-3 PUFA in combination with 21.1 mg Cur /day or an HED equal to 4.0 g of n-
3 PUFA and 4.0 g of curcumin.  However, the efficacy of n-3 PUFA and 
curcumin in preventing colon cancer must still be evaluated in prospective 
controlled human trials using ACF or adenoma recurrence as the intermediate 
end point.   
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6.3.4 Mechanism(s) by which cholesterol modulates plasma membrane-
mediated signaling 
We demonstrated that YAMC and IMCE cells respond to exogenous 
cholesterol by enhancing proliferation in a dose-dependent manner.  Similar 
results were observed using mouse colonic organoids. These findings suggest 
that the elevated cell proliferation phenotype observed in ACK mice is in part 
mediated by increased membrane cholesterol levels. Clearly, further work is 
required to elucidate the mechanism(s) by which cholesterol modulates 
plasma membrane-mediated signaling in the presence of oncogenic Apc 
and Kras.  
 
6.3.5 Mechanism by which n-3 PUFA and curcumin modulate plasma 
membrane order 
In our study, we found that plasma membrane order induced by 
compound Apc580D and KrasG12D mutations is ameliorated by n-3 PUFA + 
curcumin feeding.  Recent evidence suggests that both DHA and curcumin are 
capable of modulating plasma membrane structure and EGFR function (Soung 
and Chung, 2011; Turk et al., 2012), which regulate colon cancer stem cell 
proliferation (Feng et al., 2012). Therefore, future studies should focus on the 
mechanism by which n-3 PUFA and curcumin modulate cholesterol, plasma 
membrane order and plasma membrane-mediated signaling pathways. It 
also important to determine whether low doses of n-PUFA and curcumin 
 187 
 
exhibit similar effects in terms of modulating plasma membrane order and 
plasma membrane-mediated signaling pathways. 
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APPENDIX A 
MAKING “SWISS ROLLS” FROM INTESTINAL SECTIONS 
 
Purpose: To make Swiss rolls using 1/2 ~ 1/3 of isolated colon. 
 
Materials: PBS (Gibco, 21600-069), dissection kit (scissor, forceps, blade), 10 mL 
syringes, biomedical needle, histology paper (OBEX Industries, 245, cassette 
(Simport, M498-6), straw (4 mm diameters, 3 cm long), 20% PFA (Electron 
Microscopy Science, 15713), Swiss roll tube, 100% Ethanol (KOPEC, V1001). 
 
Procedure: 
(1) Chill 70% and 50% ethanol at 4° C. 
(2) Cut histology paper in half. 
(3) Isolate colon and flush with PBS. 
(4) Open colon along with Taeniae coli. Epiploic appendix (fat filled pouches) is 
lining close to Taeniae coli. 
 
 
External appearance of colon 
 
(5) Put colon on the PBS-wetted histology paper and cut the 1/2 ~ 1/3 of colon 
longitudinally. 
Note: Keep luminal side facing up. 
(6) Wrap the edge of the histology paper close to proximal colon end around the 
straw and slowly rolling the straw with fingers to roll the colon around the 
straw to form a Swiss roll.  
(7) Drop the Swiss roll only (without the straw) into Swiss roll tube prefilled with 
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6 mL 4% PFA and incubate for 4 hr at 4° C. 
(8) Dump PFA and wash with 50% and 70% ethanol every 20 min on ice.  
Note: keep tissue and ethanol at 4° C. 
(9) Store in 70% ethanol overnight at 4° C. 
 
 
(10) Next day, label big cassette using HB1 pencil: solution to fix tissue, Animal 
ID and date.  
Note: Be careful, only #1 pencil works 
 
 
 
(11) Cut out square in the middle of sponge and locate it in the cassette. The hole 
is preventing Swissroll from unrolling. 
 
 
 
(12) Remove straw from the Swissroll and transfer it to the middle of sponge.  
(13) Place it in a container with pre-chilled 70% ethanol.  
(14) Take it to histology lab.  
 
References:  
Bialkowska AB, Ghaleb AM, Nandan MO, Yang VW. (2016) Improved Swiss-
rolling Technique for Intestinal Tissue Preparation for Immunohistochemical and 
Immunofluorescent Analyses.J Vis Exp. (113). 
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APPENDIX B 
QUANTIFICATION OF APOPTOTIC CELLS IN DNA DAMAGED LGR5+ 
STEM CELLS 
  
Purpose: To quantify cells that are double positive to DNA damage and apoptosis. 
 
Materials: Rabbit monoclonal phospho-gamma H2AX (H2AX) Ser139 antibody 
(Cell Signaling 9718), goat polyclonal to GFP (Abcam, ab6673), Jackson donkey 
anti rabbit 649 (711-605-152) for H2AX, Jackson Donkey anti Goat 488 (705-545-
147) for GFP, TUNEL assay kit: TACS 2TdT Replenisher Kit (Trevigen, 4810-30-
R), Strepttavidine-Cy3 (ThermoFisher, 438315), sodium citrate tribasic (Sigma, 
S4641), Xylene (Fisher, X2P-1GAL), 100% Ethanol (KOPEC, V1001), 90% 
Ethanol (KOPEC, V1101), PAP pen (Invitrogen, 008899), TBST buffer (1X TBS 
with 0.1% Tween-20), Tween-20 (Sigma, P9416), IgG-free BSA (Roche, 9048-
46-8, at 4° C), PBS (Gibco, 21600-069), donkey serum (Millipore, S30-100ml), 
Cell Signaling antibody diluent (Cell signaling, 8112), TritonX-100 (Sigma, 9002-
93), ddH2O (Gibco, 15230-170), ProLong AntiFade (LifeTech, P36935), coverslip 
(VWR, 16004-336), metal pot, the immune stain moisture chamber and coplin jars 
(it is in the shelf labeled with Immunohistochemistry supplies). 
 
Solutions:  
10 X Tris Buffered Saline (TBS):  
24.2 g Trizma® base (C4H11NO3) (Fisher, BP154-1) + 80 g sodium chloride (NaCl) 
(Sigma, S3014) / 1 L dH2O. Adjust pH to 7.6. = 0.2 M Tris+1.36 M Nacl 
Note: do not use BSA or milk to block. There is cross reactivity with the goat 
secondary. 
 
Procedure: 
1st day 
(1) Prepare 1.2 L of 10 mM sodium citrate, pH 6.0 (3.52 g sodium citrate 
trisodium (C6H5Na3O7·2H2O) in 850 mL ddH2O, adjust pH to 6.0 and then 
take final volume to 1.2 L). Preheat on hot plate by bringing to a boil at the 
level 10 on Thermolyne heat plate and once boiling, switch to level 5.9.  
Note: Make sure the solution is NOT bubbling at all once the tissues go in 
the metal pot. 
 
Deparaffinization/Rehydration 
(2) Wash slides in Xylene 3 X 5 min. 
(3) Circle with PAP pen if needed. 
Note: Make a thick circle and dry out completely. 
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(4) Wash slides in 100% ethanol 3 X 4 min. 
Note: Do not allow slides to dry at any time from this procedure. 
(5) Wash slides in 95% ethanol 3 X 4 min. 
(6) Wash slides in 70% ethanol 2 x 4 min. 
(7) Wash slides in dH2O 3 X 3 min.  
Note: If paraffin is not completely removed, you will see non-specific signal.  
 
Antigen Unmasking 
(8) 20 min in sub-boiling 10 mM sodium citrate in metal pot on top of heat plate 
setting at 5.9. Cool metal pot (with slide inside) for additional 20 min in tub of 
tap water. 
Note: If these steps are not performed, the antibodies will not have complete 
access to antigens in the tissue and will be unable to bind to the correct 
epitopes. 
 
TUNEL assay to detect apoptotic cells 
Note: Thaw reagents, except TdT enzyme (keep at -20° C) at 4° C.  Warm 
up 10 x Labeling and Stop buffers at 25° C (room temperature, RT). Set oven 
temp to 37° C for the TdT step. 
(9) Wash slides in dH2O 1 X 5 min. 
(10) Wash slides in PBS, 2 X 5 min. 
(11) Blot excess liquid, then cover specimen with 13.3 g/mL Proteinase K, 30 
min, at RT. 
        per 3 sections (1:75 dilution) = 2.0 L 1 mg/mL proteinase K + 150 L good 
bottle dH2O = 152 L 
        Note: Spin proteinase K prior to taking aliquot. 
(12) Wash slides in dd H2O 3 X 2 min each. 
(13) Immerse in 1 X 0.22 µm filtered 1X labeling buffer (diluted in dH2O) for 5 min 
at RT. 
(14) Prepare TdT mixture.  
Note: Spin reagents prior to taking aliquot. 
Note: Remove TdT enzyme from freezer only briefly.  
        per 3 sections = 3.0 L TdT-dNTP + 150 L 1X labeling buffer + 3.0 L Mn2 
+ 3.0 L TdT enzyme = 159 L 
        Negative control = exclude TdT enzyme.  Keep mix on ice.         
(15) Blot (50 L) of TdT mixture carefully around each tissue section. Add TdT 
labeling mixture.  
        Note: make sure mixture covers whole tissue. 
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(16) Place slides in humidified chamber at 37° C, 1 hr. 
(17) Transfer slides to 1 X 0.22 m filtered Stop buffer which is diluted in dH2O, 
RT, 5 min. 
(18) Wash slides in PBS 2 X 2 min. 
Note: Keep samples in the dark for the following steps.  
(19) Prepare Streptavidin-Cy3 (1:60 dilution).     
Note: Spin SA-Cy3 prior to taking aliquot to avoid debris.  
 per 3 sections = 147.5 L PBS/0.05% tween + 2.5 L Strepavidin-Cy3 = 150 
L  
Note: Spin reagents prior to use. 
(20) Blot (50 L of Streptavidine-Cy3 in PBS/0.05% tween) around tissue section 
and apply Strepavidin mix to slide.   
Incubate in a humidified chamber for 30 min at RT in the dark.    
(21)  Wash slides in PBS 3 X 2 min. 
(22)  Wash slides in dH2O 3 X 5 min. 
 
Label with H2AX to detect DNA damaged cells 
(23) Wash slides in TBST 2 X 5 min. 
(24) 5% donkey serum in TBST (blocking solution) 30 min at RT. 
2.25 mL donkey serum + 42.75 mL TBST = 45 mL 
(25) Prepare 1° antibody (phospho-H2AX). 
1:200 in Cell Signaling antibody diluent.  
per 3 sections = 1 L H2AX antibody (Ab) + 199 L diluent = 200 L 
Neg control = use antibody diluent 
(26) Incubate overnight at 4° C in a humidified chamber. 
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2nd day 
(27) Wash slides in TBST 4 X 3 min.  
(28) Prepare 2° Ab (Jackson donkey anti rabbit IgG – 649). 
       1:400 in 1% donkey serum/0.3% Triton in PBS for 1 hr at RT.  
       per 3 sections 0.5 L 2° Ab + 2 L donkey serum + 6 L 10% Triton + 191.5 
L PBS = 200 L 
 
Label with GFP to detect LGR5+ stem cells 
(29) Wash slides in dH2O 2 X 5 min. 
(30) Wash slides in TBST 4 X 5 min. 
(31) Block in 5% donkey serum in TBST for 15 min at room temperature.  
2.25 mL donkey serum + 43.75 mL TBST= 45 mL 
(32) Prepare 1° antibody (GFP) 
1:400 in PBS / 1% donkey serum.  
per 3 sections = 0.5 L GFP Ab + 2 L donkey serum + 197.5 L PBS = 200 
L 
Neg control = use antibody diluent 
(33) Incubate overnight at 4° C in a humidified chamber. 
Note: The solution beads up (on some steps) into a little ball. You have to 
really drag it with a pipet tip to cover the tissue.  And you need to look very 
closely to make sure the outer edge is covered with solution.  This is the 
distal end which we want to score so we don't want it to dry out and give 
artifact.   
 
 
3rd day 
(34) Wash slides in TBST 4 X 3 min.  
(35) Prepare 2° Ab (Jackson donkey anti goat IgG – 488). 
1:400 in 1% donkey serum / 0.3% Triton in PBS for 30 min - 1 hr at RT.  
per 3 sections = 0.5 L GFP Ab + 2 L donkey serum + 6 L 10% Triton + 
191.5 L PBS =200 L 
(36) Wash slides in TBST 4 X 5 min. 
(37) Wash slides in dH2O 3 X 5 min. 
(38) Coverslip with ProLong AntiFade + DAPI. 
 
Capture image of entire Swiss roll 
(1) All immunofluorescent images of colonic crypts were captured using an 
inverted TE 300 Nikon Eclipse fluorescence microscope equipped with 
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40X/1.30 Nikon Plan Fluor oil immersion objective and a Photometrics Cool 
Snap EZ digital CCD camera and a SOLA external light source. 
(2) Images are processed using the NIS Image software, version 3.2 (Nikon). 
(3) Start scanning from the distal colon and find a GFP positive good structured 
crypt in distal colon. Capture image of GFP positive good structured crypt. 
 
 
Analysis 
(1) Using NIS element, open up image you captured. 
(2) Count number of cells positive to TUNEL, H2AX and both positive to TUNEL 
and H2AX and DAPI per crypt. 
(3) Calculate % Apoptotic cells per crypt = # of TUNEL+ stem or differentiated 
cells / total # of stem or differentiated cells per crypt x 100 
(4) Calculate % DNA damaged cells per crypt = # of H2AX+ stem or 
differentiated cells / total # of stem or differentiated cells per crypt x 100 
(5) Calculate % Non-targeted apoptosis = # of TUNEL+ and H2AX- stem or 
differentiated cells / total # of H2AX- stem or differentiated cells x 100 
(6) Calculate % Targeted apoptosis = # of double positive TUNEL+ and H2AX+ 
stem or differentiated cells / total # of H2AX+ stem or differentiated cells x 
100 
(7) Perform statistical analysis using GraphPad Prism 6. 
 
References:  
Hua G, Thin TH, Feldman R, Haimovitz-Friedman A, Clevers H, Fuks Z, Kolesnick 
R. (2012) Crypt base columnar stem cells in small intestines of mice are 
radioresistant.Gastroenterology. 143(5):1266-1276. 
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APPENDIX C 
QUANTIFICATION OF PROLIFERATING CELLS IN DNA DAMAGED LGR5+ 
STEM CELLS 
 
Purpose: To quantify cells double positive for DNA damage and proliferation. 
 
Materials: Rabbit monoclonal phospho-gamma H2AX (H2AX) Ser139 antibody 
(Cell Signaling #9718), Jackson donkey anti rabbit 649 (711-605-152) for H2AX, 
goat polyclonal to GFP (Abcam #ab6673), Alexa-488 rabbit anti goat IgG 
(Invitrogen A-21222) for GFP, Click-It Plus EdU Alexa Fluor imaging kit 
(Thermofisher, C10640), sodium citrate tribasic (Sigma, S4641), Xylene (Fisher, 
X2P-1GAL), 100% Ethanol (KOPEC, V1001), 90% Ethanol (KOPEC, V1101), 
PAP pen (Invitrogen, 008899), TBST buffer (1X TBS with 0.1% Tween-20), 
Tween-20 (Sigma, P9416), BSA (Roche, 9048-46-8, at 4°C), PBS (Gibco, 21600-
069), donkey serum (Millipore, S30-100ml), rabbit serum (Invitrigen, 10510), Cell 
Signaling antibody diluent (Cell signaling, #8112), TritonX-100 (Sigma, 9002-93), 
dH2O (Gibco, 15230-170), ProLong AntiFade (LifeTech, P36935), coverslip 
(VWR, 16004-336), metal pot, the immune stain moisture chamber and coplin jars 
are in the shelf labeled with Immunohistochemistry supplies. 
 
Solutions:  
10 X Tris Buffered Saline (TBS):  
24.2 g Trizma® base (C4H11NO3) (Fisher, BP154-1) + 80 g sodium chloride (NaCl) 
(Sigma, S3014) / 1 L dH2O. Adjust pH to 7.6. = 0.2 M Tris+1.36 M Nacl 
Note: do not use BSA or milk to block. There is cross reactivity with the goat 
secondary. 
 
Procedure: 
1st day 
(1) Prepare 1.2 L of 10 mM sodium citrate, pH 6.0 (3.52 g sodium citrate 
trisodium (C6H5Na3O7·2H2O) in 850 mL H2O, adjust pH to 6.0 and then take 
final volume of 1.2 L). Preheat on hot plate by bringing to a boil at the level 
10 on Thermolyne heat plate and once boiling, switch to level 5.9.  
Note: Make sure the solution is NOT bubbling at all once the tissues go in 
the metal pot. 
 
Deparaffinization/Rehydration 
(2) Wash slides in Xylene 3 X 5 min. 
(3) Circle with PAP pen if needed. Note: Make a thick circle and dry out 
completely. 
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(4) Wash slides in 100% ethanol 3 X 4 min. 
Note: Do not allow slides to dry at any time from this procedure. 
(5) Wash slides in 95% ethanol 3 X 4 min. 
(6) Wash slides in 70% ethanol 2 x 4 min. 
(7) Wash slides in dH2O 3 X 3 min.  
Note: If paraffin is not completely removed, you will see non-specific signal.  
 
Antigen Unmasking 
(8) 20 min in sub-boiling citrate in metal pot. Cool metal pot for 20 min in tub of 
tap water. 
Note: If these steps are not performed, the antibodies will not have complete 
access to antigens in the tissue and will be unable to bind to the correct 
epitopes. 
 
Label with H2AX to detect DNA damaged cells 
(9) Wash slides in TBST 2 X 5 min. 
(10) 5% donkey serum in TBST (blocking solution) 30 min at RT. 
2.25 mL donkey serum + 42.75 mL TBST = 45 mL 
(11) Prepare 1° antibody (phospho-H2AX). 
1:200 in Cell Signaling antibody diluent.  
per 3 sections = 1 L H2AX antibody (Ab) + 199 L diluent = 200 L 
Neg control = use antibody diluent 
 
 
(12) Incubate overnight at 4° C in a humidified chamber. 
 
 
2nd day 
(13) Wash slides in TBST 4 X 3 min.  
(14) Prepare 2° Ab (Jackson donkey anti rabbit IgG – 649). 
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       1:400 in 1% donkey serum/0.3% Triton in PBS for 1 hr at RT.  
       per 3 sections 0.5 L 2° Ab + 2 L donkey serum + 6 L 10% Triton + 191.5 
L PBS = 200 L 
 
Label with GFP to detect LGR5+ stem cells 
(15) Wash slides in dH2O 2 X 5 min. 
(16) Wash slides in TBST 4 X 5 min. 
(17) Block in 10% rabbit serum in TBST for 1 hr at RT.  
2.25 mL donkey serum + 43.75 mL TBST= 45 mL 
(18) Prepare 1° antibody (GFP) 
1:400 in PBS / 1% donkey serum.  
per 3 sections = 0.5 L GFP Ab + 2 L donkey serum + 197.5 L PBS = 200 
L 
Neg control = leave out 1° antibody 
(19) Incubate overnight at 4° C in a humidified chamber. 
Note: The solution beads up (on some steps) into a little ball. You have to 
really drag it with a pipet tip to cover the tissue.  And you need to look very 
closely to make sure the outer edge is covered with solution.  This is the 
distal end which we want to score so we don't want it to dry out and give 
artifact.   
 
 
3rd day 
(20) Wash slides in TBST 4 X 3 min.  
(21) Prepare 2° Ab (Alexa-488 rabbit anti goat IgG). 
1:400 in 1% rabbit serum / 1% BSA/ 0.3% Triton in PBS for 1 hr at RT.  
per 3 sections = 0.5 L GFP Ab + 2 L rabbit serum + 20 L 10% BSA + 6 
L 10% Triton + 171.5 L PBS = 200 L 
(22) Wash slides in TBST 4 X 5 min. 
 
Label EdU to detect proliferating cells 
(23) Wash slides in dH2O 1 X 3 min.  
(24) Wash slides in 3% BSA in PBS (dip 3-4 times). 
(25) Incubate slides in 0.5% Triton X-100 in PBS, 20 min. 
(26) Prepare Click-It Reaction Cocktail, Table below.  Add reagents in order.  
For negative control, omit Alexa. 
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 Per 5 sections 
10X Rxn buffer (D) 43.75  µl  
Water 396.25 µl 
CuSO4 (E) 10 µl 
Alexa Fluor 647(B) 1.2 µl 
10X Rxn buffer additive (F) 5 µl 
Water 45 µl 
Total  501.2µl 
 
(27) Store in the dark and use within 15 minutes. 
Note: don’t use until indicated below. 
(28) Wash slides in 3% BSA in PBS, wash (dip 3-4 times). 
(29) Add 100 µl Click-It reaction cocktail to each sample, incubate 30 min RT, in 
the immune stain moisture chamber. 
(30) Tap off slide and wash slides in 3% BSA in PBS wash (dip 2-3 times) 
(31) Wash slides in PBS, 1 X 30 sec 
(32) Coverslip with ProLong AntiFade + DAPI. 
 
Capture image of entire Swiss roll 
(1) All immunofluorescent images of colonic crypts were captured using an 
inverted TE 300 Nikon Eclipse fluorescence microscope equipped with 
40X/1.30 Nikon Plan Fluor oil immersion objective and a Photometrics Cool 
Snap EZ digital CCD camera and a SOLA external light source. 
(2) Images are processed using the NIS Image software, version 3.2 (Nikon). 
(3) Start scanning from the distal colon and find a GFP positive good structured 
crypt in distal colon. Capture image of GFP positive good structured crypt. 
 
Analysis 
(1) Using NIS element, open up image you captured. 
(2) Count number of cells positive to TUNEL, H2AX and both positive to TUNEL 
and H2AX and DAPI per crypt. 
(3) Calculate % proliferating cells per crypt = # of EdU+ stem or differentiated 
cells / total # of stem or differentiated cells per crypt x 100 
(4) Calculate % DNA damaged cells per crypt = # of H2AX+ stem or 
differentiated cells / total # of stem or differentiated cells per crypt x 100 
(5) Calculate % proliferating cells with no DNA damage = # of EdU+ and H2AX- 
stem or differentiated cells / total # of H2AX- stem or differentiated cells x 
100 
(6) Calculate % proliferating cells with DNA damage = # of double positive EdU+ 
and H2AX+ stem or differentiated cells / total # of H2AX+ stem or 
differentiated cells x 100 
(7) Perform statistical analysis using GraphPad Prism 6. 
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Click-It Reaction (https://www.youtube.com/watch?v=AZ35QQDPlH8) 
In this assay the modified thymidine analogue EdU is efficiently incorporated 
into newly synthesized DNA and fluorescently labeled with a bright, photostable 
Alexa Fluor® dye in a fast, highly-specific click reaction. This fluorescent 
labeling of proliferating cells is accurate and compatible with antibody methods 
due to the mild click protocol. EdU (5-ethynyl-2'-deoxyuridine) is a nucleoside 
analog of thymidine and is incorporated into DNA during active DNA synthesis. 
With Click-iT® EdU, mild fixation and detergent permeabilization is sufficient for 
the small molecule-based Click-iT® EdU detection reagent to gain access to 
the DNA. Click it reaction: Detection is based on a click reaction, a copper 
catalyzed covalent reaction between a picolyl azide and an alkyne. In this 
application, the alkyne is found in the ethynyl moiety of EdU, while the picolyl 
azide is coupled to Alexa Fluor™ 488 dye. 
 
References:  
Hua G, Thin TH, Feldman R, Haimovitz-Friedman A, Clevers H, Fuks Z, Kolesnick 
R. (2012) Crypt base columnar stem cells in small intestines of mice are 
radioresistant.Gastroenterology. 143(5):1266-1276.  
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APPENDIX D 
QUANTIFYING CELLS DOUBLE POSITIVE FOR DNA DAMAGE AND MGMT 
IN LGR5+ STEM CELLS 
 
Purpose: To quantify cells double positive for DNA damage and DNA adduct 
repairing enzyme. 
 
Materials: Rabbit monoclonal phospho-gamma H2AX (H2AX) Ser139 antibody 
(Cell Signaling #9718), goat polyclonal to GFP (Abcam #ab6673), Jackson 
donkey anti rabbit 649 (711-605-152) for H2AX, Jackson Donkey anti Goat 488 
(705-545-147) for GFP, Mouse monoclonal to MGMT (AbCam cat# ab54306), 
Donkey anti-mouse 546 (Invitrogen A10036) for MGMT, sodium citrate tribasic 
(Sigma, S4641), Xylene (Fisher, X2P-1GAL), 100% Ethanol (KOPEC, V1001), 
90% Ethanol (KOPEC, V1101), PAP pen (Invitrogen, 008899), TBST buffer (1X 
TBS with 0.1% Tween-20), Tween-20 (Sigma, P9416), BSA (Roche, 9048-46-8, 
at 4°C), PBS (Gibco, 21600-069), donkey serum (Millipore, S30-100ml), Cell 
Signaling antibody diluent (Cell signaling, #8112), TritonX-100 (Sigma, 9002-93), 
dH2O (Gibco, 15230-170), ProLong AntiFade (LifeTech, P36935), coverslip 
(VWR, 16004-336), metal pot, the immune stain moisture chamber and coplin jars 
are in the shelf labeled with Immunohistochemistry supplies. 
 
Solutions:  
10 X Tris Buffered Saline (TBS):  
24.2 g Trizma® base (C4H11NO3) (Fisher, BP154-1) + 80 g sodium chloride (NaCl) 
(Sigma, S3014) / 1 L dH2O. Adjust pH to 7.6. = 0.2 M Tris+1.36 M Nacl 
Note: do not use BSA or milk to block. There is cross reactivity with the goat 
secondary. 
 
Procedure: 
1st day 
(1) Prepare 1.2 L of 10 mM sodium citrate, pH 6.0 (3.52 g sodium citrate 
trisodium (C6H5Na3O7·2H2O) in 850 mL H2O, adjust pH to 6.0 and then take 
final volume of 1.2 L). Preheat on hot plate by bringing to a boil at the level 
10 on Thermolyne heat plate and once boiling, switch to level 5.9.  
Note: Make sure the solution is NOT bubbling at all once the tissues go in 
the metal pot. 
 
Deparaffinization/Rehydration 
(2) Wash slides in Xylene 3 X 5 min. 
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(3) Circle with PAP pen if needed. Note: Make a thick circle and dry out 
completely. 
(4) Wash slides in 100% ethanol 3 X 4 min. 
Note: Do not allow slides to dry at any time from this procedure. 
(5) Wash slides in 95% ethanol 3 X 4 min. 
(6) Wash slides in 70% ethanol 2 x 4 min. 
(7) Wash slides in dH2O 3 X 3 min.  
Note: If paraffin is not completely removed, you will see non-specific signal.  
 
Antigen Unmasking 
(8) 20 min in sub-boiling citrate in metal pot. Cool metal pot for 20 min in tub of 
tap water. 
Note: If these steps are not performed, the antibodies will not have complete 
access to antigens in the tissue and will be unable to bind to the correct 
epitopes. 
 
Label with H2AX to detect DNA damaged cells 
(9) Wash slides in TBST 2 X 5 min. 
(10) 5% donkey serum in TBST (blocking solution) 30 min at RT. 
2.25 mL donkey serum + 42.75 mL TBST = 45 mL 
(11) Prepare 1° antibody (phospho-H2AX). 
1:200 in Cell Signaling antibody diluent.  
per 3 sections = 1 L H2AX antibody (Ab) + 199 L diluent = 200 L 
Neg control = use antibody diluent 
 
 
(12) Incubate overnight at 4° C in a humidified chamber. 
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2nd day 
(13) Wash slides in TBST 4 X 3 min.  
(14) Prepare 2° Ab (Jackson donkey anti rabbit IgG – 649). 
       1:400 in 1% donkey serum/0.3% Triton in PBS for 1 hr at RT.  
       per 3 sections 0.5 L 2° Ab + 2 L donkey serum + 6 L 10% Triton + 191.5 
L PBS = 200 L 
 
Label with GFP to detect LGR5+ stem cells 
(39) Wash slides in dH2O 2 X 5 min. 
(40) Wash slides in TBST 4 X 5 min. 
(41) Block in 5% donkey serum in TBST for 15 min at room temperature.  
2.25 mL donkey serum + 43.75 mL TBST= 45 mL 
(42) Prepare 1° antibody (GFP) 
1:400 in PBS / 1% donkey serum.  
per 3 sections = 0.5 L GFP Ab + 2 L donkey serum + 197.5 L PBS = 200 
L 
Neg control = leave out 1° antibody 
(43) Incubate overnight at 4° C in a humidified chamber. 
Note: The solution beads up (on some steps) into a little ball. You have to 
really drag it with a pipet tip to cover the tissue.  And you need to look very 
closely to make sure the outer edge is covered with solution.  This is the 
distal end which we want to score so we don't want it to dry out and give 
artifact.   
 
 
3rd day 
(44) Wash slides in TBST 4 X 3 min.  
(45) Prepare 2° Ab (Jackson donkey anti goat IgG – 488). 
1:400 in 1% donkey serum / 0.3% Triton in PBS for 30 min - 1 hr at RT.  
per 3 sections = 0.5 L 2° Ab + 2 L donkey serum + 6 L 10% Triton + 
191.5 L PBS =200 L 
 
Label with MGMT to detect repairing cells 
(46) Wash slides in dH2O 2 X 5 min. 
(47) Wash slides in TBST 4 X 5 min. 
(48) Block in 5% donkey serum in TBST for 15 min at room temperature.  
2.25 mL donkey serum + 43.75 mL TBST= 45 mL 
(49) Incubate with 1° antibody (MGMT) 
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Drop 1-2 drop per sample 
(50) Incubate overnight at 4° C in a humidified chamber. 
 
 
4th day 
(51) Wash slides in TBST 4 X 3 min.  
(52) Prepare 2° Ab (Donkey anti-mouse 546). 
1:400 in 1% donkey serum / 0.3% Triton in PBS for 30 min - 1 hr at RT.  
per 3 sections = 0.5 L 2° Ab + 2 L donkey serum + 6 L 10% Triton + 
191.5 L PBS =200 L 
(53) Wash slides in TBST 4 X 5 min. 
(54) Wash slides in dH2O 3 X 5 min. 
(55) Coverslip with ProLong AntiFade + DAPI. 
 
Capture image of entire Swiss roll 
(1) All immunofluorescent images of colonic crypts were captured using an 
inverted TE 300 Nikon Eclipse fluorescence microscope equipped with 
40X/1.30 Nikon Plan Fluor oil immersion objective and a Photometrics Cool 
Snap EZ digital CCD camera and a SOLA external light source. 
(2) Images are processed using the NIS Image software, version 3.2 (Nikon). 
(3) Start scanning from the distal colon and find a GFP positive good structured 
crypt in distal colon. Capture image of GFP positive good structured crypt. 
 
References:  
Hua G, Thin TH, Feldman R, Haimovitz-Friedman A, Clevers H, Fuks Z, Kolesnick 
R. (2012) Crypt base columnar stem cells in small intestines of mice are 
radioresistant.Gastroenterology. 143(5):1266-1276. 
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APPENDIX E 
QUANTIFYING CELLS DOUBLE POSITIVE FOR DNA DAMAGE AND BAX 
IN LGR5+ STEM CELLS 
 
Purpose: To immunohistochemically quantify Bax expression. 
 
Materials: Rabbit monoclonal to Bax (Cell Signaling #14796), Jackson donkey anti 
rabbit 649 (711-605-152) for Bax, Goat polyclonal to GFP (Abcam #ab6673), 
Jackson Donkey anti Goat 488 (705-545-147) for GFP, sodium citrate tribasic 
(Sigma, S4641), Xylene (Fisher, X2P-1GAL), 100% Ethanol (KOPEC, V1001), 
90% Ethanol (KOPEC, V1101), PAP pen (Invitrogen, 008899), TBST buffer (1X 
TBS with 0.1% Tween-20), Tween-20 (Sigma, P9416), BSA (Roche, 9048-46-8, 
at 4°C), PBS (Gibco, 21600-069), donkey serum (Millipore, S30-100ml), Cell 
Signaling antibody diluent (Cell signaling, #8112), TritonX-100 (Sigma, 9002-93), 
dH2O (Gibco, 15230-170), ProLong AntiFade (LifeTech, P36935), coverslip 
(VWR, 16004-336), metal pot, the immune stain moisture chamber and coplin jars 
are in the shelf labeled with Immunohistochemistry supplies. 
 
Solutions:  
10 X Tris Buffered Saline (TBS):  
24.2 g Trizma® base (C4H11NO3) (Fisher, BP154-1) + 80 g sodium chloride (NaCl) 
(Sigma, S3014) / 1 L dH2O. Adjust pH to 7.6. = 0.2 M Tris+1.36 M Nacl 
Note: do not use BSA or milk to block. There is cross reactivity with the goat 
secondary. 
 
Procedure: 
1st day 
(1) Prepare 1.2 L of 10 mM sodium citrate, pH 6.0 (3.52 g sodium citrate 
trisodium (C6H5Na3O7·2H2O) in 850 mL H2O, adjust pH to 6.0 and then take 
final volume of 1.2 L). Preheat on hot plate by bringing to a boil at the level 
10 on Thermolyne heat plate and once boiling, switch to level 5.9.  
Note: Make sure the solution is NOT bubbling at all once the tissues go in 
the metal pot. 
 
Deparaffinization/Rehydration 
(2) Wash slides in Xylene 3 X 5 min. 
(3) Circle with PAP pen if needed. Note: Make a thick circle and dry out 
completely. 
(4) Wash slides in 100% ethanol 3 X 4 min. 
Note: Do not allow slides to dry at any time from this procedure. 
 262 
 
(5) Wash slides in 95% ethanol 3 X 4 min. 
(6) Wash slides in 70% ethanol 2 x 4 min. 
(7) Wash slides in dH2O 3 X 3 min.  
Note: If paraffin is not completely removed, you will see non-specific signal.  
 
Antigen Unmasking 
(8) 20 min in sub-boiling citrate in metal pot. Cool metal pot for 20 min in tub of 
tap water. 
Note: If these steps are not performed, the antibodies will not have complete 
access to antigens in the tissue and will be unable to bind to the correct 
epitopes. 
 
Label with GFP to detect LGR5+ stem cells 
(9) Wash slides in dH2O 2 X 5 min. 
(10) Wash slides in TBST 4 X 5 min. 
(11) Block in 5% donkey serum in TBST for 15 min at room temperature.  
2.25 mL donkey serum + 43.75 mL TBST= 45 mL 
(12) Prepare 1° antibody (GFP) 
1:400 in PBS / 1% donkey serum.  
per 3 sections = 0.5 L GFP Ab + 2 L donkey serum + 197.5 L PBS = 200 
L 
Neg control = leave out 1° antibody 
 
 
 
Incubate overnight at 4° C in a humidified chamber.  
Note: The solution beads up (on some steps) into a little ball. You have to 
really drag it with a pipet tip to cover the tissue.  And you need to look very 
closely to make sure the outer edge is covered with solution.  This is the 
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distal end which we want to score so we don't want it to dry out and give 
artifact.   
 
 
2nd day 
(13) Wash slides in TBST 4 X 3 min.  
(14) Prepare 2° Ab (Jackson donkey anti goat IgG – 488). 
       1:400 in 1% donkey serum/0.3% Triton in PBS for 1 hr at RT.  
       per 3 sections 0.5 L 2° Ab + 2 L donkey serum + 6 L 10% Triton + 191.5 
L PBS = 200 L 
 
Label with Bax  
(15) Wash slides in dH2O 2 X 5 min. 
(16) Wash slides in TBST 4 X 5 min. 
(17) Block in 5% donkey serum in TBST for 15 min at room temperature.  
2.25 mL donkey serum + 43.75 mL TBST= 45 mL 
(18) Prepare 1° antibody (Bax, 1:400) in Cell Signaling antibody diluent (#8112) 
per 3 sections = 0.5 L Bax Ab + 199.5 L antibody diluent = 200 L 
Neg control = leave out 1° antibody 
Incubate overnight at 4° C in a humidified chamber.  
(19) Incubate overnight at 4° C in a humidified chamber. 
 
 
3rd day 
(20) Wash slides in TBST 4 X 3 min.  
(21) Prepare 2° Ab (Jackson donkey anti rabbit IgG – 649). 
1:400 in 1% donkey serum / 0.3% Triton in PBS for 30 min - 1 hr at RT.  
per 3 sections = 0.5 L 2° Ab + 2 L donkey serum + 6 L 10% Triton + 
191.5 L PBS =200 L 
(22) Wash slides in TBST 4 X 5 min. 
(23) Wash slides in dH2O 3 X 5 min. 
(24) Coverslip with ProLong AntiFade + DAPI. 
 
Capture image of entire Swiss roll 
(1) All immunofluorescent images of colonic crypts were captured using an 
inverted TE 300 Nikon Eclipse fluorescence microscope equipped with 
40X/1.30 Nikon Plan Fluor oil immersion objective and a Photometrics Cool 
Snap EZ digital CCD camera and a SOLA external light source. 
(2) Images are processed using the NIS Image software, version 3.2 (Nikon). 
 264 
 
(3) Start scanning from the distal colon and find a GFP positive good structured 
crypt in distal colon. Capture image of GFP positive good structured crypt. 
 
Analysis 
(8) Using NIS element, open file you with to analyze. 
(9) Draw ROI of GFPhigh cells to quantify intensity of Bax in Lgr5 stem cell region. 
Go to Simple ROI Editor - Bezier.  
(10) Draw ROI of GFPneg cells to quantify intensity of Bax in non-Lgr5 stem cell 
region. Go to Simple ROI Editor - Bezier. Click finish when you are done with 
drawing. 
(11) Quantify its intensity. Go to Automated Measurement Result.  
(12) Click Update measurement in Automated Measurement Result panel. This 
will give you a mean intensity for each of the ROI. 
(13) Calculate the relative intensity of Bax in GFPhigh / GFPneg cells.  
(14) Perform statistical analysis using GraphPad Prism 6. 
 
References:  
Dumitru R, Gama V, Fagan BM, Bower JJ, Swahari V, Pevny LH, Deshmukh M. 
(2012) Human embryonic stem cells have constitutively active Bax at the Golgi 
and are primed to undergo rapid apoptosis.Mol Cell. 46(5):573-583. 
 
 
 
 
 
 
 
 
  
 265 
 
APPENDIX F 
QUANTIFYING NUCLEAR/CYTOSOLIC -CATENIN IN ACF 
 
Purpose: Labeling -catenin inn GI sections (Swiss Roll). 
 
Materials: Mouse monoclonal -catenin antibody (BD Transduction, 
610154/dilution 1:500), Anti-mouse Alexa 546 (Life Technologies, A10036/dilution 
1:200), 0.05 M Tris pH 7.6, TBST buffer (1X TBS with 0.1% Tween-20), Tween-
20 (Sigma, P9416), donkey serum (Millipore, S30-100ml), BSA (Roche, 9048-46-
8, at 4°C), PBS (Gibco, 21600-069), sodium citrate tribasic (Sigma, S4641), 
Xylene (Fisher, X2P-1GAL), 100% Ethanol (KOPEC, V1001), 90% Ethanol 
(KOPEC, V1101), PAP pen (Invitrogen, 008899), TritonX-100 (Sigma, 9002-93), 
dH2O (Gibco, 15230-170), ProLong AntiFade (LifeTech, P36935), coverslip 
(VWR, 16004-336), metal pot, the immune stain moisture chamber and coplin jars 
are in the shelf labeled with Immunohistochemistry supplies, H&E stained slide.  
Note: H&E stained slide and -catenin stain slide has to be serial section so that 
we can measure intensity of -catenin of ACF. 
 
Solutions:  
10X Tris Buffered Saline (TBS):  
24.2 g Trizma® base (C4H11NO3) (Fisher, BP154-1) + 80 g sodium chloride (NaCl) 
(Sigma, S3014) / 1 L dH2O. Adjust pH to 7.6. = 0.2 M Tris+1.36 M Nacl 
0.05 M Tris-HCl buffer:  
6.057g Tris (Fisher. BP154-1) / 1L dH2O. Adjust pH to 7.6. 
2% BSA:  
2g BSA + 100ml 0.05 M Tris-HCl buffer (pH 7.6) 
Note: Do not use BSA or milk to block. There is cross reactivity with the goat 
secondary ab. 
 
Procedure: 
1st day 
(1) Prepare 1.2 L of 10 mM sodium citrate, pH 6.0 (3.52 g sodium citrate 
trisodium (C6H5Na3O7·2H2O) in 850 mL H2O, adjust pH to 6.0 and then take 
final volume of 1.2 L). Preheat on hot plate by bringing to a boil at the level 
10 on Thermolyne heat plate and once boiling, switch to level 5.9.  
Note: Make sure the solution is NOT bubbling at all once the tissues go in 
the metal pot. 
 
Deparaffinization/Rehydration 
(2) Wash slides in Xylene 3 X 5 min. 
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(3) Circle with PAP pen if needed. 
Note: Make a thick circle and dry out completely. 
(4) Wash slides in 100% ethanol 3 X 4 min. 
Note: Do not allow slides to dry at any time from this procedure. 
(5) Wash slides in 95% ethanol 3 X 4 min. 
(6) Wash slides in 70% ethanol 2 x 4 min. 
(7) Wash slides in dH2O 3 X 3 min.  
Note: If paraffin is not completely removed, you will see non-specific signal.  
 
Antigen Unmasking 
(8) 20 min in sub-boiling citrate in metal pot. Cool metal pot for 20 min in tub of 
tap water. 
Note: If these steps are not performed, the antibodies will not have complete 
access to antigens in the tissue and will be unable to bind to the correct 
epitopes. 
 
Label -catenin 
(9) Wash slides in dH2O 2 X 5 min. 
(10) Wash slides in TBST 2X 5 min. 
(11) Block in 5% donkey serum in TBST for 40 min at RT. 
(12) Wash slides in 0.05 M Tris-HCl buffer (pH 7.6) 2 x 5 min  
(13) Tap serum off 
(14) Put slides in the immune stain moisture chamber and add primary antibody 
(15) Prepare 1° antibody (-catenin) 
1:500 in PBS / 2% BSA in 0.05 M Tris-HCl buffer (pH 7.6) 
per 5 sections = 0.5 L -catenin Ab + 249.5 L 2% BSA in 0.05 M Tris-HCl 
= 250 L 
Neg control = leave out 1° antibody 
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Incubate overnight at 4° C in a humidified chamber.  
Note: The solution beads up (on some steps) into a little ball. You have to 
really drag it with a pipet tip to cover the tissue.  And you need to look very 
closely to make sure the outer edge is covered with solution.  This is the 
distal end which we want to score so we don't want it to dry out and give 
artifact.   
 
 
2nd day 
(16) Wash in 0.05 M Tris-HCl buffer (pH 7.6) 3 X 5 min  
(17) Prepare 2° Ab (Anti-mouse Alexa 546). 
1:200 in 2% BSA in 0.05 M Tris-HCl buffer (pH 7.6) for 1 hr at RT. 
per 5 sections = 1.25 L 2° Ab + 248.75 L 2% BSA in 0.05 M Tris-HCl = 
250 L 
(18) Wash slides in 0.05 M Tris-HCl buffer (pH 7.6) 3 X 5 min  
(19) Wash slides in dH2O 3 X 5 min. 
(20) Coverslip with ProLong AntiFade + DAPI. 
 
Imaging 
(1) Have pathologist record number and location of ACF using H&E stained 
slide. 
(2) Find the ACF on -catenin stained slide and capture image. 
(3) All immunofluorescent images of colonic crypts were captured using an 
inverted TE 300 Nikon Eclipse fluorescence microscope equipped with × 
40/1.30 Nikon Plan Fluor oil immersion objective and a Photometrics Cool 
Snap EZ digital CCD camera and a SOLA external light source (Nikon, 
Melville, NY, USA), TRITC filter. 
(4) Images are processed using the NIS Image software, version 3.2 (Nikon). 
 
Analysis 
(1) Using NIS element, open file you with to analyze. 
(2) Find ACF on -catenin stained slide. Draw -catenin positive region of ACF 
you want to analyze to quantify intensity of cellular -catenin in ACF. Go to 
Simple ROI Editor - Bezier. Draw ACF.  
(3) Draw region of nucleus with in the ACF to quantify intensity of -catenin in 
nucleus. Go to DAPI channel to visualize nucleus. Go to Simple ROI Editor 
- Bezier. Draw each nucleus. Click finish when you are done with drawing. 
(4) Quantify its intensity. Go to Automated Measurement Result.  
(5) Click Update measurement in Automated Measurement Result panel. This 
will give you a mean intensity for each of the ROI. 
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(6) Calculate the intensity of nucleus and cytosolic -catenin in ACF. Subtract 
intensity of nucleic -catenin from cellular -catenin to quantify intensity of 
cytosolic -catenin. 
(7) Perform statistical analysis using GraphPad Prism 6. 
 
References:  
McGinley JN, Thompson MD, Thompson HJ. (2010) A method for serial tissue 
processing and parallel analysis of aberrant crypt morphology, mucin depletion, 
and Beta-catenin staining in an experimental model of colon carcinogenesis.Biol 
Proced Online. 12(1):9032. 
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APPENDIX G 
SINGLE CELL ISOLATION  
 
Purpose: Isolate single cells from mouse colon crypts.  
 
Materials: ADF (Gibco, SILAC Advanced DMEM/F-12 Flex; no glucose included, 
A24943-01), PenStrep (P/S) (Gibco, 15140-122), HEPES (Gibco, H0887), 
Glucose (Gibco, A24940-01), 12x75 mm polypropylene tube (BD, 352063), FBS 
(HyClone, SH30084.03), EDTA (Sigma, ED4SS), 2mM EGTA pH 8.0 (Sigma, 
E4378), 0.25% trypsin (Gibco, 25200-056), sodium butyrate (Sigma, B5887), Y-
27632 (Sigma, Y0503), N-Acetyl-L-cysteine (Sigma, A9165), 10% BSA (Roche, 
9048-46-8, at 4°C) in PBS (Gibco, 21600-069), 0.5% BSA in PBS, 20 unit/l 
DNase (Sigma, D5025) diluted in PBS, 20-gauge needle (BD, 305176), 5ml 
syringe (BD, 309646), 40 µm cell strainer (Falcon, 352340), 20 µm cell strainer 
(Partec, 04-0042-2305), Propidium Iodide staining solution. 
 
The day before: 
(1) Chill Ca/Mg free PBS in cell culture fridge and lab fridge. 
(2) Prepare ADF+ = 50 mL ADF + 0.5 mL glutamax + 0.5 mL P/S + 0.5 mL 
HEPES + 0.5mL Glucose.  
(3) Precoat flow collection tubes 12 X 75 mm polypropylene tube with 2% FBS 
in ADF+.  
Note: keep in 4° C fridge.  
 
The day of isolation: 
(1) Make 20 mM EDTA in PBS, pH 7.4 solution fresh immediately before use.  
6 colons (30 mL/ colon) = 180 mL PBS + 1.52 g EDTA  
(add 6 drops 10 M HCl + 6 drops 1 M HCl to reach pH to 7.4) 
(2) Warm EDTA to 37° C in cell culture room. 
(3) Pre-warm 0.25% trypsin to RT. 
(4) Make 0.055 g sodium butyrate in 1.0 mL PBS (500 mM stock). 
(5) Thaw FBS (1 mL per colon). 
(6) Turn on ‘Centrifuge 5920R’ and pre-cool to 4° C.    
 
Isolate crypts from colon 
(1) Remove colon from mouse and place in cold Ca/Mg Free PBS in weigh boat.   
(2) Using gavage needle, perfuse with 10 mL cold PBS, cut the colon 
longitudinally (see APPENDIX A) and drop into 50 mL tube with 30 mL cold 
PBS containing 1X Pen/Strep (0.3 mL).    
(3) Vortex colon to remove remaining debris, 6 x 5 sec each at setting 10. 
Note: Replace with fresh cold PBS and repeat to help remove bacteria, 3 X 
5 sec each. 
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(4) Incubate the intestine in a 50 mL tube of 2 mM EGTA at 37° C for 20 min. 
(EGTA is dissociating cell-cell interaction by depleating Ca2+, I added this 
step to increase the yield.  1-2 mM of EGTA is also used to separate colonal 
crypt (Ikuma et al., 1998; Kaaij et al., 2013; Robert et al., 2001; van der Wurff 
et al., 1998)). 
(5) Incubate the intestine in a 50 ml tube of 20 mM EDTA at 37° C for 15 min. 
(EDTA is dissociating basolateral membrane of crypt from stroma by 
depleating Ca2+ (Munoz et al., 2012; Sato et al., 2011)). 
(6) Meanwhile prepare single cell cocktail (1 mL/ colon). 
1 mL of single cell cocktail = 1 mL ADF+ + 1 L 10 mM Y-27632 + 2.5 L 400 
µM N-Ac + 30 L 10% BSA + 10 L DNase (20 unit/L) + 8 L 0.25 M EGTA 
+ 1 L 500 mM butyrate. 
(7) After 35 min, transfer the suspended tissue to a fresh tube of 30 mL cold 
PBS + 30 L butyrate and vortex (setting 10 for 2 X 5 sec) to release crypts. 
 
Dissociate single cells from crypt 
(8) Remove colon and add FBS to tube of crypts to 2% (0.6 mL) and spin down 
the crypts at 300 x g, 5 min at 4° C. 
(9) Aspirate solution and gently resuspend crypts with 10 mL cold ADF+ + 10 L 
butyrate. (Or vortex for 5 sec X 2 at setting 7). 
(10) Spin at 200 x g, 2 min at 4° C (helps prevent pelleting of single cells).   
(11) Aspirate and gently resuspend in 10 mL ADF++10 L butyrate. (Or vortex for 
5 sec X 2 at setting 7).  
Note: Take a 10 L aliquot to count. 
(11) Spin at 300 x g, 3 min at 4° C. 
(12) Aspirate and resuspend (or vortex for 5 sec X 2 at setting 7) crypts in 5 ml 
0.25% trypsin + 50 L of DNase (20 unit/L).  
(13) Incubate at 37° C water bath for 7 min. 
 
Isolate single cells from crypt 
(14) After incubation, pass suspension through 20-gauge needle gently 3x to aid 
complete dissociation. Let sit 1 min then pass each sample thru needle 1x 
more. 
(15) Add 10 mL ice cold ADF+ + 250 L FBS (final 1% FBS) + 1.5 mL 20 mM 
EGTA (final 1.2 mM EGTA) to stop reaction.  
(16) Pass through 40 m cell strainer, changing strainer when it becomes too 
slow.   
(17) Add additional 10 mL ADF+ and 2 L Y-27632 + 20 L butyrate + 80 L 0.25 
M EGTA.  
         (This may be a problem step.  I’m dropping 5% FBS to 1% because it may 
cause problem in spinning cells down. If cells don’t filter well, need to dilute 
with larger volume.) 
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(18) Spin down at 500 X g, 3 min.  Make sure you see pellet.  If there is still fluffy 
stuff, spin at 550 X g, 1 min. If you still don’t have a pellet, go up to 600 X g 
for 1-2 min. 
(19) Carefully aspirate and resuspend in 200 L single cell cocktail (prepared 
above) to achieve 4 ~ 5 x 106 cells/mL.  
(20) 200 L of single cell cocktail will be added when you sort single cell 
(APPENDIX H).  
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APPENDIX H 
SORTING CELLS USING THE MOFLOW CELL SORTER 
 
Purpose: Sorting cells using fluorescence intensity on the MoFlow. 
 
Materials: 20 µm cell strainer (Partec, 04-0042-2305), Propidium Iodide staining 
solution, PI (BD, 51-66211E), single cell cocktail, Precoated flow collection tubes 
(12x75 mm polypropylene tube) with 2% FBS in ADF+ kept in 4° C fridge.  
 
Procedure:  
(1) Isolate single cells (APPENDIX G). 
 
Take to Vet School:   20 µm cell strainer, Lab book or old flow runs, extra flow 
tubes, gloves, 1000 and 10 L Pipets and tips, PI, coated flow tubes, PBS/ADF+ 
to collect into (1 mL per sample), sharpie & pen       
Note:  pipet gently about 3-4 times with P-1000. Excessive pipetting is not 
needed and is harmful. 
(2) At flow lab, filter again thru 20 m cell strainer into coated tube, rinsing with 
a 200 L of single cell cocktail. 
(3) Add PI to detect dead cells (5 L of 100 g /mL PI per 500 L cells) and 
vortex to mix it with cells.  
Note: DO NOT ADD PI if sorting with tomato. Tomato cells show up in same 
area as PI (562-588nm) positive cells. 
(4) Add 500 L of single cell cocktail into a pre-coated tube and collect sorted 
cells into it using Beckman Coulter MoFlo (Indianapolis, IN, USA). 
 
References:  
Fan YY, Davidson LA, Callaway ES, Wright GA, Safe S, Chapkin RS. (2015) A 
bioassay to measure energy metabolism in mouse colonic crypts, organoids, and 
sorted stem cells. Am J Physiol Gastrointest Liver Physiol. 309(1):G1-9. 
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APPENDIX I 
QUANTIFYING SINGLE CELLS POSITIVE FOR H2AX AND CLEAVED 
CASPASE-3 
 
Purpose: To quantify DNA damaged cells undergoing apoptosis using the 
FlowSight imaging flow cytometer. 
 
Materials: Phospho H2AX-AF647 conjugated antibody (Cell Signaling, #9720), 
cleaved caspase3-AF555 conjugated antibody (Cell Signaling, #9604), 20% PFA 
(Electron Microscopy Science, 15713), rabbit serum (Invitrigen, 10510), 200 proof 
pure Ethanol (KOPTEC, 64-17-5), BSA (Roche, 9048-46-8, at 4°C). 
Note: Ethanol has to be kept in -20° C. 
 
Procedure: 
(1) Prepare single cells (APPENDIX G) or sorted cells (APPENDIX H). 
(2) Add the same volume of 8 % PFA (diluted from the 20% PFA stock in PBS) 
to the tube containing sorted single cells right after the cells were collected 
to make 4% PFA. 
(3) Fix cells for 20 min at RT. 
(4) Remove PFA by centrifugation (1000 X g for 5 min) and resuspend cells in 
pre-chilled 1.5 mL PBS. Keep it on ice from this step. 
(5) Transfer cells in PBS into 5 mL tube and permeabilize cells by adding 3.5 
mL of ice-cold 100% ethanol drop by drop slowly to pre-chilled cells, while 
gently invert tube up and down to a final concentration of 70% ethanol. 
(6) Incubate 24 hr at -20° C. PFA-fixed sorted cells in 70% ethanol can be store 
at -20° C up to 1 month. 
(7) Spin the cells at 1000 X g for 10 min to remove the ethanol at 4° C. 
(8) Rehydrate the cells with 3 mL pre-chilled PBS (the volume?) for 10 on ice 
min and spin down at 1000 x g for 10 min at 4° C.  Repeat. 
(9) Blocking the cells with 5 mL 5% rabbit serum buffer (diluted in PBST, 0.1% 
Tween 20) for 30 min on ice and wash by centrifugation (1000 X g for 5 min 
at 4° C). 
(10) Resuspend cells in 100 L pre-chilled incubation buffer on ice (0.5% BSA in 
PBS).  
(11) Add 2 L of H2AX (1:50) and/ or 2 L of Caspase-3 (1:50) Ab into sample 
tubes. 
(12) Incubate on rotator for overnight at 4° C. 
 
 
(13) Next day, wash sample by centrifugation (1000 X g for 5 min at 4° C) in 1 mL 
incubation buffer (2 times). 
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(14) Resuspend cells in 25 L PBS (recommended concentration of cells by 
Amnis is 1 x 106 cells/50 L PBS). 
(15) Add 2.5 L of DAPI (10x) to the 25 L of samples. Keep on ice. 
(16) Run FlowSight. 
 
References:  
Heo SK, Noh EK, Yoon DJ, Jo JC, Choi Y, Koh S, Baek JH, Park JH, Min YJ, Kim 
H. (2015) Radotinib Induces Apoptosis of CD11b+ Cells Differentiated from Acute 
Myeloid Leukemia Cells. PLoS One. 10(6):e0129853. 
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APPENDIX J 
MEASUREMENT OF CELLULAR FREE CHOLESTEROL LEVELS 
 
Purpose: To label sorted cells with Filipin III to measure free cholesterol levels in 
the cell.   
 
Materials: 0.5 mg/mL Filipin III stock (10X), 1 mg of Filipin III from Streptomyces 
filipinesis (Sigma, F4767), DMSO, PBS (Gibco, 21600-069), 20% PFA (Electron 
Microscopy Science, 15713), 1.5 mL Low Retantion Microtubes (Phenix, MAX-
815S), Cell Imaging Coverglass (8 chamber) slides (Eppendorf, 0030742036). 
Note: Filipin III stock preparation is described after procedure 
 
Procedure: 
(1) Transfer single cells (APPENDIX G) or sorted cells (APPENDIX H) in 1.5 
mL Low Retantion Microtubes (105 cells/ mL). 
(2) Rinse cells with 1 mL PBS (300 X g for 3 min at 4° C) and fix with 1.5% 
paraformaldehyde (PFA) for 30 min at room temperature. 
(3) Rinse again with 1 mL PBS (1000 X g for 10 min at RT) and resuspend cells 
in PBS. 
(4) Resuspend cells in 100 L PBS 
(5) Incubate cells with Filipin at a final concentration of 50 g/mL in PBS for 45 
min at RT. Add 90 L cells in PBS + 10 L of 0.5 mg/ml Filipin III stock in 1.5 
mL Low Retantion Microtubes. 
(6) Transfer 100 L cells onto Cell Imaging Coverglass (8 chamber) slides for 
microscopic analysis. 
(7) Acquire images using 360/40 nm excitation and 480/40 nm emission filters 
with a 365 nm dichroic long pass filter. (Other similar UV filters should work.)  
(8) It is very important to use a low level (10 ms) of exposure time. Depending 
on lamp, filters, etc., you can attenuate excitation by 90–99% with a neutral 
density filter. This reduced excitation will slow photobleaching. 
 
 
Making 0.5 mg/ml Filipin III stock solution:   
 
Materials: 1 mg of Filipin III from Streptomyces filipinesis (Sigma, F4767), DMSO, 
PBS (Gibco, 21600-069), DMSO safe acrodisk filter (VWR, PN4433), 
Acrodisk filter (VWR, PN4192), 20-gauge needle (BD, 305176), 5mL syringe 
(BD, 309646), 1mL syringe (BD, 309659), 
 
 Procedure: 
(1) Prepare 0.6 mL tubes for aliquot.  
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(10 tubes X 33 L stock, 10 tubes X 44ul stock, 10 tubes X 55L stock, 10 
tubes X 66L stock) 
(2) Filter 500 L DMSO and 2 mL 1 X PBS into 2 mL eppy tube separately. 
(Use DMSO safe acrodisk filter and acrodisk filter to filter DMSO and PBS 
respectively) 
(3) Fill syringe with 400 L filtered DMSO and inject it into Filipin III vial and 
invert it to mix. 
(Use 20G needle on 1mL syringe). 
(4) Fill syringe with 1.6 mL filtered PBS and inject it into Filipin III vial (Use 20G 
needle on 5 mL syringe) and dissolve Filipin III for 2-3 min by inverting it. 
(5) Take Filipin III vial, prepared tubes, 200p pipet and 200 tips into chemical 
hood. 
(6) Aliquot dissolved Filipin III into prepared tubes. 
Note: Flush nitrogen gas before close the lid to eliminate oxygen in epi tube. 
(7) Wrap with foil to protect it from lights. 
(8) Keep it in a box containing desiccant pack at -20° C. 
 
Note: The aliquoted Filipin III won’t freeze at -20°C. The freezing point of DMSO 
is greatly decreased by the presence of water, requiring much lower temperatures 
to freeze the sample. Company recommend to use Fillipin III in DMSO (80% 
hydration) and it is not frozen in -20°C. Do not surprised that DMSO Fillipin III in 
DMSO is not frozen at -20°C.  
 
Reference:   
Maxfield FR, Wüstner D. (2012) Analysis of cholesterol trafficking with fluorescent 
probes. Methods Cell Biol. 108:367-393. 
Norman AW, Demel RA, de Kruyff B, van Deenen LL. (1972) Studies on the 
biological properties of polyene antibiotics. Evidence for the direct interaction of 
filipin with cholesterol. J Biol Chem. 247(6):1918-1929. 
Schroeder F, Holland JF, Bieber LL. (1971) Fluorometric evidence for the binding 
of cholesterol to the filipin complex. J Antibiot (Tokyo). 24(12):846-849. 
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APPENDIX K 
MEASUREMENT OF PLASMA MEMBRANE ORDER 
 
Purpose: To measure membrane order using confocal microscope 
 
Materials: 
5 mM Di4-ANEPPDHQ (ThermoFisher, D36802), Cell Imaging Coverglass (8 
chamber) slides (Eppendorf, 0030742036), Leibovitz's L-15 Medium, no phenol 
red (Gibco, 21083-027) 
Note: 5 mM Di4-4-ANEPPDHQ is stored in a 200 L aliquots wrapped in aluminum 
foil at -20° C. 
 
Procedure: 
(1) Prepare single cells (APPENDIX G) or sorted cells (APPENDIX H) in 
Leibovitz's L-15 Medium (105 cells/ mL). 
(2) Bring cells and Di4 dye to the microscope room. 
Note: Keep cells and Di4 Dye wrapped in aluminum foil on ice. 
(3) Setting up the microscope 
 
Dye Excitation Emission (Ordered) Emission (Disordered) 
Di-4-ANEPPDHQ 488 520-600 620-700 
 
Note: These ordered and disorder emissions are arbitrary and can vary, however 
the included reference has excellent guidelines 
(4) Di-4-ANEPPDHQ is mixed with cells (at a final concentration of 1 M)  
(5) Cells are transferred onto Cell Imaging Coverglass (8 chamber) slides for 
microscopic analysis using a laser confocal microscope (Leica DMi8 S 
Platform EII). 
(6) Immediately image cells to avoid internalization of dye.  
 
Generation of general polarization (GP) images:  
1. Download and install FIJI (FIJI Is Just ImageJ) software. Fiji is an image 
processing package — a "batteries-included" distribution of ImageJ, bundling 
a lot of plugins which facilitate scientific image analysis. (https://fiji.sc/) 
2. Install General Polarization Plug in. (https://github.com/dwaithe/GP-plugin) 
3. Place all the images you would like to analyze in one folder. 
4. Using FIJI convert all images in the folder to tiffs. Process  Batch Convert. 
Then select the folder the images are in as the “Input” and then create a new 
folder “Raw Tiffs” as the “Output”. Make sure interpolation is set to “None”. See 
the example below.  
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5. To generate GP images. Process  Batch  Macro.  Paste the “GP macro” 
text into the white area. Select the “Raw Tiffs” folder as the “Input” and then 
create a new folder “GP images” as the “Output”. Then select “Process”. Note: 
A threshold will need to be selected. Open an image, place the mouse in an 
area that has no cells, to determine the background intensity. Sum the intensity 
for the order and disordered channel, and then use this as a guide. Do the 
same for a region that has a strong membrane signal and record the values.  
It is usually best to set the threshold at a value that falls above the background 
sum but below the sum membrane signal.  
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6. The “GP” folder will now contain GP images.
Analysis of general polarization (GP) images 
1. To draw regions of interest (ROIs) on the images.  Analyze  Tools  ROI
Manger.
2. Select the polygon tool, and draw and ROI. Then on the ROI manger select
“Add”.
3. Repeat this process until you collect all the necessary ROIs. Then on the ROI
Manger select “Measure”. This will generate a list of measurements that can
be copied and pasted into excel, and used for analysis.
Reference:   
Ashdown GW, Owen DM. (2015) Imaging membrane order using environmentally 
sensitive fluorophores. Methods Mol Biol. 1232:115-122. 
Owen DM, Rentero C, Magenau A, Abu-Siniyeh A, Gaus K. (2011) Quantitative 
imaging of membrane lipid order in cells and organisms. Nat Protoc. 7(1):24-35. 
Sáenz JP, Sezgin E, Schwille P, Simons K. (2012) Functional convergence of 
hopanoids and sterols in membrane ordering. Proc Natl Acad Sci U S A. 
109(35):14236-14240. 
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MAKING A CHOLESTEROL STOCK SOLUTION 
Purpose: Preparation of 10 mM MCD:cholesterol stock solution 
Materials: MCD:cholesterol (Sigma, C4951), MCD (Sigma, C4555). 
Procedure:  
(1) MCD:cholesterol (Sigma, C4951-30MG) contains 40 mg of cholesterol and 
1000 mg of MCD in a bottle. 
(2) Molar ratio of MCD:cholesterol is 7.4:1 and, solubility is increased by adding 
extra uncomplexed MCD to make molar ratio of 10:1. 
(3) Add 351 mg of uncomplexed MCD powder (Sigma, C4555) into 
cholesterol:MCD (Sigma, C4951-30MG) container and add 9.34 mL 
cholesterol free organoid media (APPENDIX N) to dissolve it. It will come up 
with 10 mM cholesterol in 10.34 mL media. 
Note: 10 mM MCD:cholesterol is stored in a 100 L aliquots wrapped in 
aluminum foil at -20° C.  
Note: Flush nitrogen gas before close the lid to eliminate oxygen in epi tube. 
Note: 5 mM MCD:600 M (cholesterol molar ratio of 8:1) or 2.5 mM MCD:250 
M (cholesterol molar ratio of 10:1) is known to be a soluble form and deliver 
cholesterol in both Fu5AH and CHO cells. 
References:  
Zidovetzki R, Levitan I. (2007) Use of cyclodextrins to manipulate plasma 
membrane cholesterol content: evidence, misconceptions and control strategies. 
Biochim Biophys Acta. 1768(6):1311-1324. 
APPENDIX L 
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APPENDIX M 
CHOLESTEROL INCUBATION WITH ORGANOIDS 
 
Purpose: To incubate cholesterol with organoids in culture. 
 
Materials: ADF (Gibco, SILAC Advanced DMEM/F-12 Flex, A24943-01), 
PenStrep (P/S) (Gibco, 15140-122), HEPES (Gibco, H0887), Glucose (Gibco, 
A24940-01), 100 µg/mL EGF mouse recombinant (LifeTech, PMG8041, 100 g 
EGF/ 1 mL PBS + 0.5% FBS), 0.2 mM LDN/Noggin replacement (Cellagen Tech, 
0.2 mM stock in PBS + 0.5% FBS), 1 mg/mL R-Spondin mouse (Sino Biological 
Lnc., 50316-M08S, 0.5 g/mL final concentration), N2 supplement (LifeTech, 
17502-048, 100X), B27 supplement (LifeTech, 12587-010, 50X), N-Acetyl-L-
cysteine (Sigma, A9165), 100 g/mL Wnt (TimeBioscience, rmW3aL-002, final 30 
ng/mL), 10mM MCD:cholesterol stock solution (APPENDIX L).  
 
Solutions:  
(1) Prepare ADF+ = 50 mL ADF + 0.5 mL glutamax + 0.5 mL P/S + 0.5 mL 
HEPES + 0.5 mL Glucose.  
(2) Make cholesterol free media. 
Note: L-WRN media contains cholesterol so do not use it. Instead Wnt, R-
Spondin and Noggins has to be added to the ADF+ media separately. 
 
 
 
Procedure:  
(1) Prepare organoid (200 organoid per well). 
Note: Replace media with cholesterol containing media 24 hr after seeding 
cells. 
(2) Prepare cholesterol containing media = 5 L of 10mM MCD:cholesterol 
stock solution (APPENDIX M) + 495 L cholesterol free media per well.  
(3) Remove media and replace with cholesterol containing media. 
(4) Change media every 24 hr to avoid oxidization. 
(5) Harvest organoid upon cholesterol incubation for 72 hr. 
 
Organoid media Final concentration 500 µL/well
EGF (100 µg/mL) 50 ng/mL 0.25
LDN (Noggin replacement (0.2 mM) 0.2 M ~ 81.3 ng/mL 0.5
R-Spondin (1 mg/mL) 1x 0.25
N2 supplement (100x) 1x 5
B27 supplement (50x) 1x 10
N-Acetylcys (400 µM) (A) 1 M 1.25
ADF
+
 (w/ Gln, HEPES) 482.5
Wnt (100 ug/mL) 50 ng/mL 0.25
500Total volume
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References:  McFarlane MR, Cantoria MJ, Linden AG, January BA, Liang G, 
Engelking LJ. (2015) Scap is required for sterol synthesis and crypt growth in 
intestinal mucosa. J Lipid Res. 56(8):1560-15671.
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APPENDIX N 
QUANTIFYING PROLIFERATING CELLS FOLLOWING CHOLESTEROL 
INCUBATION WITH ORGANOIDS 
 
Purpose: To determine whether increased cholesterol promotes cell proliferation 
in organoids culture.  
 
Reagents: ADF (Gibco, SILAC Advanced DMEM/F-12 Flex, A24943-01), 
PenStrep (P/S) (Gibco, 15140-122), HEPES (Gibco, H0887), Glucose (Gibco, 
A24940-01), FBS (HyClone, SH30084.03), 0.25% trypsin (Gibco, 25200-056), 
100 g/mL EGF mouse recombinant (LifeTech, PMG8041, 100 g EGF/ 1 mL 
PBS + 0.5% FBS), 0.2 mM LDN/Noggin replacement (Cellagen Tech, 0.2 mM 
stock in PBS + 0.5% FBS), 1 mg/mL R-Spondin mouse (Peprotech, 315-32, 0.5 
g/mL final concentration), N2 supplement (LifeTech, 17502-048, 100X), B27 
supplement (LifeTech, 12587-010, 50X), N-Acetyl-L-cysteine (Sigma, A9165), 
100 g/mL Wnt (TimeBioscience, rmW3aL-002, final 30 ng/mL), 50 mM 
cholesterol (Sigma, C4951), 40 mM EdU stock (Life Technologies, A10044) in 
PBS (Gibco, 21600-069), Click-iTTM Plus EdU Alxa FluorTM 647 Imaging Kit 
(ThermoFisher, C10640), 4% PFA (Electron Microscopy Science, 15713) in PBS, 
3% BSA (Roche, 9048-46-8, at 4°C) in PBS, 0.5% TritonX-100 (Sigma, 9002-93) 
in PBS, DAPI (LifeTech, H3570), 10mM MCD:cholesterol stock solution 
(APPENDIX L). 
 
Organoid preparation: 
Prepare organoid incubated with or without cholesterol (APPENDIX N). 
 
EdU preparation: 
(1) Make 10 mg/mL EdU solution (40 mM stock solution) in saline, heat in water 
bath until dissolved (37o C for 20-30 min).  
(2) Aliquot 1 mL of 10 mg/mL EdU into 2.0 ml tubes. Avoid multiple freeze/thaws. 
(3) Store at -20o C protected from light. 
(4) Can be stored at -20o C for 6 months from time of preparation. 
(5) Prepare a working solution of 1X Click–iT EdU reaction buffer (Component 
D) 
(6) Transfer the solution (4 mL) in the Component D bottle to 36 mL of deionized 
water. 
(7) To make a 10X stock solution of the Click-iT EdU buffer additive (Component 
F, 400 mg) 
(8) Add 2 mL deionized water to the vial, then mix until fully dissolved.  
(9) After use, store any remaining solution at ≤ –20° C. (need to aliquot it if you 
won’t use it with in one year) 
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Note: When stored as directed, this stock solution is stable for up to 1 year. 
If the solution develope a brown color, it has degraded and should be 
discarded. 
 
Label EdU: 
(1) Prepare a 5 mM solution of EdU using EdU stock solution (40 mM), then mix 
well. 
32 samples (32 L) = 4 L of 5 mM EdU + 28 L ADF+  
(2) After use, store any remaining stock solution at ≤–20°C. When stored as 
directed, this stock solution is stable for up to 1 year.  
(3) Directly add 0.5 L 5 mM EdU to 500 L cholesterol containing media in 24 
well (5 M final concentration). 
(4) Incubate the cells for 1.5 hours (1~2 hr is recommended). 
Note: incubation time and concentration of EdU is different depending on 
experiment and cell. For mouse study we inject EdU 2 hr before terminate it 
however, organoid grow faster upon cholesterol incubation so I reduced 
incubation time down to 1.5 hr to avoid saturated EdU+ cellstype. 
(5) Aspirate culture medium, add 0.5 ml ice cold ADF+ and mechanically pipette 
and scrap the matrigel with a P1000 on ice. 
(6) Transfer the dissociated matrigel into a 2 ml tube (pooling 3 wells for 1 
sample).   
(7) Use another 0.5 ml cold ADF+ to finish transfer of all material from the wells.   
(8) Spin down the organoids at short (5000 X g for 4 sec at 4° C) .  Remove 
media (may see a glutinous Matrigel area above pellet.  Careful not to 
aspirate organoids!) 
(9) Resuspend organoids in 0.3 ml 0.25% EDTA-Trypsin and incubate at 37 °C 
for 8~12 min using heat block.  
(10) Every 2 minutes, pipet solution well (6 to 10 times). 
(11) Add 900 L cold 10% FBS ADF+ solution to stop reaction. 
 
EdU reaction: 
(1) Spin down at 500 X g (or 600 X g) for 3 min at 4 °C.   
(2) Remove supernatant as much as possible 
(3) Resuspend dissociated cells completely in 500 L PBS. 
(4) Note: resuspend organoid well to prevent fixing organoid without dissociation 
(5) Add 500 L 8.0% PFA in PBS to dissociated cells in 500 L PBS (4% PFA 
final). Incubate 15 min at room temperature.  
(6) Spin down to remove PFA (1500 x g, 2 minat RT), wash once with 1mL 3% 
BSA in PBS.   
(7) Spin and remove BSA.  (Note:  once organoids are PFA fixed, you can use 
a faster speed to centrifuge them, 1500 x g for 2 minutes, and operate fixed 
cells at RT). 
(8) Add 1 mL 0.5% Triton X-100 in PBS. Incubate 20 min at RT to permeabilize. 
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(9) Prepare Click-iT reaction cocktail during triton incubation.  All reagent should 
warm to RT before use. 
(10) Add reagents in order shown.  Store in the dark until ready to use and use 
within 15 minutes. 
 
 Per 5 sections 
10X Rxn buffer (D) 43.75  µl  
Water 396.25 µl 
CuSO4 (E) 10 µl 
Alexa Fluor 647(B) 1.2 µl 
10X Rxn buffer additive (F) 5 µl 
Water 45 µl 
Total  501.2 µl 
 
(11) Spin down to remove 0.5% Triton X-100 from cells.   
(12) Wash once in 3% BSA in PBS. Spin down to remove wash solution. 
(13) Add 100 L Click-It reaction cocktail to each sample.  Pipet gently to make 
sure all cells are exposed to buffer.   
(14) Incubate 30 min RT, in the DARK. 
(15) Spin down to remove reaction cocktail.   
(16) Wash once with 1 mL 3% BSA in PBS, transfer to 1.7 mL eppy tube. Spin 
down to remove wash solution. 
(17) Resuspend pellet in 20 L cold ADF+ (total volume should less than 50 L). 
(18) As soon as possible, analyze the stained cells by flowsight, measuring the 
fluorescence emission at 675 using 640 nm excitation. 
(19) Power setting for Flowsight machine: 640 nm: 5%.  
(20) If cells contain GFP, 488 nm: 40% or even higher (Fixed GFP is very weak!). 
 
References:  McFarlane MR, Cantoria MJ, Linden AG, January BA, Liang G, 
Engelking LJ. (2015) Scap is required for sterol synthesis and crypt growth in 
intestinal mucosa. J Lipid Res. 56(8):1560-15671. 
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APPENDIX O 
MEASURING PLASMA MEMBRANE ORDER AND CHOLESTEROL LEVELS 
IN ORGANOIDS 
 
Purpose: To assess the effect of exogenous cholesterol on plasma membrane 
order using organoids.  
 
Reagents: ADF (Gibco, SILAC Advanced DMEM/F-12 Flex, A24943-01), 
PenStrep (P/S) (Gibco, 15140-122), HEPES (Gibco, H0887), Glucose (Gibco, 
A24940-01), FBS (HyClone, SH30084.03), 0.25% trypsin (Gibco, 25200-056), 
100 g/mL EGF mouse recombinant (LifeTech, PMG8041, 100 g EGF/ 1mL PBS 
+ 0.5% FBS), 0.2 mM LDN/Noggin replacement (Cellagen Tech, 0.2 mM stock in 
PBS + 0.5% FBS), 1 mg/mL R-Spondin mouse (Peprotech, 315-32, 0.5 g/mL 
final concentration), N2 supplement (LifeTech, 17502-048, 100X), B27 
supplement (LifeTech, 12587-010, 50X), N-Acetyl-L-cysteine (Sigma, A9165), 
100 g/mL Wnt (TimeBioscience, rmW3aL-002, final 30 ng/mL), 50 mM 
cholesterol (Sigma, C4951), 40 mM EdU stock (Life Technologies Cat #A10044) 
in PBS (Gibco, 21600-069), Click-iTTM Plus EdU Alxa FluorTM 647 Imaging Kit 
(ThermoFisher, C10640), 4% PFA (Electron Microscopy Science, 15713) in PBS, 
3% BSA (Roche, 9048-46-8, at 4°C) in PBS, 0.5% TritonX-100 (Sigma, 9002-93) 
in PBS, DAPI (LifeTech, H3570), 10 mM MCD:cholesterol stock solution 
(APPENDIX L). 
 
Procedure:  
(1) Prepare organoid incubated with or without cholesterol in 1.5 mL 
(APPENDIX M). 
(2) Aspirate culture medium, add 0.5 mL ice cold ADF+ and mechanically pipette 
and scrap the matrigel with a P1000 on ice. 
(3) Transfer the dissociated matrigel into a 2 mL tube (pooling 3 wells for 1 
sample).   
(4) Use another 0.5 mL cold ADF+ to finish transfer of all material from the wells.   
(5) Spin down the organoids at short (5000 X g for 4 sec at 4° C).  Remove 
media (may see a glutinous Matrigel area above pellet. Careful not to 
aspirate organoids!) 
(6) Resuspend organoids in 0.3 mL 0.25% EDTA-Trypsin and incubate at 37 °C 
for 8~12 min using heat block.  
(7) Every 2 minutes, pipet solution well (6 to 10 times). 
(8) Add 900 L cold 10% FBS ADF+ solution to stop reaction. 
(9) Spin down at 500 g for 3 min at 4° C and carefully aspirate. 
(10) Add 200 L of ADF+ media, resuspend with cells.  
(11) Take 50 L of cells in the media is for measuring plasma membrane order. 
(12) Measure plasma membrane order (APPENDIX K). 
(13) Measure cholesterol levels in the plasma membrane (APPENDIX J). 
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References:   
Maxfield FR, Wüstner D. (2012) Analysis of cholesterol trafficking with fluorescent 
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APPENDIX P 
GENERAL CHOLESTEROL INCUBATION WITH YAMC/ IMCE CELLS 
 
 
Purpose: To stimulate cholesterol activation in YAMC/ IMCE cells. 
 
Materials: Trypsin-EDTA (Gibco, #25300-054), 500 mL RPMI without glutamine 
(Mediatech, 15- 040 CV), 26.6 mL Fetal Bovine Serum (Hyclone, AK 12434), 5.3 
mL Glutamax (Gibco, 35050-061), 0.532 mL ITS “-” minus (Insulin, Transferrin, 
Selenious acid without Linoleic acid) (Collaborative Biomed products, 4351), -
Interferon (Gibco BRL, 13284-021), Lipoprotein free serum (Kalen Biomedical, 
880100-1), 10mM MCD:cholesterol stock solution (APPENDIX L). 
 
Solution:  
Reconstitution of ITS “-”: 
Add 5 mL of sterile distilled water into lysophylized powder. Aliquot and store at 
-20°C.  
500 mL of RPMI complete media: 
500 mL RPMI without glutamine + 26.6 mL Fetal Bovine Serum + 5.3 mL 
Glutamax + 0.532 mL ITS “-” minus  
Note: Add 1L of -Interferon (-IFN, 10 L aliquot in -20° C) per 10 mL of 
complete RPMI 1640 medium just prior to use.  
50 mL of cholesterol free RPMI complete media: 
50 mL RPMI without glutamine + 2.66 mL Lipoprotein free serum + 0.53 mL 
Glutamax + 53.2 L ITS “-” minus  
Note: Add 1L of -Interferon (-IFN) per 10 mL of complete RPMI 1640 medium 
just prior to use.  
 
 
Lipoprotein free serum (Kalen Biomedical, 880100-1): Lipoprotein depleted FBS 
contains 0.04 mg/mL of cholesterol whereas normal FBS contains 1.4 mg/mL of 
cholesterol. Using HDL and LDL/VLDL cholesterol assay kit from abcam 
(ab65390), Kalen Biomedical reported that 35-fold reduction in cholesterol of 
Lipoprotein depleted FBS is found as compared to traditional FBS. 
(https://kalenbiomed.com/products/lipoprotein-depleted-fetal-bovine-serum).  
Note: 0.3 mg/mL cholesterol in FBS also reported (Gstraunthaler, 2003).  
Concentration of cholesterol in serum and 5% FBS media:  
0.04 mg/mL (10 M) cholesterol in serum = 0.5 M cholesterol in 5% FBS media 
0.3 mg/mL (75 M) cholesterol in serum = 3.75 M cholesterol in 5% FBS media 
1.4 mg/mL (350 M) cholesterol in serum = 17.5 M cholesterol in 5% FBS media 
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Procedure: 
(1) Culture YAMC and IMCE cells in a T-75 flask in complete media at 33° C and 
5% CO2 until they become ~70% confluent. 
(2) Add 15 mL RPMI complete media in a 50 mL conical tube (to spin cells) – 
always use at least 2X as much media as trypsin to stop the trypsinization. 
(3) Add 25 mL cholesterol free complete RPMI 1640 medium plus 2.5 L -IFN 
to a 50 mL conical tube (to grow cells). 
(4) Warm both conical tubes of media in water bath (37o C). 
(5) Aspirate old media from flask. 
(6) Rinse monolayer of cells with 10 mL PBS by adding and aspirating gently 
without disturbing the cell monolayer. 
(7) Add 5 mL Trypsin-EDTA to the flask and incubate cells at 37˚ C for 3 min or 
until > 90% cells are lifted. Gently tap the bottom of the flask to assist in cells 
lifting. 
(8) Add the 15 mL RPMI complete media from the conical tube to the flask of 
trypsinized cells (add by rapidly dispensing the media and moving the pipette 
in a back and forth motion across the flask to dislodge any stuck cells). Then, 
transfer the media and trypsin to the 50 mL conical tube. 
(9) Transfer 10 L of the cell suspension onto each end of the hemacytometer. 
 
Note: Cell number (per mL) = Living cells count x 10,000 
                                                               # Squares counted 
 
(10) Centrifuge cells at 200 x g (1096 rpm, countertop centrifuge for 5 min). 
(11) Vacuum aspirate supernatant (media with trypsin), taking care not to disturb 
the pellet. 
(12) Seed cell according to desired density in cholesterol free RPMI complete 
media with-IFN. 
 
 
 
 
(13) Add 10 L of 10 mM cholesterol per 1 mL of cholesterol free complete RPMI 
1640 medium (final concentration = 100 M). 
(14) Change cholesterol containing media every 24 hr to avoid oxidization. 
(15)  Harvest cells every 24 hr and measure plasma membrane order, cholesterol 
level in plasma membrane and proliferation rate. 
 
 
Culture plates
Surface area 
(cm
2
)
Seeding 
density
Cells at 
confluency
Growth 
medium (mL)
6-well (plasma membrane order and 
Filipin III experiment)
9 0.05 x 10
6
1.2 x 10
6 3–5
24-well (proliferation rate using 
CellTiter Blue)
2 0.03 x 10
6
0.2 x 10
6 0.5–1.0
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References: Zhao C, Deng Y, Liu L, Yu K, Zhang L, Wang H, He X, Wang J, Lu 
C, Wu LN, Weng Q, Mao M, Li J, van Es JH, Xin M, Parry L, Goldman SA, Clevers 
H, Lu QR. (2016) Dual regulatory switch through interactions of Tcf7l2/Tcf4 with 
stage-specific partners propels oligodendroglial maturation.Nat Commun. 
7:10883. 
Gstraunthaler G.(2003) Alternatives to the use of fetal bovine serum: serum-free 
cell culture.ALTEX. 20(4):275-281. 
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APPENDIX Q 
DETERMINE CELL PROLIFERATION RATES USING CELLTITER-BLUE 
 
 
Purpose: To determine proliferation rates of YAMC/IMCE cells upon cholesterol 
incubation.  
 
Materials: Trypsin-EDTA (Gibco, #25300-054), 500 mL RPMI without glutamine 
(Mediatech, 15- 040 CV), 26.6 mL Fetal Bovine Serum (Hyclone, AK 12434), 5.3 
mL Glutamax (Gibco, 35050-061), 0.532 mL ITS “-” minus (Insulin, Transferrin, 
Selenious acid without Linoleic acid) (Collaborative Biomed products, 4351), -
Interferon (Gibco BRL, 13284-021), Lipoprotein free serum (Kalen Biomedical, 
880100-1), 10mM MCD:cholesterol stock solution (APPENDIX L). CellTiter-Blue 
Cell Viability Assay (Promega, G8080), Microplate Reader (BMG LABTECH, 
CLARIOstar). 
 
Procedure: (perform all step in sterile hood, as the cells will continue 4 hr 
incubation after the addition of Cell titer Blue) 
(1) Prepare cells incubated with or without cholesterol (APPENDIX Q). 
(2) Thaw CellTiter-Blue Reagent and bring to ambient temperature. A 33◦ C 
water bath may be used to thaw the reagent.  
Note: protect the CellTiter-Blue Reagent from direct light. 
(3) Remove 24 well plate from 33◦ C incubator and add CellTiter-Blue Reagent 
(6X stock solution) to appropriate wells. 100 L CellTiter-Blue Reagent + 500 
L RPMI media with or without cholesterol. 
Negative control: 3 wells with CellTiter-Blue Reagent + media without cells  
Note: leave 3 empty wells for the subtraction of the background fluorescence. 
(4) Incubate in 33◦ C incubator for 4 hr (1~4 hr is recommended). 
(5) Shake/swirl plate for 10 sec and record fluorescence at 560/590 nm. 
Note: Fluorescence filter set at 530-570 nm for excitation and 580-620 nm 
for fluorescence emission. 
 
References: 
Habermann N, Christian B, Luckas B, Pool-Zobel BL, Lund EK, Glei M. (2009) 
Effects of fatty acids on metabolism and cell growth of human colon cell lines of 
different transformation state. Biofactors. 35(5):460-467. 
  
 292 
 
APPENDIX R 
ASSESSMENT OF PLASMA MEMBRANE ORDER AND CHOLESTEROL 
LEVELS IN CELL PLASMA MEMBRANE USING FLOWSIGHT  
 
Purpose: Determine membrane order (Di4) and free cholesterol levels (Filipin) in 
cell lines or single cells from mice using the FlowSight imaging flow cytometer. 
 
Materials: 5 M Di4-ANEPPDHQ (ThermoFisher, D36802), 1 mg of Filipin III from 
Streptomyces filipinesis (Sigma, F4767), DMSO, PBS (Gibco, 21600-069), 4% 
PFA (Electron Microscopy Science, 15713) in PBS 
 
Procedure: 
(1) Prepare single cells incubated with or without cholesterol (APPENDIX Q). 
(2) If you use cells from same well, take 75% of cells in the media, fix in 1.5% 
paraformaldehyde for 20 min at RT for the measuring cholesterol in the 
plasma membrane. 25% of cells in the media is for measuring plasma 
membrane order. 
 
Membrane order:  
(1) Turn on FlowSight, Run start up, and Calibration.  
(2) Load template. Robert  Template  Single Cell Di4 (1M).  
(3) This template should have the 488 laser on.  
(4) Take 36 L single cells 105 cells/ mL and add 4L Di4 (10 M) to make a 
final concentration of 1M. Note: This must be done immediately before 
running on the FlowSight.  
(5) Run on FlowSight. Note: Make sure the signal is not saturated in the 
disordered channel. If it is you can lower the laser power. 
(6) Use the Ideas analysis template. (170724 YAMC post di4.ist). 
Note: This was generated by Michael and has different mask that analyze 
the whole cells, just the membrane, or the internal membrane. Although it is 
not truly just the internal membrane since it is a wide field image.   
(7) Batch the data with the template to generate all the statistics.  
Filipin III: 
(1) In a 1.7 mL eppy tube, fix the remaining cells (~150 L) in 4% PFA for 15 
min on ice.  
Note: I do this by adding equal parts 8% PFA to the same volume of cells to 
make 4% PFA.  
(2) Add 1 mL PBS to the fixed cells, and spin down at 1000 g for 5 min at 4◦ C.   
Note: The fix cells are fine at this speed and they make a nice pellet.  
(3) Aspirate carefully and do not disturb the pellet.  
(4) Add 1.5 mL PBS to wash the pellet.  
(5) Spin down at 1000 g for 5 min at 4◦ C.   
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(6) Carefully aspirate the media.  
(7) Re-suspend the pellet in 40 L PBS. 
(8) Transfer 36 L of cells to a new 1.7 mL eppy tube.  
(9) Add 4 L of Filipin (500 g/mL) to make a final concentration of 50 g/mL. 
Note: Filipin photo bleaches very easy so keep the samples protected from 
light from now on when possible.  
(10)  Incubate on ice covered in the dark for 45 minutes.  
(11)  Add 1.5 mL PBS, and spin down at 1000 g for 5 min at 4◦ C.  
Note: This washes out excess Filipin III. 
(12)  Aspirate carefully and do not disturb the pellet. Repeat the wash and spin. 
(13)  Resuspend the pellet in 40 L PBS. 
(14)  Load the Filipin template: Robert  Template  Fillipin III.   
Note: The 405 Laser should turn on and will be at 100%, since the 405 barely 
excites Filipin III.  
(15)  Run the sample on the FlowSight.  
(16)  Use the Ideas analysis template. (170724 YAMC Filipin.ist). 
Note: This was generated by Michael and has different mask that analyze 
the whole cells, just the membrane, or the internal membrane. Although it is 
not truly just the internal membrane since it is a wide field image.  
(17)  Batch the data with the template to generate all the statistics. 
References: Chapkin lab developed the protocol. 
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EXTRACTION OF DNA AND RNA USING RNA ISOLATION KIT 
Purpose: Extract DNA and RNA from isolated GI crypts using the RNA miniprep 
kit (Zymo Research, R1050). 
Materials: RNA miniprep kit (Zymo Research, R1050), 100% RNase free ethanol 
(KOPEC, V1001), DNA-free DNA removal kit (Ambion, AM1906). 
Note: all steps at RT, unless specified. 
Procedure: 
(1) Make sure to add ethanol to RNA Wash Buffer concentrate.    
(2) Preheat DNase/RNase-free water to 75° C for elution (~ 60 L/sample). 
(3) Prepare cells in RNA lysis buffer. 
(4) Transfer the lysed cell solution to a Zymo-Spin IIICG column in a RNase free 
collection tube (max 700 L at a time). Collection tube should be a RNase-
free 2mL round bottom tube. 
(5) Centrifuge at 30 sec at 13,000 X g.  Repeat loading if necessary. Do not 
discard flow thru. 
(6) DNA is on a collection tube. Flow thru is for the isolating RNA. 
DNA extraction: 
(7) Place a column in a new collection tube that comes with a kit. 
(8) Add 400 L RNA Prep buffer to the column.  
(9) Centrifuge for 30 sec at 13,000 X g. Discard flow thru. 
(10) Add 700 L RNA Wash buffer to the column.  
(11) Centrifuge for 30 sec at 13,000 X g. Discard flow thru. 
(12) Add 400 L RNA Wash buffer to the column.  
(13) Centrifuge for 30 sec at 13,000 X g first, then centrifuge for 2 min at 13,000 
X g, to ensure complete removal of the wash buffer. Discard flow thru. 
(14) Place the column in RNase-free 1.7 mL eppy tube (not provided in the kit).   
(15) Add 30 ~ 60 L pre-heated DNase/RNase-free water directly to the matrix. 
(16) Centrifuge for 30 sec at 16,000 X g.   
(17) The flow thru is the isolated DNA.  
(18) You can repeat the elution again to get more yield, but the concentration will 
decrease. Minimum elution volume is 30 L. 
RNA extraction: 
(1) Add same volume of 95 ~ 100% ethanol to the sample in RNA lysis buffer 
(1:1).  Mix well. 
(2) Transfer the mixture to a Zymo-Spin IC Column in a Collection Tube. 
APPENDIX S 
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(3) Centrifuge at 30 sec at 13,000 X g.  Discard flow thru. Repeat loading if 
necessary. 
(4) Add 400 L RNA Prep buffer to the column.   
(5) Centrifuge for 30 sec at 13,000 X g. Discard flow thru. 
(6) Add 700 L RNA Wash buffer to the column.   
(7) Centrifuge for 30 sec at 13,000 X g. Discard flow thru. 
(8) Add 400 L RNA Wash buffer to the column.   
(9) Centrifuge for 2 min at 13,000 X g to ensure complete removal of the wash 
buffer.  Discard flow thru. 
(8) Place the column in RNase-free 1.7 mL eppy tube (not provided in the kit).  
(9) Add ~ 10 L (at least 6 L) pre-heated DNase/RNase-free water directly to 
the matrix.   
(10) Centrifuge for 30 sec at 16,000 X g.   
(11) The flow thru is the isolated RNA.  
(12) You can repeat the elution again to get more yield, but the concentration will 
decrease.  Minimum elution volume is 6 L. 
 
DNase I treatment: 
(13) Use DNA Free kit from Ambion (Ambion, AM1906), not the one in the Zymo 
kit). 
(14) Add 0.1 volume (of the RNA eluate) of 10X DNase I buffer and 1 L of DNase 
I to the RNA eluate.   
(15) Mix gently.  
(16) Incubate at 37° C for 20 min. 
(17) Vortex DNase Inactivation Reagent to disperse the slurry before use.   
(18) Add 0.1 volume (of RNA/DNase mixture) of DNase Inactivation Reagent to 
the mixture. 
(19) Mix gently by flicking the tube, incubate at RT for 2 min.  
(20) Flick the tube once more during the incubation. 
(21) Centrifuge at 13,000 x g for 1.5 min. Transfer supernatant to a new RNase-
free tube. 
(22) Now ready for RT-PCR.   
(23) Measure the concentration in Nano drop, and check the quality in Agilent 
Bioanalyzer. 
 
Remove Guanidine after isolating RNA using Zymo Quick-RNA MicroPrep kit 
(Cat# R1050) 
(1) Add 100 µL RNA lysis buffer. Mix well. 
(2) Transfer the mixture to a Zymo-Spin IC Column in a Collection Tube.  
(3) Centrifuge at 30 sec at 13,000 X g.  Discard flow thru. Repeat loading if 
necessary. 
(4) Add 400 L RNA Prep buffer to the column.   
(5) Centrifuge for 30 sec at 13,000 X g.  Discard flow thru. 
 296 
 
(6) Add 700 L RNA Wash buffer to the column.   
(7) Centrifuge for 30 sec at 13,000 X g.  Discard flow thru. 
(8) Add 400 L RNA Wash buffer to the column.   
(9) Centrifuge for 2 min at 13,000 X g to ensure complete removal of the wash 
buffer. Discard flow thru. 
(10) Place the column in RNase-free 1.7 mL eppy tube (not provided in the kit).  
(11) Add ~ 10 L (at least 6 L) pre-heated DNase/RNase-free water directly to 
the matrix.   
(12) Centrifuge for 30 sec at 16,000 X g.   
(13) The flow thru is the isolated RNA.  
(14) You can repeat the elution again to get more yield, but the concentration will 
decrease.  Minimum elution volume is 6 L. 
 
References:  
https://www.zymoresearch.com/rna/total-rna-purification/cell-soft-tissue-
rna/quick-rna-microprep 
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APPENDIX T 
GENOTYPING OF KRAS MICE  
 
Purpose: Detecting wild type KRAS, LSL-G12D Kras (floxed but not recombined) 
and G12D-Kras (recombined) allele using DNA extracted from crypts isolated 
from CDX2P-CreERT2-Apc
580D/+
; Kras
G12D/+
 mouse colon. 
 
Materials: 2X master mix (Denville Hot Start, CB4030-4), 10M primers (order 
from https://www.idtdna.com/Primerquest/Home/Index), PCR machine (AB, 2720 
Thermocycler), dH2O (Gibco, 15230-170). 
 
Solution: 
Dissolve primer in TE buffer to make 100 M stock primer, aliquot into 10 L and 
keep it in -80° C.  
Dilute100 M stock primer in TE buffer to make 10M. 
 
Source of primers: Jackson lab (https://jacks-
lab.mit.edu/protocols/genotyping/kras_cond) and Hinoi et al., 2007  
Kras Jackson F1 (P1) 5’-GTCTTTCCCCAGCACAGTGC-3′  
Kras 1AS (Reverse)   5′-GCAGCGTTACCTCTATCGTA-3′  
Kras Jackson F2 (P3) 5’-AGCTAGCCACCATGGCTTGAGTAAGTCTGCA-3′ 
 
Reaction Mix (30 L reaction): 
Reaction mix Volume (l) 
Master mix (2X) 15 
10M Kras P1 (0.5 M final concentration) 1.5 
10M Kras P2 (0.5 M final concentration) 1.5 
10M Kras P3 (0.5 M final concentration) 1.5 
DNA (25 ng) 4 
Water 6.5 
Total 30 
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PCR parameters: 
95°C 2 min Initialization 
35 cycles of:   
95°C 30 sec Denaturation 
61°C 30 sec Annealing 
72°C 45 sec Extension/elongation 
   
72°C 10 min Final elongation 
4°C keep Final hold 
 
Amplified fragments:    
 
 
 
 
Note: 20 bp difference between G12D and WT can be acquired when you run 
samples for 1.5 hr in 1.5% gel.      
Note: Recombination efficiency is not 100% so, you will see both LSL-G12D and 
G12D. 
 
References:  
Jackson lab (https://jacks-lab.mit.edu/protocols/genotyping/kras_cond),  
Hinoi, T., Akyol, A., Theisen, B.K., Ferguson, D.O., Greenson, J.K., Williams, 
B.O., Cho, K.R., and Fearon, E.R. (2007). Mouse model of colonic adenoma-
carcinoma progression based on somatic Apc inactivation. Cancer research 67, 
9721-9730. 
 
  
WT (700bp) 
G12D (720bp) 
LSL-G12D (570bp) 
Kras
LSL-G12D/+
+TAM Kras
+/+
 
 299 
 
APPENDIX U 
GENOTYPING OF APC MICE  
 
Purpose: Detecting wild type Apc, Apc580S (floxed but not recombined) and 
APC580D (recombined) allele using DNA extracted from crypts isolated from 
CDX2P-CreERT2-Apc
580D/+
; Kras
G12D/+
 mouse colon 
 
Materials: 2X master mix (Denville Hot Start, CB4030-4), 10M primers (order 
from https://www.idtdna.com/Primerquest/Home/Index), PCR machine (AB, 2720 
Thermocycler), dH2O (Gibco, 15230-170). 
 
Solution: 
Dissolve primer in TE buffer to make 100 M stock primer, aliquot into 10 L and 
keep it in -80° C.  
Dilute100 M stock primer in TE buffer to make 10M. 
 
Source of primers: Shibata et al., 1997  
Apc F1 (P3) 5′- GTTCTGTATCATGGAAAGATAGGTGGTC-3′ 
Apc R1 (P4) 5′- CACTCAAAACGCTTTTGAGGGTTGATTC -3′ 
Apc R2 (P5) 5'-GAGTACGGGGTCTCTGTCTCAGTGAA-3' 
 
Rxn Mix (30 L reaction): 
Reaction mix Volume (l) 
Master mix (2X) 15 
10M Apc F1 (P3) (0.5 M final concentration) 1 
10M Apc R1 (P4) (0.5 M final concentration) 1 
10M Apc R2 (P5) (0.5 M final concentration) 1 
DNA 4 
Water 8 
Total 30 
 
 
 
 
 
 
 
 
 
 
 300 
 
PCR parameters:     
95°C 3 min Initialization 
35 cycles of:   
95°C 30 sec Denaturation 
59°C 30 sec Annealing 
72°C 40 sec Extension/elongation 
   
72°C 2 min Final elongation 
4°C keep Final hold 
 
 Amplified fragments:    
 
 
 
 
Note: Recombination efficiency is not 100% so, you will see both 580D and 580S. 
 
 
References:   
Shibata, H., Toyama, K., Shioya, H., Ito, M., Hirota, M., Hasegawa, S., 
Matsumoto, H., Takano, H., Akiyama, T., Toyoshima, K., et al. (1997). Rapid 
colorectal adenoma formation initiated by conditional targeting of the Apc gene. 
Science 278, 120-123. 
 
 
 
 
 
 
 
 
  
Apc
580S/++TAM Apc
+/+
 
580D (258bp) 
580S (314bp) 
WT (226bp) 
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APPENDIX V 
PREPARATION OF TOTAL CELL LYSATES 
 
 
 
Purpose: To isolate cell lysates from mouse colonic crypts. 
 
Materials: 
5 mL of Homogenization buffer (HB)  
Final 
concentration 
500 L of 500 mM Tris-HCl (Sigma, T1503)  50 mM 
1.25 mL of 1 M sucrose (Sigma, S9278)  250 nM 
50 l of 200 mM EDTA(Sigma, ED4SS)  2 mM 
50 l of 100 mM EGTA (Sigma, 34596)  1 mM 
500 l of 10% Triton-X (Sigma, T6878)  1% 
0.625 l of 0.4 M NaF (Sigma, S6521)  50 M 
2395.875 l of double distilled water   
50 l of 10 mM activated sodium orthovanadate (Sigma, S6508)  100 M 
200 l of protease inhibitor cocktail (Sigma, P8340)   
3.5 l of 14.2 M β-mercaptoethanol (Bio-Rad, 161-0710)  10 mM 
* Items in red are to be added on the day of use 
 
Procedure: 
(1) Harvest crypts according to the SINGLE CELL ISOLATION protocol  
(2) Transfer extracted crypts into 1.7 mL eppy tubes and add 100 l of HB. 
(3) Pass through 29G needle once into the same set of 1.7 mL eppy tubes, flush 
the suspension very hard to sheer the cells (perform on ice). 
(4) Incubate the total lysate in ice for 30 min. 
(5) Centrifuge at 16,000 X g at 4° C for 20 min. 
(6) Transfer the supernatant (lysate) to clean 1.7 mL eppy-tube and pipette up 
and down to mix. 
(7) Quantify levels of protein using Coomassie Plus and immunoblotting. 
 
References:  
Turk HF, Barhoumi R, Chapkin RS. (2012) Alteration of EGFR spatiotemporal 
dynamics suppresses signal transduction. PLoS One. 2012;7(6):e39682. 
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APPENDIX W  
NUCLEAR AND CYTOPLASMIC PROTEIN EXTRACTION  
 
Purpose: Quantify nuclear/cytosolic beta-catenin protein levels. 
 
Aim: Extract cytoplasmic and nuclear protein fractions from isolated crypts. 
 
Reagents: ADF (Gibco, SILAC Advanced DMEM/F-12 Flex; no glucose included, 
A24943-01), PenStrep (P/S) (Gibco, 15140-122), HEPES (Gibco, H0887), 
Glucose (Gibco, A24940-01), EDTA (Sigma, ED4SS), 2mM EGTA pH 8.0 (Sigma, 
E4378), NE-PER Nuclear and Cytoplasmic Extraction (Thermofisher, 78833), 
Protease inhibitors (e.g., Thermo Scientific™ Halt™ Protease Inhibitor Cocktail, 
Product No. 78425 or 78437), 10 mM activated sodium orthovanadate (Sigma 
#S6508), 0.4 M NaF (Sigma, S6521) 
   
Procedure:  
Extract cytosolic proteins:  
(1) Transfer crypts in PBS to a pre-weighed 1.7 mL eppy tube and pellet by 
centrifugation at 500 X g for 5 min. 
(2) Use a pipette to carefully remove and discard the supernatant, leaving the 
cell pellet as dry as possible. Weigh the 1.7 mL epi-tube with cells. 
(3) Add ice-cold CER I to the cell pellet (Table below). Proceed to Cytoplasmic 
and Nuclear Protein Extraction, using the reagent volumes indicated in Table 
below. 
(4) Vortex the tube vigorously on the highest setting for 15 sec to fully suspend 
the cell pellet.  
(5) Incubate the tube on ice for 10 minutes. 
(6) Add ice-cold CER II to the tube. 
(7) Vortex the tube for 5 sec on the highest setting. 
(8) Incubate tube on ice for 1 min. 
(9) Vortex the tube for 5 sec on the highest setting.  
(10) Centrifuge at 16,000 X g at 4° C for 5 min  
(11) Immediately transfer the supernatant (cytoplasmic extract) to a clean pre-
chilled tube.  
        Note: Keep pellet fraction for nuclear extraction below 
(12) Place this tube on ice until use or storage extracts at -80° C until use. 
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Tissue Weight (mg) 
CER I 
(L) 
CER II 
(L) 
NER 
(L)  
20 200 11 100  
40 400 22 200  
80 800 44 400  
100 1000 55 500  
 
Note: Scale this protocol depending on the cell pellet volume (Tables above). 
Maintain the volume ratio of CER I:CER II:NER reagents at 200:11:100µL, 
respectively. 
 
Extract nuclear proteins:  
(13) Suspend the insoluble (pellet) fraction, which contains nuclei, in ice-cold 
NER.  
(14) Vortex on the highest setting for 15 seconds. Place the sample on ice and 
continue vortexing for 15 seconds every 10 minutes, for a total of 40 minutes.  
(15) Centrifuge at 16,000 X g at 4° C for 10 min.  
(16) Immediately transfer the supernatant (nuclear extract) fraction to a clean pre-
chilled 1.7 mL eppy tube. Place on ice.  
(17) Store extracts at -80° C until use. 
Note: Extracts obtained with this product generally have less than 10% 
contamination between nuclear and cytoplasmic fractions, which is sufficient 
purity for most experiments involving nuclear extracts. 
 
References:  
Calviello G, Resci F, Serini S, Piccioni E, Toesca A, Boninsegna A, Monego G, 
Ranelletti FO, Palozza P. (2007) Docosahexaenoic acid induces proteasome-
dependent degradation of beta-catenin, down-regulation of survivin and apoptosis 
in human colorectal cancer cells not expressing COX-2. Carcinogenesis. 
28(6):1202-1209.  
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APPENDIX X 
COOMASSIE PROTEIN ASSAY 
 
Purpose: To determine the protein concentration of samples. 
 
Materials: 
Homogenization buffer (whichever was used to collect samples), EIA/RIA clear 
polystyrene 96-well plate (Corning #9017), Coomassie Plus assay reagent 
(ThermoFisher #23238), Disposable borosilicate glass tubes (VWR #47729-572) 
 
Procedure: 
(1) Use this assay with homogenization buffer (HB) used to collect the total cell 
lysate (TCL). 
(2) Before beginning, turn on SpectroMax and prepare a template. 
(3) Prepare samples and standards in glass tubes by mixing the amounts of 
standard/sample, water, HB, and reagent listed below. Make triplicates of all 
samples and standards. 
(4) After adding everything to each tube, vortex tubes for 3 sec and transfer 300 
mL of standard/sample to the designated well on the 96-well plate. 
(5) Immediately after adding all standard and samples to the plate, bring to the 
SpectroMax plate reader and read at 595 nm. 
 
Standard curve 
(g protein) 
0.25 g/L 
BSA  
1 g/L 
BSA  
2 g/L 
BSA  
dH2O HB Reagent 
Well 
position 
0 0     497.5 2.5 500 A1-A3 
0.5 2     495.5 2.5 500 B1-B3 
1 4     493.5 2.5 500 C1-C3 
2   2   495.5 2.5 500 D1-D3 
4   4   493.5 2.5 500 E1-E3 
10   10   487.5 2.5 500 F1-F3 
20     10 487.5 2.5 500 G1-G3 
Samples: 2.5 L sample + 497.5 L dH2O + 500 L Reagent 
References:  
Turk HF, Barhoumi R, Chapkin RS. (2012) Alteration of EGFR spatiotemporal 
dynamics suppresses signal transduction. PLoS One. 2012;7(6):e39682. 
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APPENDIX Y  
WESTERN BLOTTING 
 
Purpose: To measure the amount of total or phosphorylated proteins in cell 
lysates. 
 
Materials: Protein loading buffer (Tribioscience, TBS5014), Protein marker 
(Invitrogen, LC5602), 4-12% pre-made gel (Expedeon, NXG41212), running 
buffer (RunBlue, NXB60500), a pair of forceps, a tray for transfer, transfer buffer 
(VWR, 0783-5L), methanol (Fisher, A4333P-4), 0.45 m PVDF membrane 
(millipore, IPVH00020),  filter paper (MIDSCI, 6MW-2020), stir bar, instant dry milk 
powder, β-catenin antibody (BD, 610154), β-actin (AbCam, Ab8227), horseradish 
peroxidase labeled Goat anti-rabbit conjugated (HRP) IgG (H+L) (SeraCare, 074-
1516), horseradish peroxidase labeled Goat anti-mouse conjugated (HRP) IgG 
(H+L) (SeraCare, 074-1806), SuperSignalWestFemtoTrial kit (ThermoFisher, 
34094). 
 
Preparation: 
(1) Thaw samples on ice. 
(2) Label 0.6 mL eppy tubes. 
(3) Turn heating block on and set temperature to 98° C. 
(4) Prepare the western template sheet. 
(5) Cut PVDF membrane and filter papers ready. 
 
Procedure: 
Sample preparation 
(1) Thaw the samples on ice while you turn on the heating block and set the 
temperature to 98°C (takes about 15 min). 
(2) Dye used for the sample dilution is 5X Pyronin. Use 1X of the dye based on 
the total volume of sample required (usually 25 mL total). 
(3) With the aid of western template sheet make the necessary dilution (if 
required) and add the calculated amount of dye and water to the samples 
and standard. 
(4) Quick spin. 
(5) Boil the samples for 5~10 min depending on the volume of the samples (25 
mL volume boil for 10 min). Do not boil the marker. 
(6) Quick- spin of the samples on the tabletop. 
 
Gel unit set up 
(1) Take the pre-made gel (usually 4~20%) and carefully rip off and discard the 
white tape and the comb. Mark the lanes on the plate. 
(2) Attach the gel to the gel rack align 3rd with the lower gasket and clamp the 
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unit. (Note that the red clip should have the broad end facing you, broad ends 
face outside on all 4 clips).  Either run a gel on each side or attach the white 
space holder on the empty side. 
(3) Pour running buffer to fill the stand and the trough up to the top mark. 
(4) Use gel-loading tips (or 10 mL XL tips) and load the complete sample volume. 
(5) Close the unit with the lid and check the leads and make sure black-to-black 
and red-to-red. 
(6) In the cold room run the gel at 125 V for as long as needed.  Check after 10 
minutes to make sure it is running. 
(7) After about 1 h check every 15 min. 
(8) Stop the gel when it has run as far as needed. 
 
Gel transfer 
(1) Crack open the plate with a scalpel between the markings on the plate all 
around by keeping the large side of the gel down. 
(2) Cut the gel just above the bottom. 
(3) Carefully separate the gel from the plate and cut the gel at lane one to identify 
the side (left end). 
(4) Take the gel transfer unit in a staining tray and pour transfer buffer into it and 
the trough.  Allow gel to equilibrate in transfer buffer for 15-30 min. Wet 
membrane with methanol then equilibrate in transfer buffer for ~5 min. 
(5) Take the cassette and lay it open. 
(6) Put a sponge on the black side of the cassette and place a filter paper on top 
of it. 
(7) Pour transfer buffer to keep it wet. 
(8) Take the gel plate out of the running through and transfer the running buffer 
into the bottle for reuse. 
(9) Place the gel on the filter paper with lane one on the right (protein side facing 
the membrane. 
(10) Cut the right hand top corner of the membrane to identify the side. 
(11) Place the membrane on the gel and place the other filter paper on the 
membrane. Now, use a roller on the filter paper to eliminate any air bubbles 
in between. 
(12) Place the sponge and close the white side of the cassette and clip it. 
(13) Place the cassette in the transfer unit with the hinges facing the top and black 
side facing back. 
(14) Put a stir bar into the transfer trough. 
(15) Fill the trough with transfer buffer just enough to cover the hinges of the 
cassette. Check the terminals black to black correspond. 
(16) Place it on the cold room stir plate. 
(17) Connect black-to-black and red-to-red and set current to 400 milliamps and 
let it transfer for at least 90 min. 
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Blocking 
(1) At the end of 90 min- make 4% nonfat dry milk/ PBST in a 50 mL tube (to 30 
mL of PBST and add 1.2 g of pre-weighted milk powder). Mix gently by 
inverting.  If 5% BSA is required, add 1.5 g IgG free BSA to 30 mL PBST. 
(2) Pour the milk into a dish and keep ready to transfer the membrane into it. 
(3) After the transfer is complete- open the gel unit and transfer the transfer buffer 
into the bottle. 
(4) Use a pair of forceps to take the membrane and place the membrane into the 
milk dish (with the side facing gel-protein side now facing top) 
(5) Place it on the shaker for 1 hr at room temperature. 
 
Primary antibody 
(1) Take a dish with 1.2 gm dry milk powder and 30 mL PBST. Mix and pour into 
a new dish. 
(2) Transfer the membrane from the blocking buffer into the dish with fresh milk. 
(3) Now, add the appropriate volume of the primary antibody (based on the 
dilution and add it into the dish). 
(4) Close the lid of the dish and shake it gently on the cold room shaker 
overnight. 
 
Washing 
(1) The next day take the membrane and give a quick wash with PBST. 
(2) Then replace the membrane in fresh PBST in the dish and keep on the 
shaker at room temp for 10 min. Let it shake vigorously. 
(3) Repeat the wash 2 times at 5-10 min interval. 
 
Secondary antibody 
(4) Make 30 mL milk/ PBST and pour into the dish after the second wash. 
(5) Add the required volume of secondary antibody based on the dilution. 
(6) Set on shaker for 1 hr at room temperature. 
(7) Repeat washing with PBST 3 times. 
(8) While the 1 wash of 2° antibody is going on turn on the imager and set focus. 
 
Developing 
(9) Cut an acetate sheet into 2 halves and remove the black sheet. 
(10) Mix equal parts of chemiluminescent super signal reagent A and reagent B 
in an eppy tube. Mix gently by inversion. 
(11) Transfer the membrane between the layers of the acetate sheet and evenly 
disperse the developing solution across on the top of the membrane. 
(12) Slowly close the top layer so that the solution gets evenly distributed on the 
membrane. 
(13) Expose for 5 minutes and then transfer the membrane on to the clean acetate 
sheet. 
(14) Transfer it into the BioRad imager for imaging immediately. 
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Imaging 
(15) Turn on switch and make sure the lever on the hood is at 
chemiluminescence. 
(16) Select QuantityOne on program on desktop. 
(17) Select scanner – click on chemidoc.xrs. 
(18) Step 1- option is chemiluminescences. 
(19) Step 2 – live focus. Focus with a printed sheet and set the iris as you need 
for brightness. Zoom and focus, as you need for clarification. 
(20) Freeze. Put the gel in the imager and zoom and freeze again. Close the door. 
(21) Click on live acquire. 
(22) Set the Starting exposure time, Total exposure time, and Number of 
exposures as needed. 
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